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Abstract: Strategic decisions to reorient population-based prevention and clinic- and hospital-based 
care policies toward noncommunicable diseases (NCDs)
1
 will enable healthier aging and reduce loss of 
productivity among the working-age population in Sri Lanka. This report aims to stimulate policy 
dialogue for NCDs and to provide an evidence base to facilitate decisions. Its focus is mainly on chronic 
NCDs—that is, cardiovascular disease (CVD), diabetes, and asthma/chronic obstructive pulmonary 
disease (COPD), and to a lesser extent cancer—and their major modifiable risk factors (tobacco use, 
unhealthy diet, lack of exercise, and harmful alcohol use). This is not to detract, though, from the 
importance of injuries and mental health since both are major issues that carry a huge burden, as 
supported by evidence in this report.  
 
Sri Lanka, now having transitioned from a low income country to a middle income country, has a life 
expectancy for its citizens of 71 years, and is in the advanced stages of a demographic transition. The 
proportion of people 60 years and older is likely to more than double by 2040, to just above 24 percent 
However, these gains have not been even. Male life expectancy gains have stagnated since 1970, while 
those for females have continued. In addition, an epidemiologic transition is shifting the disease pattern 
from maternal and child health and infectious diseases towards NCDs, which now account for nearly 
90 percent of the disease burden. Because NCDs are more common with aging—but not inevitable—
timely actions now could trigger many future benefits such as healthy aging, lower disability, and longer, 
more productive lives.  
During the past half-century the proportion of deaths due to circulatory disease (such as heart disease and 
stroke) has increased from 3 percent to 24 percent, while that due to infectious diseases has decreased 
from 42 percent to 20 percent. Mortality rates from NCDs are currently 20–50 percent higher in Sri Lanka 
than in developed countries. The NCD burden is not equally distributed among the rich and the poor. In 
Sri Lanka the pattern is more complex and changing. Deaths from heart disease are higher among the rich 
while those from asthma are higher among the poor.  
In the public sector, NCDs are largely managed by specialist clinics as long-term outpatients and as 
inpatients in higher-level (secondary or tertiary) facilities. Primary health care facilities are not expected 
to initiate management of chronic NCDs, but only provide follow-up care in some lower-level hospitals. 
In 2008, bed-occupancy rates were nearly 85 percent in higher-level facilities and below 50 percent in 
lower-level facilities. In terms of inpatient morbidity among all admissions, in 2008, chronic NCDs 
accounted for 24 percent and injuries for 18 percent, while infectious diseases accounted for 26 percent, 
maternal and child health conditions for 12 percent, and other causes for 20 percent of the total. Specialist 
clinics in secondary and tertiary facilities manage 65 percent of the chronic NCDs in overcrowded clinics. 
                                                     
 
1  NCDs are defined by the World Health Organization (WHO) to include chronic diseases, principally cardiovascular disease, 
diabetes, cancer, and asthma/chronic obstructive pulmonary disease (COPD), in addition to injuries and mental illness. 
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Primary care facilities manage follow-up for approximately 33 percent of the acute NCDs. About 60% of 
the asthma is managed in public facilities.  
Diagnostic testing and essential medicines for NCDs are limited. Essential clinical investigation and 
medical equipment necessary to diagnose and manage NCDs are frequently unavailable at primary and 
secondary care levels and low availability of essential medications for treating NCDs is a problem.  
Health information systems are reasonably well developed but suffer from some major limitations. Both 
inpatient and outpatient data lack key information on patient characteristics and diagnosis, limiting data 
usefulness for assessment and planning. Also, a surveillance system for NCDs and their risk factors is 
missing. These systems are critical for planning and policy development.  
Owing to the current system‘s organization, a substantial proportion of care for NCDs is delivered in the 
private sector where patients pay for almost all their treatment costs. In the public sector, patients receive 
clinic visits without paying fees but frequently obtain prescribed medicines and laboratory tests from the 
private sector where they bear the costs. Treatment of cancer and acute myocardial infarction is mostly or 
predominantly publicly financed, while expenditures for chronic NCDs, such as diabetes, asthma, and 
other types of ischemic heart disease (IHD), are predominantly paid for out of pocket.  
Several major areas for policies and actions emerged from the analysis of Sri Lanka‘s health sector 
organization and capacity as well as its NCD orientation. Some areas are not specific to NCDs but, rather, 
will strengthen the health sector generally while leading to better NCD prevention and control.  These 
areas include: (i) increasing financial resources for NCD prevention and control, (ii) increasing access to 
NCD drugs, especially for the poor, (iii) addressing social determinants, (iv) focusing on specific NCDs, 
(v) addressing undernutrition and overnutrition, (vi) creating an intensified national NCD program,  
strengthening and reorganizing NCD prevention and curative care services, (vii) moving services closer to 
clients and improving efficiency, (viii) further decentralizing and devolving health service delivery, (ix) 
human resource development for NCD prevention and control, (x) creating a national NCD surveillance 
system, (xi) developing public–private partnerships and aligning service delivery  
Keywords: chronic non-communicable diseases, demographic transition, epidemiologic transition, 
health services utilization, out-of pocket spending or health, policy options and actions 
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Preface 
To achieve healthy aging during its rapid demographic transition, Sri Lanka will need to effectively tackle 
noncommunicable diseases. The rationale for this report is that strategic decisions to reorient population-
based prevention and clinic- and hospital-based care policies toward noncommunicable diseases will 
enable healthier aging.  
The main target readership comprises policy makers in the governments of Sri Lanka and the South Asia 
region more widely, both inside and outside the health sector. The report will also be useful for 
professionals working in development in South Asia and elsewhere.  
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Prevention and Control of Selected Chronic NCDs in Sri Lanka: 
Policy Options and Actions 
Executive Summary 
Introduction 
Strategic decisions to reorient population-based prevention and clinic- and hospital-based care policies 
toward noncommunicable diseases (NCDs)
2
 will enable healthier aging and reduce loss of productivity 
among the working-age population in Sri Lanka. This report aims to stimulate policy dialogue for NCDs 
and to provide an evidence base to facilitate decisions. Its focus is mainly on chronic NCDs—that is, 
cardiovascular disease (CVD), diabetes, and asthma/chronic obstructive pulmonary disease (COPD), and 
to a lesser extent cancer—and their major modifiable risk factors (tobacco use, unhealthy diet, lack of 
exercise, and harmful alcohol use). This is because global and national policies target these diseases and 
risk factors because the burden from them is large and the evidence base to reduce their impact tends to 
be stronger than for other NCDs. This is not to detract, though, from the importance of injuries and 
mental health since both are major issues that carry a huge burden, as supported by evidence in this 
report.  
Current and Future Disease Burdens 
Demographic (aging) and epidemiologic (disease pattern) transitions are under way 
Sri Lanka, now having transitioned from a low income country to a middle income country, has a life 
expectancy for its citizens of 71 years, and is in the advanced stages of a demographic transition. The 
proportion of people 60 years and older is likely to more than double by 2040 to just above 24 percent 
(Figure 1).
3
 However, these gains have not been even. Male life expectancy gains have stagnated since 
1970, while those for females have continued.  
 
 
 
 
 
 
 
 
 
 
                                                     
 
2  NCDs are defined by the World Health Organization (WHO) to include chronic diseases, principally cardiovascular disease, 
diabetes, cancer, and asthma/chronic obstructive pulmonary disease (COPD), in addition to injuries and mental illness. 
3  See the main text for sources to this executive summary. 
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Figure 1 Proportion of people in older (≥60 years) age groups, Sri Lanka, 2001–2100 
 
Source: De Silva 2007.  
 
In addition, the epidemiologic transition is shifting the disease pattern from maternal and child health and 
infectious diseases to NCDs, which now account for nearly 90 percent of the disease burden (Figure 2). 
Because NCDs are more common with aging—but not inevitable—timely actions now could trigger 
many future benefits such as healthy aging, lower disability, and longer, more productive lives. NCDs are 
often associated with changes in lifestyle related to urbanization, improvements in economic status, and 
exposure to undernutrition early in life.  
Figure 2 Disease burden for main health conditions, South Asia, Sri Lanka, and high-income 
countries, 2004  
 
Source: WHO 2004a. 
Note: Burden is in disability adjusted life years (DALYs) which account for premature death and for years 
lived with significant disability. 
 
The NCD burden is rising 
During the past half-century the proportion of deaths due to circulatory disease (such as heart disease and 
stroke) has increased from 3 percent to 24 percent while that due to infectious diseases has decreased 
from 42 percent to 20 percent (Figure 3). Mortality rates from NCDs are currently 20–50 percent higher 
in Sri Lanka than in developed countries. The disparities are most substantial for CVD and asthma. This 
is because in developed countries, mortality rates from NCDs, especially CVD, have fallen significantly 
during the past three decades, but not in Sri Lanka.  
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Figure 3 Trend of proportion of deaths from major causes, Sri Lanka, 1945–2003 
 
Sources: Analysis by authors of data of the Registrar General‘s Department for 2000 and 2003; UN ESCAP (1976); Department 
of Census and Statistics (1987). 
Note: Infectious diseases include infectious, parasitic, and respiratory diseases, dysentery (all forms), tuberculosis of the 
respiratory system, typhoid, malaria, pneumonia, and bronchitis. Maternal and child health include anemia, and complications of 
pregnancy and child-birth. Injuries include violent or accidental deaths. Ill-defined deaths are not classified to any specific cause. 
 
The NCD burden is shifting toward the poor 
The NCD burden is not equally distributed among the rich and the poor. In high- and middle-income 
countries chronic NCDs tend to be concentrated in the poor. However, in Sri Lanka the pattern is more 
complex and changing. Deaths from heart disease are higher among the rich while those from asthma are 
higher among the poor (Figure 4). Other countries in the region with similar demographics to Sri Lanka‘s, 
such as Maldives, are seeing this pattern change with all chronic NCDs concentrating in the poor. The 
main reasons for chronic NCDs concentrating in the poor in high-income countries are their lesser uptake 
of healthy lifestyles and lesser access to health services.  
Figure 4 Death rates for heart disease and asthma by wealth quintiles and sex, Sri Lanka, 1999–
2003 
Ischemic heart disease (deaths per 100,000)    Asthma (deaths per 100,000)  
 
 
Source: Institute for Health Policy 2010. 
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Most NCDs and their risk factors are expected to increase  
Compared to developed countries, NCD risk factors in Sri Lanka are lower for some diseases (for 
example, hypertension, obesity, tobacco, physical inactivity, and alcohol use) but higher for others (such 
as dyslipidemias [high cholesterol]). Some risk factor levels can be expected to increase in the coming 
years, especially those associated with urbanization and development gains (for example, obesity and 
physical inactivity).  
Health services for chronic NCDs are mostly delivered at higher-level facilities  
Health service delivery for chronic NCDs has developed a specific pattern. In the public sector, NCDs are 
largely managed by specialist clinics as long-term outpatients and as inpatients in higher-level (secondary 
or tertiary) facilities. Primary health care facilities are not expected to initiate management of chronic 
NCDs but only provide follow-up care in some lower-level hospitals. A formal referral system is not in 
place and government policy allows self-referral on demand to secondary and tertiary facilities. Thus 
patients often use these higher-level facilities, aware that primary facilities lack the capacity to manage 
NCDs in terms of their ability to perform clinical investigations and provide all medications. In addition, 
after-hours patients seeking care are typically admitted to hospital when it might not be warranted.  
These patterns are confirmed with public sector data. In 2008 bed-occupancy rates were nearly 85 percent 
in higher-level facilities and below 50 percent in lower-level facilities (Figure 5). In terms of inpatient 
morbidity among all admissions, in 2008 chronic NCDs accounted for 24 percent and injuries for 
18 percent, while infectious diseases accounted for 26 percent, maternal and child health conditions for 
12 percent, and other causes for 20 percent of the total. Specialist clinics in secondary and tertiary 
facilities manage 65 percent of the chronic NCDs in overcrowded clinics. Primary care facilities manage 
follow-up for approximately 33 percent of the acute NCDs. About 60% of the asthma is managed in 
public facilities.  
Figure 5 Bed-occupancy rates and the proportion of total clinic visits by level of facility, Sri Lanka, 
2008 
 
Source: Computed by World Bank based on Annual Health Statistics 2008 provisional data and 2007 data from the Medical 
Statistics Unit. 
 
Diagnostic testing and essential medicines for NCDs are limited 
Several capacity features that are important for NCD prevention and control have gaps. Essential clinical 
investigation and medical equipment necessary to diagnose and manage NCDs are frequently unavailable 
at primary and secondary care levels. In addition, low availability of essential medications for treating 
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NCDs is a problem (Figure 6). Lower-level (primary care) facilities
4
 such as divisional hospitals often not 
have the full spectrum of medicines for heart disease, asthma, cancer, and diabetes patients. These 
patterns are similar for other essential chronic NCD medicines, and more recent assessment (in 2009) 
finds little change.  
Figure 6 Availability of essential medicines for ischemic heart disease at different facility levels, Sri 
Lanka, 2005 
 
Source: Institute for Health Policy/Ministry of Health Public Facility Survey 2005.  
Note: Estimates are for the districts of Colombo, Badulla, and Matale. ―Availability‖ means at any time during the year.  
MOOH = Medical officer of health unit; RH = rural hospital; CDMH = central dispensary maternal home; CD = central 
dispensary; PU = peripheral unit; DGH = district general hospital; Base = base hospital. 
 
 
The short supply of key medications and its impact is confirmed by the overall rates of essential NCD 
medicine use in Sri Lanka being below the range among Organisation for Economic Co-operation and 
Development (OECD) countries with comparable NCD disease burden patterns (Figure 7). One 
explanation is the low volumes of essential NCD medicines available in the public sector. Other possible 
explanations include provider practice patterns and patients not following their treatments plans.  
Figure 7 Consumption of selected NCD medicines in defined daily dose units, Sri Lanka, 2008 and 
OECD countries, 2006 
 
                                                     
 
4 This pattern is due in part to primary care protocols and is worsened with stock outs.   
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Source: OECD countries for 2006 from OECD Health Data 2008, and Sri Lanka for 2008 computed from data provided by 
MOH and IMS-Health (Sri Lanka). 
 
Health information systems and surveillance for NCDs are incomplete  
Health information systems are reasonably well developed but suffer from some major limitations. Both 
inpatient and outpatient data lack key information on patient characteristics and diagnosis, limiting data 
usefulness for assessment and planning. Also, a surveillance system for NCDs and their risk factors is 
missing. These systems are critical for planning and policy development.  
NCD care depends heavily on out-of-pocket spending 
Owing to the current system‘s organization, a substantial proportion of care for NCDs is delivered in the 
private sector. In the private sector, patients pay for almost all their treatment costs. In the public sector, 
patients receive clinic visits without paying fees but frequently obtain prescribed medicines and 
laboratory tests from the private sector where they bear the costs. However, for emergency inpatient care 
of NCDs and for some illnesses, such as cancer, most patients rely on the public sector. Treatment of 
cancer and acute myocardial infarction is mostly or predominantly publicly financed, while expenditures 
for chronic NCDs, such as diabetes, asthma, and other types of ischemic heart disease (IHD), are 
predominantly paid for out of pocket (Figure 8).  
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Figure 8 Expenditures on major NCDs, by public and private sources (%), Sri Lanka, 2005 
 
Source: Computed from estimates of the Institute for Health Policy Sri Lanka Disease-specific Accounts Project in 2005. 
 
Because of the government‘s ability to purchase most medicines at prices far lower than the whole price 
paid by the private sector, the cost to the public sector of increasing the supply of most NCD medicines to 
80 percent of the median level of NCD drugs used in OECD countries would be cost effective and might 
be financially feasible. Such an increase would also be pro-poor, as the marginal benefits would be 
greatest for those in the poorest households.  
Patterns of service utilization show that much NCD care is based in higher-level facilities and that, in 
addition to limited availability of medications, medication use also appears low, and financing depends 
largely on out-of-pocket expenses and puts all people potentially, especially the poor, at great financial 
risk.  
Sector Characteristics: The Tools to Respond 
The health infrastructure for preventive and curative care is solid 
Tackling NCDs will require adjustment in the country‘s existing health infrastructure, which has achieved 
remarkable health gains with modest health spending. As a low-income country that has recently 
transitioned to low middle-income status, its key indicators for maternal and child health are better than 
many high- middle-income countries and match those in some high-income countries. Long-standing 
national social policies for education and health, alongside modest public resource investments in key 
strategic areas, largely account for this position.  
Such health gains have hinged on an educated population and on two key health sector attributes. First, a 
well-developed preventive health system tooled to provide antenatal, prenatal, and postnatal care, 
immunizations, infectious disease prevention, and health promotion. Second, a curative care system that 
has geographically well-distributed facilities to improve access, and that has a major focus on key outputs 
including universal institutionalized deliveries, access to timely outpatient and inpatient services, and 
reduction of equity issues. 
On the other side of the coin, however, human resources are inequitably distributed, largely because 
human resource distribution has historically been based on patient demand created by facility expansion, 
leading to unplanned expansion of postings. In addition, NCD training is yet to be institutionalized, while 
clinical guidelines for some selected NCDs are available but not widely disseminated. Finally, with the 
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exception of tobacco control, population-level prevention programs to promote healthy lifestyles are 
limited.  
Developed-country experiences lend insight into Sri Lanka’s NCD strategies  
Developed countries provide an evidence base for CVD reduction at both the population level—by 
reducing tobacco use and improving diet (such as reductions in salt, trans fats, and saturated fats)—and at 
the primary care level—through treatment of conditions with medications (such as hypertension and 
cholesterol). High-income countries have developed several service delivery models for NCDs that focus 
on efficiently providing primary care, and, even though these structures vary, some common lessons 
emerge. For example, most care delivery models in developed countries have multi-professional teams of 
physicians, nurses, and other health professionals who are responsible for delivering primary care, 
including most routine curative care. They also have patients registered with a specific primary care 
facility. Additionally, primary health care provision is closely coordinated and integrated with the 
delivery of hospital and secondary care services.  
Less is known of middle-income countries and their service delivery models. In general they focus on 
primary care systems. Some early models from Malaysia and Thailand are showing promise.  
Some policy simulations for heart disease suggest that interventions can reduce deaths 
significantly 
Because of the importance of CVD among NCDs, outcomes of various policy option scenarios to address 
the disease were simulated using developed-country assumptions. Clinic-based interventions targeted at 
high-risk groups, alongside aggressive population-based health promotion approaches, could reduce 10-
year cardiovascular deaths in Sri Lanka by nearly 25 percent, assuming ideal implementation (Figure 9).  
Figure 9 Deaths avoided at 10 years under different intervention strategies for heart disease among 
Sri Lankans, 18–74 years 
 
 
Source: Institute for Health Policy 2010. The Framingham cardiovascular risk prediction equation and data from Katulanda et al. 
(2008) were used for the calculation. 
 
Policies need to address both treatment of those affected and reductions in risk factors 
From the overall policy standpoint, the developed-country experience with CVD highlights opportunities 
for improving the Sri Lankan trends, while the expected shift in burden toward the poor, similar to that in 
other countries, highlights the need for future pro-poor health policies to address NCDs. Policies have to 
address both NCDs and their risk factors in order to have the best returns.  
Intervention strategy 
(Number of avoided deaths) 
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Policy Options and Actions  
Several major areas for policies and actions emerged from our analysis of Sri Lanka‘s health sector 
organization and capacity as well as its NCD orientation. Some areas are not specific to NCDs but, rather, 
will strengthen the health sector generally while leading to better NCD prevention and control.  
Increasing Financial Resources for NCD Prevention and Control  
Factors that will drive increased future health expenditures in general and NCD interventions in particular 
are:  
 the NCD burden in Sri Lanka, which is already at comparable levels to those in developed 
countries, is set to increase further as the population ages;  
 current system capacity needs significant strengthening to meet the growing NCD burden;  
 the population expects the government to ensure the provision of high-quality clinic-based 
curative care services through the public sector delivery system, free at the point of 
delivery, and these expectations will only rise as Sri Lanka‘s economic status improves;  
 the cost of addressing the NCD challenges will be much higher than those of infectious 
diseases and maternal and child health issues; and  
 overall, total and government health spending in Sri Lanka is still at the lower end of the 
international spectrum, given its level of national income.  
In addition to clinic-based services, population-level risk-factor reduction efforts will also increase 
resource needs. Such efforts will need to be financed from public funds because they deliver public goods 
or positive externalities, or both.  
A financing policy option package for Sri Lanka should consider efforts to:  
 mobilize greater resources for NCD control and prevention (from both public and private 
sources) which may require expanding public financing and/or exploring alternative 
sources;  
 establish mechanisms for reducing out-of-pocket contributions from the poorer segments 
of the population;  
 look for ways to increase efficiencies in the public sector,  for example, bulk purchase 
negotiations by the government on behalf of the population; and 
 ensure that additional allocation for NCD does not come at the expense of action to 
control infectious diseases or to provide maternal and child health services. 
Total and public health expenditures are relatively low in Sri Lanka. Public health expenditures have not 
kept up with needs and demands, and out-of-pocket spending has been increasing as a share of total 
spending.  NCDs will increase and accelerate the demands on the system, along with other factors that 
will push up future health care costs. The question to be asked at this time is: how will the needs be met? 
Raising tax revenues commensurate with increasing demands might be the best way forward, given the 
growing proportion of out-of-pocket contributions to total health expenditures and the context of 
consecutive years with budget deficits. The low revenue tax-based financing may be unable to cope with 
future increased health care costs. The government may need to consider securing alternative sources of 
financing.. 
Increasing Access to NCD Drugs, Especially for the Poor 
It is evident that essential drugs for NCD management are underutilized in Sri Lanka. In addition, low 
availability of such drugs has been found to be more pressing at the primary care level than secondary and 
tertiary levels, at least partially contributing to the inappropriate use of higher-level facilities by patients 
who could have been managed at lower-level facilities. To ensure adequate supply of essential NCD 
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drugs, the most appropriate approach might be through public sector procurement of these drugs, due to 
economies of scale.  
Increasing the drug supply through public financing and/or procurement is a feasible option. It may be 
financially feasible in Sri Lanka to increase the level of drugs to 80 percent of the utilization rates in 
OECD countries through public financing for two reasons. First, public sector unit prices for key NCD 
drugs are a small fraction of private sector  wholesale prices. . The private sector costs are as much as four 
times that of the public sector. Second, the overall cost of these drugs is a small fraction of total public 
spending on health. Raising supply levels of these essential NCD medicines, excluding statins, would 
have represented less than 1 percent of total public sector health expenditures in 2008.  
If the supply of drugs in the public sector remains inadequate, then the government many need to consider 
policies to protect poor segments of the population who may underutilize drugs because they can not 
afford to pay for them out of pocket.  
Addressing Social Determinants 
The causative and risk-enhancing determinants of most NCDs include social factors. Educational status, 
income level, gender issues, peer pressures impinging on lifestyles (such as smoking, harmful alcohol 
use, unhealthy diet, and lack of exercise—key risk factors), occupational exposure to certain carcinogens, 
and environmental health are just some examples illustrating the importance of policies and actions in 
nonhealth sectors to national efforts to prevent and control NCDs.  
Successful prevention of NCDs therefore calls for well-coordinated intersectoral action, but such action 
needs to be initiated and led by the Ministry of Health. Institutional mechanisms need to be created to 
involve various nonhealth ministries in a multi-disciplinary effort. Examples of nonhealth ministries are 
Education, Social Services, Agriculture, Environment, Labor, Commerce, Law & Justice, Urban 
Development, Home Affairs (Police) and, of course, Finance and Planning.  
Because the prevalence of NCDs increases with age and the diseases have important long-term care 
implications beyond medical treatment, there is a critical role for the Ministry of Social Services in 
developing services for the elderly, with special attention to those with NCDs. Policies targeting 
workplaces with a view to making them conducive to healthy lifestyles should be developed and 
implemented. Finally, the health sector itself should design and implement effective communication 
campaigns aimed at changing population behaviors with respect to the key risk factors. 
Focusing on Specific NCDs  
Because NCDs are such a broad category of diseases, this report adopts a strategic approach to focus on 
selected diseases, keeping in mind their disease burden and the availability of cost-effective interventions. 
As policies and efforts for these diseases are refined, the knowledge and experience gained in both public 
and private sectors and among all the major stakeholders will be useful for addressing other NCD areas. 
The risks of expanding or of going too broad, too quickly are the dilution of strategic efforts and 
nonsustainability. 
Addressing Undernutrition as well as Overnutrition 
There is a growing body of evidence that low birth weight and childhood undernutrition increase the risk 
of NCDs at a later age. Reducing childhood and maternal undernutrition is an unfinished agenda for Sri 
Lanka—appropriate policies and programs are urgently needed. Community-based nutrition interventions 
are required, targeting vulnerable population groups, such as mothers and children in the tea estate sector 
and in certain rural districts. The targeting needs both to be at the right age group (conception to 24 
months, which is generally described as the ―window of opportunity‖ for nutrition interventions), and to 
adopt a life-cycle approach, that is, include adolescent girls and lactating women. Such interventions 
should focus on household behaviors related to eating, feeding, and caring. 
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At the other end of the spectrum, overweight and obesity are growing public health problems, causing 
another sort of ―double burden,‖ in addition to the double burden of noncommunicable and infectious 
diseases. Both population-based and personal interventions aimed at improving dietary practices would be 
similar to those targeting the other key NCD risk factors. 
Creating an Intensified National NCD Program  
National NCD prevention and control efforts are spread across three key directorates (for NCDs, cancer, 
and mental health), yet they need support from many other directorates. An intensified national NCD 
program with the resources and authority to make it effective—working through existing systems and 
structures rather than creating a vertical parallel program—is an option for developing, organizing, and 
implementing national prevention and control policy.  
Strengthening and Reorganizing NCD Prevention and Curative Care Services 
The emergence of NCDs as a major health problem may need fundamental reorientation in the way that 
primary health care is delivered. Such care comprises public services that include preventive services and 
a separate stream of curative services, and private physicians who work independently of the public 
sector. Organized this way, primary health care is poorly placed to deliver primary care for NCDs for the 
following reasons: preventive efforts such as individual counseling on smoking, diet, or exercise tend to 
be neglected by the purely curative-oriented providers, especially in the private sector; Medical Officer of 
Health activities on prevention are difficult to coordinate with the independent curative services; and 
private practitioners, being outside the purview of the public system, do not report data on patients they 
see, and are extremely difficult to regulate on quality.  
Expansion and improvement of the curative services to provide better quality care must be an integral 
component of a successful response to NCDs. Currently, apart from specialist clinics, the delivery system 
is not set up for providing organized, high-quality, continuing care for NCD patients. Outpatient clinics 
have no system to ensure long-term follow-up management for many NCD patients. Medical Officer of 
Health units focus on preventive care for maternal and child health and infectious disease prevention, and 
have the potential to provide population-level outreach prevention activities for NCDs. Primary care 
facilities lack access to all the necessary NCD drugs and required laboratory facilities, as well as 
experience and training in NCD case management to provide high-quality NCD care.  
The curative care response to NCDs should prioritize the expansion of treatment with cheap and cost-
effective drug treatment of NCDs, in particular for CVD and asthma. However, drug availability needs to 
be closely linked with the service delivery system. Even if all NCD medicines are made available, the 
current primary care system probably lacks the capacity to assess patients adequately with routine follow-
up tests, to provide long-term follow-up with appropriate calibration of treatment schedules, and to 
coordinate with the treatment of other chronic conditions. The use of specialist clinics based in higher-
level hospitals likely makes expansion with a specialist-led care model unfeasible, and will require 
expansion of the primary care system, with specialists shifting their role to providing backup for more 
difficult cases, as well as supporting initial assessment of new patients.  
Moving Services Closer to Clients and Improving Efficiency 
Many of the patients treated at tertiary care facilities could be managed at lower cost in a secondary or 
even primary facility. This would also be more convenient for patients. The fact that they are willing to 
travel longer distances for higher-level facilities shows that the quality difference, perceived or real, is 
significant. Therefore, unless higher-quality care—perceived to be as good as what is offered in a tertiary 
hospital—is provided in secondary and primary facilities (and in the absence of an effective referral 
system or gate-keeping function of primary care providers), this trend cannot be reversed. Once the 
quality improvements are made, in terms of the availability of skills, equipment, and drugs, an education 
campaign needs to be launched to change care-seeking behaviors. 
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Additionally, anecdotal observations indicate that many hospital inpatients could be managed as 
outpatients or clinic patients; the current approach clearly has negative cost implications and results in 
systemic inefficiency. The choice of being admitted to the hospital resides with the doctors. Added to this, 
there has been a policy that prohibits outpatient services after 4 pm, compelling public sector hospitals to 
admit any patient who shows up after that time (for overnight stay) regardless of the clinical need for 
inpatient care. The introduction of emergency treatment units and preliminary care units is addressing this 
practice and improving the quality of care, but these units are not yet available in all facilities. 
After more careful analysis of hospital admission policies, a clear policy on triaging outpatients before 
admission to the ward and emergency care facilities for acute NCDs and acute events for chronic NCDs 
need to be established, a nationwide training program launched for doctors on appropriate practices with 
regard to inpatient admissions and emergency treatment, and an education campaign started to stimulate 
appropriate attitudinal and behavioral changes in the population. 
Further Decentralizing and Devolving Health Service delivery 
Sri Lanka has already seen much decentralization of health services. The central level is vested with 
stewardship functions, such as financing, policy making, planning, coordination, monitoring and 
oversight, standard setting, guidelines development, and a few support functions such as human resources 
and pharmaceuticals. The provinces (and districts under them) are responsible for service delivery with 
the exception of tertiary (teaching) hospitals and a few selected secondary-level hospitals.  
The current system functions relatively smoothly, but lacks an effective referral system. Though this lack 
has other dimensions than decentralization, a seamless referral system may be easier to achieve if all 
service delivery is decentralized, including tertiary hospitals.  
Human Resource Development for NCD Prevention and Control 
A human resource needs assessment of current and future NCD efforts would provide much-needed 
guidance for developing a strategy. Medical, nursing, and other relevant curricula do currently cover the 
various NCDs, but improvements could be made by providing latest knowledge and by emphasizing the 
commonalities of risk factors among several NCDs. Such a more integrated approach could result in 
preventive interventions that can deal with multiple conditions at the same time. In addition, the new 
national clinical standards and guidelines of 2008 include many NCDs, but these are yet to be applied in 
practice. These guidelines need to be institutionalized by integration into training curricula, by in-service 
training for current staff, and by periodic updating and review to assure that the latest information is 
incorporated.  
An aspect of NCD service provision that may need to be included explicitly in medical education and its 
curricula (and subsequent in-service training) is training for decision making on when and where to refer 
cases. Similarly, the proper triaging of patients before admission to the ward also warrants such inclusion.  
Creating a National NCD Surveillance System 
A national NCD surveillance system is needed. Its major elements should include behavior risk factors; 
NCD morbidity; mortality; health services utilization and quality of care (public and private sector); 
special registries (for example, cancer and injury); and the economic burden. In addition, as prevention 
efforts using nonhealth sector policies are developed and implemented (for example, taxation of tobacco, 
and reductions in salt and harmful fats in manufactured foods), surveillance of key indicators outside the 
health sector will be needed (again, on cigarette consumption and on salt and fat content in manufactured 
foods, for example).  
NCD morbidity data from both inpatient and outpatient services are limited. For public inpatients at all 
levels of the public system, although the diagnosis is recorded, individual data with demographic and 
other characteristics are not. For outpatients using public systems, neither diagnosis nor individual 
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demographic data are collected in the returns. In addition, data are not routinely collected on private 
sector health service delivery.  
Mortality will continue to be an important element of surveillance and Sri Lanka has a comprehensive 
system in place, in contrast to many other developing countries. However, areas needing improvement 
include accuracy of recording the cause of death; appropriate coding; and timeliness of the data 
collection, collation, analysis, and report dissemination. Finally, as prevention efforts unfold, 
development of surveillance tools for outside the health sector should be tailored to fit the needs of 
tracking progress and evaluating impacts.  
Public–private Partnerships and Aligning Service Delivery 
The market share of private providers is significant (about 50 percent of ambulatory care and 10 percent 
of inpatient care), almost all of which is financed through out-of-pocket payments. Given this share, as 
well as the cost of NCD care and the need for modern technology, there is an even stronger argument for 
a more proactive policy of public–private sector engagement, both for financing and for provision of 
NCD curative care services.  
Private sector service delivery remains poorly understood and its quality of care delivered is mostly 
uncharacterized. Therefore, the first step in building the platform for effective public–private partnerships 
is to carry out a private health sector assessment, so that public policy makers can understand the 
configuration of the clinics, clientele, costs, and quality of services. The aim of public–private 
partnerships would be to leverage the private sector toward public policy goals.  
Chapter 1: Introduction 
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Chapter 1: Introduction 
Key Messages 
 Using modest levels of health expenditures, Sri Lanka has made substantial gains in 
health. Its key indicators approach those in high-income countries.  
 The country, now transitioned from a low income to middle income  is also in the later 
stages of the demographic and epidemiologic transitions—that is, it is both aging and 
shifting the disease burden from maternal and child health and infectious diseases toward 
noncommunicable diseases (NCDs).
5
  
 Developed countries‘ experience with NCDs has shown that the combination of 
population-based prevention efforts (for example, reducing tobacco use) and basic 
primary care can substantially reduce the disease burden.  
 Because NCDs are such a broad issue, this report focuses on strategic areas where policy 
and actions can have a high impact on NCDs. 
Context 
Sri Lanka, now transitioned from a low income to middle income country had an estimated population of 
20.2 million in 2008. From before the middle of the 20th century, it had invested significant public 
resources into the social sector, with particular emphasis on expanding universal access to education and 
health care through public financing. As a result, literacy rates and access to primary and secondary 
education are high as are use of health services, despite limited national health expenditures compared to 
other countries (Rannan-Eliya and Sikurajapathy, 2008) (Table 1.1). 
Public financing of health care services and education, and investments in a minimum level of food 
security, have been major factors behind a high level of life expectancy and generally good health 
indicators, which are generally better than in other countries at a similar level of development (Table 1.2). 
Gains in maternal and child health and control of vaccine-preventable diseases are impressive. In 
combination with substantial declines in fertility since the 1970s, these advances have led to rapid 
demographic aging (World Bank, 2008). This demographic transition has been accompanied by an 
epidemiologic transition, that is, a growing NCD burden which increasingly outweighs the disease burden 
caused by infectious and maternal and child health issues. In addition to these transitions, nutrition-related 
problems (underweight, anemia) remain and new health issues have emerged, such as dengue and 
leptospirosis. 
                                                     
 
5  Noncommunicable diseases are defined by the World Health Organization (WHO) to include chronic diseases, principally 
cardiovascular disease, diabetes, cancer, and asthma/chronic obstructive pulmonary disease (COPD), in addition to injuries 
and mental illness. Injuries include unintentional injuries such as road traffic crashes, drowning, burns, poisoning, falls, and 
other mechanical injuries (occupational, sports, etc.) and injuries related to mental health such as intentional injuries (suicides, 
violence, etc.) Mental illness includes its prevention and control and can include mental health issues related to alcohol and 
tobacco control. 
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Table 1.1 International comparison of health expenditures, 2008 
Country 
GNI per capita, 
Atlas method 
(current US$) 
Total 
expenditure on 
health as % of 
gross domestic 
product 
General 
government 
expenditure on 
health as % of 
total expenditure 
on health 
General 
government 
expenditure on 
health as % of 
total government 
expenditure 
Per capita total 
expenditure on 
health at average 
exchange rate 
(US$) 
Sri Lanka 1,780 4 43 8 81 
India 1,070 4 28 4 43 
Maldives 3,630 11 70 13 462 
Australia 40,350 9 68 18 4,301 
Chinaa 2,940 4 47 10 142 
Malaysia 6,970 4 44 7 353 
Republic of Korea 21,530 7 55 13 1,255 
Russian Federation 9,620 5 66 10 620 
United Kingdom 45,390 9 83 16 3,924 
United States 47,580 16 47 19 7,536 
Source: Data for GNI per capita are from the World Bank. Health Expenditure data (provisional estimates) are World Bank 
calculations based on data from World Health Organization, National Health Accounts (http://www.who.int/nha/country/en/). 
a. Excluding Hong Kong (China) and Macao Special Administrative Region. 
 
Table 1.2 Health status in selected countries 
Country 
Maternal 
mortality 
ratio (per 
100,000 live 
births), 
2005 
Infant 
mortality 
rate (per 
1,000 live 
births) both 
sexes, 2007 
Total 
fertility rate 
(per 
woman), 
2007 
Malnutrition 
(% of children under 
5 years, 2000–2007) Immunization 
coverage among 
1-year-olds (%), 
measles, 2007 
Population with 
sustainable access 
to improved 
drinking water 
sources (%) rural, 
2006 
Life expectancy at 
birth (years), 2007 
Stunting 
Under- 
weight 
Female Male 
Sri Lanka 58 11 2.3
a 18.4 22.8 98 79 75 68 
India 450 54 2.8 47.9 43.5 67 86 65 63 
Maldives 120 26 2.6 31.9 25.7 97 76 75 70 
Australia 4 5 1.8 — — 94 100 84 79 
Chinab 45 19 1.7 21.8 6.8 94 81 75 72 
Malaysia 62 10 2.6 — — 90 96 75 70 
Republic of Korea 14 4 1.2 — — 92 — 82 76 
Russian 
Federation 28 10 1.3 — — 99 88 73 60 
United Kingdom 8 5 1.8 — — 86 100 82 77 
United States 11 6 2.1 3.9 1.3 93 94 81 76 
Source: WHO 2009.  
a. Department of Census and Statistics 2008. The World Health Statistics figure (WHO 2009) for Sri Lanka is 1.9.  
b. Excluding Hong Kong (China) and Macao Special Administrative Region. 
— = not available.  
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NCDs: The Emerging Disease Burden 
The health trends in Sri Lanka are consistent with the later stages of the epidemiologic transition, which is 
characterized by receding pandemics, control of infectious diseases, improved maternal and child health, 
and increasing life expectancy (Omran, 1971). In part due to increased aging, NCDs are more common 
and now account, by far, for the majority of the disease burden in Sri Lanka.  
The demographic transition is characterized by population aging, that is, a larger proportion of older age 
groups than in earlier years.
6
 A major health implication is that the transition will change both the volume 
and the types of health services required. Population aging is occurring much faster in Sri Lanka than in 
other developing countries. But although Sri Lankans now live longer, they also tend to spend more years 
in poor health and with more disabilities than people in developed countries. In fact, disability rates 
among the aging population may be increasing. Reasons for this trend are unclear, although in part they 
could be related to longer exposures to NCD risk factors, development of disease and its complications, 
and potentially suboptimal use of NCD-related health services.  
Global and National Policy Context for NCDs 
In 2000, the World Health Assembly adopted a resolution (WHA/53.17) endorsing a WHO Global 
Strategy for the Prevention and Control of NCDs (WHO, 2008a). The Director-General of WHO was 
requested to continue giving priority to the prevention and control of NCDs and the member states were 
requested to develop national policy frameworks and to promote initiatives. A Global Forum for NCDs 
was created. In 2003 and 2004 the World Health Assembly adopted the Framework Convention on 
Tobacco Control and the Global Strategy on Diet, Physical Activity and Health. In 2008, the 2008–2013 
Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases was 
released. The Plan focused on four types of NCDs—cardiovascular disease (CVD), cancers, chronic 
respiratory diseases, and diabetes—because current evidence indicates that these make a large 
contribution to mortality in the majority of low- and middle-income countries. These diseases are also 
largely preventable by means of effective interventions that tackle their risk factors—tobacco use, 
unhealthy diet, physical inactivity, and harmful use of alcohol.  
The document National Policy and Strategic Framework for Prevention and Control of 
Noncommunicable Diseases, 2009, was developed by the NCD Directorate in the central Ministry of 
Health (MOH) with input from several policy guidance documents related to NCDs. The overall goals of 
the national policy are to reduce the burden due to chronic NCDs by promoting healthy lifestyles, 
reducing the prevalence of common risk factors, and providing integrated evidence-based treatments for 
diagnosed patients. Policy objectives are to reduce premature mortality due to chronic NCDs by 2 percent 
annually over 10 years through expansion of evidence-based curative services and individual and 
community-wide health promotion measures for reduction of risk factors. The document is not linked to a 
budgeted nor detailed work plan, however.  
Prevention and Treatment of NCDs 
Developed-country experiences can lend important insight into prevention and control strategies for 
developing countries. CVD mortality saw major declines in several developed countries during the 1960s 
and 1970s, which have continued into the present (Figure 1.1). These findings received considerable 
attention and much effort was made to understand the underlying reasons. 
                                                     
 
6  The epidemiologic and demographics transitions are discussed further in Chapter 2. 
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Figure 1.1 Heart disease death rates among men aged 30 years and older, Australia, Canada, 
United Kingdom, and United States, 1950–2002 
 
Source: WHO 2005. 
 
During the last half century knowledge of pathophysiology, risk factors and their role in causing disease, 
and the impact of reducing risk factors on developing disease have all increased dramatically. In addition, 
many effective treatments to lower the risk of complications have been developed. Several studies 
examined these secular trends to determine the factors that accounted for these declines (see the sources 
for Table 1.3 for a nonexhaustive listing). The main finding was that on average, about half the reduction 
can be attributed to population-level changes in risk factors such as tobacco use, diet, and physical 
activity, and about half to treatment of disease and its complications, with most of the treatment effect due 
to medication use (Table 1.3). This makes the case that both prevention and treatment are needed and that 
the challenge is determining the strategic mix.  
In Chapter 2, we note that treatment interventions may have more favorable cost-effectiveness for CVD 
prevention and control, although comprehensive models that include sectorwide interventions call for 
both. For mental health and injuries, the situation is similar and calls for consideration of both prevention 
and treatment. 
Table 1.3 Reduction in secular trend of CVD mortality attributed to population-level risk factors 
and to treatment with medication and surgery (%) 
Jurisdiction and period Population-level risk factor Treatment with medication and 
surgery 
Scotland, 1975–94 60 40 
New Zealand, 1982–93 54 46 
Finland, 1982–97a 48 31 
Ireland, 1985– 2000a 48 44 
United States, 1980–2000a 47 44 
Sources: Vartiainen et al. 1994; Capewell 1999; Capewell, Morrison et al. 1999; Capewell et al. 2000; Capewell, 
Beaglehole et al. 2000; Bennett et al. 2006;  Ford et al. 2007. 
a. Do not add up to 100% because some deaths are unexplained.  
 
An early and important policy question that concerns government decision makers universally is how 
much focus should be on prevention of disease and how much on treating those already affected, while 
tackling NCDs. In parallel, whether governments should focus more on populations or more on 
individuals requires careful consideration of the burden, capacity, and many other country-level factors. 
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Reducing the risk factor burdens for NCDs is a major challenge in high-income countries and can be 
more so in low- and middle-income countries—the challenges posed by Sri Lanka‘s demographic and 
epidemiologic transitions are, for example, huge. And once a person develops a chronic disease, such as 
heart disease, lifelong clinic- and hospital-based care is needed. Delivering effective prevention and 
primary care services for NCDs may require retooling current efforts, including new skills for human 
resources, population-level policies and health promotion strategies, health services linkages, and 
sustainable financing strategies. This report aims to help low-income countries along that path. 
Rationale, Objectives, and Methods of this Report 
The rationale for this World Bank report is that strategic health policy decisions to reorient population-
based prevention and clinic- and hospital-based services toward NCDs can more effectively address the 
future burden. The focus of this report is mainly on chronic NCDs—CVD, diabetes, and asthma/COPD, 
and to a lesser extent cancer—and their major modifiable risk factors (tobacco use, unhealthy diet, lack of 
exercise, and harmful alcohol use). This is because global and national policies target these diseases and 
risk factors because the evidence base to reduce their impact tends to be stronger than for other NCDs. 
This is not to detract from the importance of injuries and mental health, since both carry a huge burden as 
supported by evidence in this report. This report focuses on chronic NCDs affecting the working and 
aging population. Its main objectives are to: 
 Describe the chronic NCDs and prevalence of risk factors  
 Describe the health sector‘s organization and its capacity to address NCDs and identify 
potential organizational opportunities for moving toward more efficient and effective 
NCD prevention and control efforts  
 Describe health services utilization and trends with special reference to NCDs 
 Describe key health financing issues for NCDs 
 Develop policy options to improve population-based prevention efforts and delivery of 
clinic- and hospital-based services for NCDs. 
The analysis underlying this report required several sources of data. Previously published reports and 
analyses of data were used to describe the disease burden, risk factors, service utilization trends, and 
sector financing. Health sector reports and interviews with MOH officials and staff were used to describe 
the organizational structure, current prevention and control efforts, and service utilization patterns. 
Comparisons with other countries with similar NCD burden patterns were made to identify potential 
opportunities where policy options and actions can be targeted. However, because of Sri Lanka‘s 
exceptional health indicators, its stage in the epidemiologic and demographic transitions, and its current 
and likely future disease burden pattern, countries used for comparisons are often middle- and high-
income countries, rather than low-income countries. Thus statistical models that were used to simulate the 
potential impact of various policy options employed assumptions mainly from high- and middle-income 
countries. Finally, on the basis of the findings from the analysis, policy options and actions were 
developed for country-level consideration.  
During the analysis, the MOH was engaged. It provided a technical review of early drafts to ensure that 
the report would be useful for subsequent policy discussions and actions, and that the report was focused 
on the key issues that will help future government decisions.  
We made three key decisions for this report. First, since NCDs are such a broad issue, the focus—at the 
expense of being comprehensive—is on chronic NCDs and their major modifiable risk factors, where 
incremental, strategic policy and actions can have a high impact.  
Second, because data from the Sri Lanka national health information and surveillance systems are not 
specifically designed for NCD assessments (although these data were included whenever possible), 
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several different data sources, including global, regional, national, and subnational studies, were used to 
describe the NCD burden. In addition, new secondary analyses were conducted to study equity issues and 
facilitate development of policy options.  
Third, most country-level comparisons to Sri Lanka are made with high- or middle-income (not low-
income) countries. At first pass, these countries may seem like suboptimal comparators. However, with 
Sri Lanka‘s current disease burden profile, these comparisons are more suited for identifying strategic 
areas to target as well as policy options.  
This report is organized to focus on key areas that should help identify policy solutions. Here, in Chapter 
1, we start with an orientation to the Sri Lankan context and introduce the country‘s epidemiologic 
transition. Chapter 2 explores the evolving NCD disease burden and the demographic and epidemiologic 
transitions. Chapter 3 goes on to examine the organization, capacity, and activities of the health sector 
that are important for a response to NCDs. Chapter 4 details the utilization and trends in clinic-based 
health services for NCDs. Chapter 5 briefly reviews overall health financing, then examines key financing 
issues for NCDs. Chapter 6 reviews prevention and control strategies, largely in middle- and high-income 
countries, then moves to simulating the impact of CVD-oriented policy scenarios. Finally, Chapter 7 
develops policy options and actions that aim to improve both the NCD response and the health 
infrastructure overall. These options and actions relate to financing, social determinants, strategic focus, 
organizational structure, human resources, information and surveillance systems, and public–private 
partnerships.  
Chapter 2: Evolving Disease Burden and Risk Factors 
7 
 
Chapter 2: Evolving Disease Burden and Risk Factors 
Key Messages 
 Sri Lanka is aging rapidly and the proportion of people 60 years and older will double 
from 12.1 percent to 24.4 percent between 2010 and 2040.  
 Life expectancy gains have been unequal, with females making steady gains since 1920 
while gains among males have stalled since 1980.  
 NCDs now account for 85 percent of the disease burden. During the past half century the 
proportion of deaths due to circulatory disease (for example, heart disease and stroke) 
increased from 3 percent to 24 percent while that due to infectious diseases decreased 
from 42 percent to 20 percent.  
 NCD mortality rates are higher in Sri Lanka than in middle- and high-income countries 
(especially for asthma among younger populations) and, on the basis of limited national 
morbidity data, heart disease hospitalization and diabetes rates are similar to those in 
Organisation for Economic Co-operation and Development (OECD) countries.  
 Lipid levels (such as cholesterol) are high. This is not necessarily due to a high fat intake 
in the diet, since at 25 percent of total energy intake this is relatively low. Rather, the main 
explanation is an exceptionally high ratio of saturated fats to polyunsaturated fats of 9:1 
compared to a recommended ratio of <1:1. This has food policy implications. 
 The poor are experiencing significant NCD-related mortality, morbidity, and risk factor 
burdens, which, in some cases, are higher than among the rich.  
Demographic Trends and Population Aging 
The most important feature of Sri Lanka‘s current and future demography is population aging, due to its 
past rapid fertility decline and the increase in life expectancy. By 2007, life expectancy had reached 71 
years,
7
 and the total fertility rate had declined to 2.3 (Table 1.2, above). In the coming decades the 
population will age faster than in almost all other developing countries, with the percentage of the 
population aged more than 65 years more than doubling by 2035 to 16.2 percent, a level comparable to 
Western Europe today (Figure 2.1). This rate of change is many times faster than that experienced by 
developed countries earlier, most of which saw this level of aging over more than a century.  
  
                                                     
 
7  http://www.who.int/gho/countries/lka.pdf, accessed April 30, 2010. 
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Figure 2.1 Growth in percentage of population aged 65 years and above, Sri Lanka and world 
regions, 2000–2050 
 
Source: De Silva (2007) for Sri Lanka; UN Population Division (2009) for other regions. 
 
An important feature of Sri Lanka‘s demographic aging is the pattern within the older age groups. The 
population 60 years and above will increase from one tenth of the population in 2010 to almost one third 
by 2050 (Figure 2.2), at which time the 80 years and older age group—those most likely to be frail and 
dependent—will account for 5 percent of the population.  
The growth in all these age groups will pose challenges not only for health policy but also social policy, 
as these Sri Lankans are likely to need extensive provision of long-term care and other services. It will 
also increase dependency ratios. 
Figure 2.2 Proportion of people in older (≥ 60 years) age groups, Sri Lanka, 2001–2100 
 
Source: De Silva 2007.  
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Mortality Trends and the Problem of Adult Mortality 
Comparing the trends in life expectancy since the 1920s at 30 and 60 years of age, in both men and 
women in Sri Lanka, to that in the United States lends insight into the Sri Lanka pattern (Figures 2.3 and 
2.4). First, in the case of Sri Lankan women, the history is initially of a large gap in life expectancy in the 
1920s, and then rapid gains in the 1940–1950s, narrowing the gap with the United States to less than four 
years by the 1950s, and then sustained, slower increases, which have gradually further reduced the gap.  
The story with adult men is more complex. In the United States, gains in life expectancy at 30 and 60 
years of age stagnated from the 1940s to the 1970s and gains in life expectancy in Sri Lanka actually 
caught up with the levels in the United States by the 1960s. Then in the mid-1970s, life expectancy in the 
United States started to improve again, keeping pace with that of women. By contrast, in the same period 
Sri Lanka‘s male life expectancy appears to have stagnated. Unfortunately, more recent life expectancy 
data will not be available until the census in 2011.  
Figure 2.3 Changes in life expectancy at 30 years of age, Sri Lanka and the United States, 1921–
2001 
 
Sources: Sri Lanka from Sarkar (1951); Department of Census and Statistics (1970); De Silva (2007); and Institute for Health 
Policy‘s computations from the same sources; the United States from Bell and Miller (2005).  
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Figure 2.4 Changes in life expectancy at 60 years of age, Sri Lanka and the United States, 1921–
2001 
 
Sources: Sri Lanka from Sarkar (1951); Department of Census and Statistics (1970); De Silva (2007); and Institute for Health 
Policy‘s computations from the same sources; the United States from Bell and Miller (2005).  
 
These trends have resulted in a substantial male–female gap in life expectancy at birth of almost nine 
years (De Silva, 2007), one of the largest in the world. This is more than the four to six years seen in 
Europe and North America, but is smaller than the 13-year gap in the Russian Federation. 
This lack of improvement in adult male mortality rates once a certain level of life expectancy has been 
achieved is not unique to Sri Lanka. A similar pattern was noted in Malaysia at similar levels of life 
expectancy in the 1970s (United Nations, 1982).  
The reasons why adult male life expectancy improved, then stagnated, and improved again in the United 
States are well understood. The initial improvements in both male and female mortality in developed 
countries in the first half of the 20th century were primarily due to reductions in infectious disease deaths. 
Then in many of these countries, there was a slowdown in mortality improvement in the 1950s–1980s, 
owing to the persistence of mortality from NCDs, and in particular CVD, which affects males more than 
females. The peaking of the smoking epidemic in the 1940s–1950s was a key contributor to CVD.  
However, starting in the 1970s, declines in smoking and then the increasing impact of medical therapies 
and interventions for CVD led to older adult mortality falling in both sexes in the United States (and other 
advanced economies). Since CVD accounts by far for the largest share of older adult mortality in 
advanced economies, these reductions in CVD mortality are the principal driver today of increasing older 
adult life expectancy there (Cutler and Meara, 2001).  
To fully establish the reasons why older male mortality in Sri Lanka has continued to stagnate since the 
1960s requires a more detailed analysis that would quantitatively decompose the changes in life 
expectancy in Sri Lanka by disease and age, and would compare these with trends in advanced 
economies, whose life expectancy indicators were similar to Sri Lanka‘s in the 1960s. While beyond the 
scope of this report, such an analysis is critically needed for the period since the 1960s because there do 
not appear to be comparable analyses for other developing countries from which findings can be 
generalized. Sri Lanka is almost unique among lower-income countries in having the detailed historical 
mortality data required to do this type of assessment.  
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Health Burden: Disability-Adjusted Life Years 
When describing the health burden from diseases, the disability-adjusted life years (DALYs) method 
measures the number of years lost to disability and premature mortality. Using this method, the death of a 
child would contribute more forgone DALYs to the disease burden than that of an older person. An 
advantage of using DALYs to measure the burden of disease is that it considers years with disability and 
so it includes conditions that, although not fatal, can be a large economic and social burden, as is the case 
with many NCDs. Another major strength of DALYs is that a similar methodology has been used 
globally, allowing country and regional comparisons.  
However, this method does have limitations. Researchers have raised concerns over the weights used to 
measure disability, since these have not been fully validated in the South Asian region (Anand and 
Hanson, 2005). In addition, for countries without data, DALYs have been calculated by extrapolating 
level and composition of death and disability from countries of similar epidemiologic and economic 
profile, allowing assessment only by broad groups of diseases and leading conditions within those groups.  
Using this standard method, Sri Lanka‘s health burden reflects the later stages of both the epidemiologic 
and demographic transitions (Figure 2.5). NCDs account for approximately 85 percent of the forgone 
DALYs (35 percent are from injuries). This pattern is more similar to high-income countries (and 
Maldives) than to South Asia as a whole. Sub-Saharan Africa has not yet begun these transitions. Thus for 
this report, Sri Lanka‘s comparisons are largely made to middle- and high-income countries experiencing 
similar disease burden patterns.  
Figure 2.5 Disease burden as a proportion of forgone DALYs, selected regions and countries, 2004 
 
Source: WHO 2004a.  
Note: Injuries are included in the NCD category. 
NCD Mortality 
International Comparisons 
Mortality data indicate that the predominant mortality burden in Sri Lanka is, as said, from NCDs. For the 
following analysis, injuries are segmented from other NCDs because they account for a significant 
proportion.  
Although NCDs account for proportionately higher mortality, it is not the case that NCD mortality rates 
must inevitably increase with reductions in infectious disease, or that the increase in NCD mortality rates 
is a corollary of economic development. As noted by Adeyi et al. (2007), on an age-standardized basis 
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both noncommunicable and infectious disease mortality rates tend to be lower as per capita GDP 
increases. Analysis of Sri Lanka‘s mortality data for 1999–2003 confirms this—that is, while the 
proportion of the total mortality burden is less than that of high-income countries (Figure 2.5) the age-
standardized mortality rates for all NCDs are 20–50 percent higher in Sri Lanka than in developed 
countries (Figure 2.6, and see Appendix 1). Thus, this finding identifies an opportunity for improvement.  
Figure 2.6 Comparison of age-standardized mortality rates by cause of mortality, Sri Lanka and 
selected countries 
 
Source: Institute for Health Policy 2010. 
Note: Mortality rates standardized using Sri Lanka 2001 population as reference. 
 
Further international comparisons for specific types of NCDs were estimated using country-level ratios of 
mortality rates for all causes, CVD, diabetes, and injuries, to those in Sweden. Sweden is used as the 
comparison country because it has low overall mortality rates, and because this comparison was 
previously made in the 1970s when the stagnation in male life expectancy was first noted (UN ESCAP, 
1976). The overall mortality rates in Sri Lanka are higher than in most developed countries; relative to 
Sweden, mortality rates from all diseases are 100–200 percent higher (see Appendix 2). When overall 
mortality rates are examined by sex, it is evident that higher mortality rates in Sri Lanka, compared to 
developed countries, are largely among men, with female mortality rates at some ages lower than in some 
OECD nations, including the United States.  
Among specific NCDs, CVD mortality rates in Sri Lanka are almost double those in developed countries, 
demonstrating that CVD is the major driver of the higher rates of NCDs and all-cause mortality in Sri 
Lanka. These findings suggest that a major reason that Sri Lanka has been unable to improve its 
performance relative to these countries since the 1970s is its worse performance in NCD mortality, and in 
particular, in CVD.  
Pattern and Trends in Sri Lanka 
Past reductions in mortality in Sri Lanka have come largely from decreases in deaths due to infectious 
diseases and maternal and child health conditions (Table 2.1). At the same time, NCD mortality has 
increased its share. In 1945, diseases of the circulatory systems, diabetes, and cancer accounted for 
Chapter 2: Evolving Disease Burden and Risk Factors 
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2.8 percent, 0.4 percent, and 0.6 percent, respectively, of all deaths, but these proportions increased to 
23.8 percent, 3.0 percent, and 7.6 percent, respectively, by 2003.  
Table 2.1 Percentage of deaths from major causes, Sri Lanka, 1945–2003 
Cause of death (%) 
Deaths (%) 
1945 1960 1980 2000 2003 
Disease of the circulatory system 2.8 8.6 24.3 21.3 23.8 
Infectious diseases 41.8 24.1 12.9 18.0 19.7 
Cancer 0.6 2.6 5.7 6.8 7.6 
Diabetes mellitus 0.4 0.7 1.1 2.3 3.0 
Maternal and child health 4.8 4.4 1.7 0.5 0.5 
Injuries 2.5 5.0 6.5 14.3 9.5 
Other 47.1 54.6 47.8 36.8 35.9 
All causes (number)  142,931 84,918 91,020 114,554 104,508 
Sources: Analysis by Institute of Health Policy using data of the Registrar General‘s Department for 2000 and 2003; UN ESCAP 
(1976); Department of Census and Statistics (1987). 
Note: Infectious diseases include infectious, parasitic, and respiratory diseases, dysentery (all forms), tuberculosis of respiratory 
system, typhoid, malaria, pneumonia, and bronchitis. Maternal and child health include anemia, and complications of pregnancy 
and child-birth. Injuries include violent or accidental deaths. Ill-defined deaths are not classified to any specific cause.  
 
Mortality data for 2005 (the most recent available to this study, as provided by the MOH in 2010), used 
different disease categories and are problematic for direct comparison to the above table (especially for 
injuries, where a much broader definition is used) and confirmed a similar trend. 
CVD, Diabetes, and Cancer 
The mortality burden for these conditions clearly demonstrates the importance of age for NCDs, and a 
very strong age gradient is universally present (Figure 2.7), as in all developed countries. Of concern are 
the significant rates among working and near-retirement age groups since they indirectly reflect the 
impact that these diseases have on indicators such as workforce participation. These data also reflect the 
higher mortality rate among males, especially for CVD (combined hypertension and IHD), during 
working age years, contributing to the lagging gains in adult male mortality already noted.  
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Figure 2.7 Mortality rate for hypertension, IHD, diabetes, and cancer (per 100,000) by sex, Sri 
Lanka, 2005 
Hypertension 
 
 
IHD 
 
Diabetes 
 
 
Cancer 
 
Sources: Mortality from the Registrar General‘s Department and population data from 2005 midyear census estimate.  
 
Asthma and Chronic Respiratory Disease 
The trends in the crude mortality rate due to asthma from 1991 to 2003 point to an increasing burden, as 
illustrated by Figure 2.8. Since 1991, mortality rates from asthma have doubled, with annual recorded 
deaths from asthma also doubling from under 2,000 a year to more than 4,000 in 2003. Asthma accounts 
for 4 percent of all deaths. This can be contrasted with 1 percent of all deaths attributed to the bronchitis 
category, which would have included asthma, during the 1940s–1960s (UN ESCAP, 1976).  
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Figure 2.8 Annual crude mortality rate due to asthma, Sri Lanka, 1991–2003 
 
Source: Institute for Health Policy computations based on data from the Registrar General‘s Department. Standard mortality 
rates not calculated owing to the lack of reliable population data for the whole period.  
 
However, recorded mortality from asthma is not a reliable measure of the asthma burden for two reasons. 
The first is the high potential for misdiagnosis of asthma deaths in the elderly, because its signs and 
symptoms can be confused with other diseases (such as COPD), leading to an overreporting of asthma 
mortality. This issue is pertinent since the recorded mortality from asthma in Sri Lanka is concentrated 
among the elderly (Figure 2.9). The mortality rate from asthma in the 5–39-year age group is 
internationally considered a more reliable measure (Masoli et al., 2004). For Sri Lanka this rate was 1.3 
deaths per 100,000 a year during 2001–2003, which is significantly higher than all countries for which 
data are reported to the WHO Mortality Database or to the OECD, and two to five times the levels seen in 
European and other developed countries (Figure 2.10). Such a high relative level of asthma mortality in 
Sri Lanka has not been previously reported.  
The second reason, as with all diseases, is that the share of asthma cases that result in death is highly 
susceptible to treatment interventions, and so the mortality rate is a function both of disease incidence and 
of overall treatment success. The high rates of mortality in Sri Lanka could be the result of an 
unexceptional rate of asthma prevalence combined with high case fatality rates. However, even if this 
were the case, the very high mortality from asthma would still imply that the disease imposes a high 
disease burden, since death is the ultimate burden. Consequently, it is valid to interpret the available 
evidence as indicating that asthma imposes a disease burden that is exceptionally high in relative terms. 
The matter deserves further research. 
(Year) 
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Figure 2.9 Number of deaths from asthma by age group, Sri Lanka, 1999–2003 
 
 
Source: Institute for Health Policy computations based on data from the Registrar General‘s Department. 
 
Figure 2.10 Asthma mortality in 5–39-year olds per 100,000, Sri Lanka and other selected 
economies 
 
 
                                                                                                                 (Deaths per 100,000)  
Source: Institute for Health Policy computations: Sri Lanka estimate for 1999–2003 based on Registrar General Department 
data, estimates for OECD countries around 2005 from OECD (2007), and estimates for other countries estimated from the 
WHO Mortality Database.  
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Chronic NCD Morbidity 
It is not easy in Sri Lanka to track the prevalence or incidence of most NCDs, as in nearly all developing 
countries. The two main approaches in developed countries to measure trends in chronic diseases are 
using population surveys, and tracking morbidity via clinical records maintained by primary care 
providers. In the first approach, surveys need to be continually conducted to estimate incidence and 
prevalence of most NCDs, and are not currently undertaken in Sri Lanka. The second approach depends 
on an organized system of service delivery and on a good health information system, which registers the 
whole population and maintains detailed clinical records on the problems with which patients present to 
the health system. Such a health information system does not exist in Sri Lanka (see Chapter 3). Even if 
this second approach were possible, it could still produce different estimates of prevalence for chronic 
NCDs because inclusion depends on the NCD being diagnosed and entered in the health information 
system (Esteban-Vasallo et al., 2009). 
IHD 
Hospital admissions for IHD, in particular acute myocardial infarction, are a crude indicator of underlying 
IHD trends, because a substantial proportion of IHD cases (even in developed countries) are identified 
only when acute events occur. In 2005, 82,000 admissions in government hospitals were IHD cases, 
equivalent to a rate of 410 admissions per 100,000. (This figure does not take into account private IHD 
admissions, which may add a significant number, since IHD admission rates are known to be higher in 
Colombo district, where most private hospitals are located.) This rate is comparable to those in OECD 
countries of 330–1,200 admissions per 100,000 (Moïse, 2003). Given that the Sri Lankan population is 
younger than the OECD average, this rate is higher on an age-standardized basis than in most developed 
countries.  
Hypertension
8
 
Hypertension is a major risk factor for CVD, including stroke. The prevalence of hypertension in Sri 
Lanka is low by international standards. A population survey of cardiovascular risk factors in Sri Lanka in 
1998–2002 (Wijewardene et al., 2005) found that the age-standardized prevalence rate for hypertension 
(defined as systolic blood pressure ≥140 mmHg and diastolic pressure ≥90 mmHg) was 19 percent in Sri 
Lanka, with little difference between men and women. A more recent national survey by Katulanda et al. 
(2008) reported a national prevalence of hypertension in adults of 13 percent in men and 14 percent in 
women. These levels are lower than those reported for most developed countries (Wolf-Maier et al., 
2003), such as the United States (28 percent) or countries in Europe (44 percent). Thus other risk factors, 
in addition to hypertension, must account for the CVD profile.
9
  
Diabetes 
Table 2.2 presents the estimates of diabetes prevalence as reported in different surveys in Sri Lanka since 
the 1990s. Although these studies focused on different populations and used different methods, the 
prevalence appears to be increasing. The earliest study found a prevalence of 5.8 percent in a community 
study of urban older men (35–59 years) in 1990, while the Sri Lanka Diabetes, Cardiovascular Study 
(SLDCS) (Katulanda et al., 2008) found a prevalence of 10 percent in a national sample of those aged 18 
years and above.
10
 Because diabetes is more common with age, studies of older populations find higher 
prevalence rates. Increases in diabetes prevalence over the past two decades can be partly due to the aging 
                                                     
 
8  Hypertension is considered both a disease and a risk factor (for cardiovascular disease) and is placed in the morbidity section 
arbitrarily. Treating hypertension is considered secondary prevention for cardiovascular disease.  
9  Undernutrition is now recognized as a major long-term risk factor in the development of adult coronary heart disease, stroke, 
diabetes, and hypertension. See the section Fetal and Childhood Undernutrition and Epigenetic Determinants, below. 
10  The survey was carried out in seven of the nine provinces (not Northern and Eastern provinces). 
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of the population (since diabetes prevalence increases with age), and to increasing age-specific prevalence 
rates for diabetes. These levels indicate that Sri Lanka already has a prevalence of diabetes similar to or 
more than those seen in many developed countries (10.7 percent in the United States among those aged 20 
years and above),
11
 and a high prevalence compared to most other developing countries (though 
comparable national data are sparse). 
Taking into account the aging of the population, Katulanda et al. (2008) projected that the diabetes 
prevalence in Sri Lanka would increase to 14 percent by 2030. However, their estimate does not take into 
account factors such as unfavorable changes in diet or physical activity, which may further increase 
prevalence rates.  
Table 2.2 Changes in prevalence of diabetes mellitus as estimated by different surveys, Sri Lanka, 
1993–2006 
Period Study population Sample size Ages (years) Prevalence (%) 
1990 
(1) 
Suburban community (urban older males) 975  35–59 5.8 
1991 
(2) 
Rural community 200 ≥18 2.5 
1994 
(3) 
Suburban community 633 30–64 5.2 
2000 
(4) 
Suburban community 1,303 30–64 6.6 
2000 
(5) 
Rural community 200 19–80 8.5 
2004
 (6) 
National 6,047 30–65 Males: 14.9 
Females: 13.9 
2005/06 
(7) 
National 5,000 ≥ 18 10.3 
Sources: (1) Mendis and Ekanayake 1994; (2) Illangasekara et al. 1993; (3) Fernando et al. 1994; (4) Malavige et al. 2002; 
(5) Illangasekera et al. 2004; (6) Wijewardene et al. 2005; (7) Katulanda et al. 2008. 
 
Cancer  
Morbidity for cancer is tracked primarily through cancer registries that capture all types of cancer. Each 
cancer can differ in its etiology, prevention strategies, case detection methods, and treatments. This makes 
them difficult to address as a group. However, the more common types, which have established 
prevention strategies (such as tobacco control for reducing oral cancer and lung cancer), and which have 
established detection methods and effective treatments (such as screening for breast and cervical cancers) 
are the focus of prevention and control efforts.  
In Sri Lanka, the National Cancer Control Program started an institution-based cancer registry
12
 in 1985, 
and has periodically generated reports. The overall rate of all cancers combined is rising, with the age-
adjusted rate increasing from 37.6 to 70.6 per 100,000 from 1985 to 2005 (NCCP, 2009). Cancer rates 
have risen among both men and women. Similar to the mortality pattern, incidence increases markedly 
with age, and most cases are in the 50 years and above group.  
Gender determines the dominant cancer type. Among men, oral cancer and lung cancer are the top two 
and account for 30–35 percent of all cancers. While lung cancer is on the rise and increased two or three 
times from 1985 to 2005, oral cancer declined by 20–25 percent during the same period (Figure 2.11). 
Among women, breast and cervical cancer are the top two and account for 35–40 percent of all cancers. 
Trend analyses find that breast cancer rates doubled from 1985 to 2005 while cervical cancer rates rose 
slightly, but then almost returned to the base year rate (Figure 2.11).  
                                                     
 
11  www.cdc.gov/diabetes, National Diabetes Factsheet 2007. 
12  Population-based cancer registries are the gold standard and (attempt to) include all cancers in the covered area, whereas 
institutional registries only include those who receive care at the institution. But if most people are accessing care, data from 
the latter source can still be very useful.  
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Figure 2.11 Incidence of leading types of cancer among men and women, Sri Lanka, 1985–2005 
  
Source: NCCP 2009.  
 
Asthma  
Population-based studies of asthma morbidity are scant. The bulk of the information for our analysis 
comes from mortality and utilization data where together asthma and chronic respiratory disease account 
for about 8 percent of patient discharges (Chapter 4, Table 4.5).  
Major NCD Risk Factors 
Moving from mortality and the disease burden to NCD risk factors, two important concepts need 
consideration. First, the period between risk factor exposure and its related morbidity or mortality can be 
long (decades for tobacco and lung cancer, for example), especially compared with some infectious 
diseases where the duration between exposure and disease onset can be quite short (months, days, or even 
hours). Second, in some countries people die from other causes (such as infectious diseases) at younger 
ages before the full impact of NCD risk factor exposure is felt. Thus, morbidity and mortality do not 
always track risk factors.  
In Sri Lanka, where the demographic transition is advanced, increasing life expectancy can result in 
longer exposure to risk factors, making their ill effects more likely to develop. Conversely, the delayed 
benefit of risk factor reduction at younger life stages can be enjoyed at later stages. This section 
summarizes what is known about some of the risk factors for the major chronic NCDs in the country. 
Fetal and Childhood Undernutrition and Epigenetic Determinants 
Despite some maternal and child health indicators that rival those of developed countries (Table 1.2 
above), the prevalence of malnutrition is high among Sri Lankan children, with 21 percent under five 
years of age classified as underweight (Department of Census and Statistics, 2008). Furthermore, these 
national aggregates mask widening inequalities between different population groups. The problem is 
concentrated in the tea estate sector and in some rural areas, particularly in districts of the east where 
chronic malnutrition (stunting) and acute malnutrition (wasting) rates reach 42 percent and 28 percent, 
respectively. Rates of stunting are highest in areas where the tea estates are located, whereas the highest 
rates of wasting are in the post-conflict areas of the east.  
Thanks to the work of Barker and colleagues (Barker and Robinson, 1992; Barker and Clark, 1997), fetal 
undernutrition is now recognized as a major long-term risk factor in the development of adult coronary 
heart disease, stroke, diabetes, and hypertension. In addition, recent research has identified epigenetic 
mechanisms as potentially providing a pathway by which conditions of scarcity in the past can influence 
the pathogenesis of heart disease in subsequent generations (NHLBI Working Group, 2008). 
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Maternal undernutrition was widespread in Sri Lanka in the past and continues today. The legacy should 
be expected to act as a significant predisposing factor for adult CVD and diabetes for many years to 
come, and must be considered as one of the key explanations for current high levels of CVD. However, 
there has been little research on this in Sri Lanka, and is an area that should be a future national research 
priority. Still, Sri Lanka should ensure that raising mothers‘ nutritional levels is a continuing priority, 
regardless of the NCD risk associated with maternal undernutrition. 
Tobacco 
Tobacco use is a major risk factor for heart disease, chronic respiratory disease, and cancer. Overall 
smoking prevalence in Sri Lanka is approximately 18 percent, which is lower than in other South Asian 
countries and some developed countries (Figure 2.12). The share of the population who smoke at all and 
who smoke on a daily basis, and the mean number of cigarettes consumed per capita, are lower than in 
most other developing countries and have been declining in the past two decades (Rahman and Ramaboot, 
2003; Central Bank of Sri Lanka, 2005). However, there is a marked sex disparity in smoking: it is almost 
exclusively confined to men, similar to the pattern in most South Asian countries but different from high-
income countries. The actual rate of smoking in men is thus higher than implied by the overall population 
average. This disparity may help explain part of the gender disparity in overall NCD mortality rates.  
Figure 2.12 Age-standardized prevalence of current smoking of any tobacco product among men 
and women (≥ 15 years), selected countries, 2006  
 
Source: WHO MPOWER Report 2009. http://www.who.int/tobacco/mpower/en/. 
Note: Smoking is at the time of the survey, including daily and non-daily smoking, of any form of tobacco, including cigarettes, 
cigars, pipes, but excluding smokeless tobacco. 
 
Smoking rates in children and youth are also lower than in other low-income countries but are still very 
concerning. According to the Global Youth Tobacco Survey, 2007, 5.1 percent of youth (students 13–15 
years) had ever smoked tobacco cigarettes, and of them, 39.5 percent of them had smoked cigarettes 
before age 10, and 8.6 percent were current users of other tobacco products (WHO/SEARO, n.d.) 
Air Pollution  
Air pollution is recognized as an emerging public health problem in developing countries. However, most 
countries, including Sri Lanka, do not have adequate data to fully characterize its extent. The main source 
of indoor air pollution, other than second-hand tobacco smoke, is cooking fuels (Nandasena et al., 2010). 
In the 2006/7 Demographic and Health Survey (Department of Census and Statistics, 2008), 78 percent of 
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households in Sri Lanka used firewood as the main type of cooking fuel. While the impact of exposure to 
firewood smoke is not well characterized, studies suggest that it may be significant. In one study, the use 
of firewood fuel for cooking was a significant risk factor for respiratory systems among household 
members. In a school-based study among children (Nandasena et al., 2010), firewood smoke, use of 
mosquito coils, and a dusty environment at home all significantly increased the risk for asthma.  
Obesity 
Obesity is a risk factor for CVD and diabetes, and it also plays a role in some cancers. Overall obesity 
levels in Sri Lanka have been increasing for the past 20 years.  
Wijewardene et al. (2005) found that 20.3 percent of men and 36.5 percent of women aged 30–65 years 
were obese (body mass index [BMI]≥25 kg/m2), compared with 25.0 percent and 24.7 percent of men and 
women in the United States, and 12.0 percent and 28.5 percent of men and women in the Russian 
Federation. However, WHO recommends the classification of obesity at smaller BMIs in Asian than 
European populations, so this comparison understates the problem. Using this recommended cutpoint for 
Asian populations, data from the SLDCS carried out by Katulanda et al. (2008) (Chapter 3), which 
included, on average, a younger population (≥18 years) than the studies above, found obesity rates of 
7 percent in men and 13 percent in women. Thus while cross-comparisons of these data are difficult, 
obesity levels are probably lower than in developed countries.  
Arambepola et al. (2008) also shows that obesity levels are higher among women than men in Sri Lanka, 
and that they are higher in urban than rural areas. The mean BMI of the urban population in Colombo 
district was found to be 1 kg/m
2 
higher than that of rural counterparts, which suggests that urbanization 
will lead to increased BMI. 
Lipid Levels 
Abnormal lipid levels—specifically, high levels of triglycerides—and a low ratio of high-density 
lipoprotein (HDL) cholesterol to low-density lipoprotein (LDL) cholesterol, are major risk factors for 
CVD. A risk factor survey of 1998–2002 found that mean total cholesterol levels were in the 200–
236 mg/dl category in Western Province (Sri Lanka Medical Association, 2004), compared to levels of 
200–240 mg/dl reported from developed countries. The more recent, more nationally representative 
SLDCS (Katulanda et al., 2008) reported similar levels. It found mean total cholesterol and LDL-
cholesterol levels in the population to be 203 mg/dl and 133 mg/dl, respectively, with levels significantly 
higher in females than in males. 
The high prevalence of abnormal lipid levels is not necessarily due to a high fat intake in the diet, since at 
25 percent of total energy intake this is relatively low. Instead the main explanation is an exceptionally 
high ratio of saturated fats to polyunsaturated fats, of 9:1, compared to a recommended ratio of <1:1 
(Abeywardena, 2003). This finding has potential food policy implications.  
Physical Inactivity 
Physical inactivity is a risk factor for both CVD and diabetes, and an increase in inactivity is a widespread 
global corollary of modernization (Guthold et al., 2008). Rapid urbanization, economic growth, and 
technological changes are contributing to the likelihood of increased physical inactivity in the developing 
world, and in Sri Lanka specifically to the need to focus on developing interventions to counter increasing 
levels of physical inactivity among men and women. 
Figure 2.13 presents a comparison of the physical inactivity levels by sex in Sri Lanka with other selected 
countries. (The note to the figure defines inactivity as ―Category 1‖). The data are from surveys that have 
used the International Physical Activity Questionnaire instrument to measure inactivity levels in national 
populations. The level of inactivity in men in Sri Lanka in 2002 was 7.3 percent and in women 13.8 
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percent. These levels are in fact low (that is, favorable) relative to international standards, and lower than 
in most developed and in many developing countries.  
Figure 2.13 Comparison of physical inactivity by sex in Sri Lanka with other selected economies 
 
Source: Data for Malaysia, and Sri Lanka are from the World Health Survey, 2002–2003 (Guthold et al., 2008), and data for 
the other countries are from Bauman et al. (2009). 
Note: Category 1 (low level) physical activity as found in the International Physical Activity Questionnaire defined by less 
activity than in Category 2 (moderate level). To meet Category 2, during 1 week there are 3 or more days of vigorous 
activity of at least 20 minutes a day, OR 5 or more days of moderate-intensity activity or walking of at least 30 minutes a 
day, OR 5 or more days of any combination of walking, moderate intensity, or vigorous intensity, achieving a minimum of 
at least 600 metabolic equivalent of task (MET)-minutes per week. 
 
Alcohol 
Excessive consumption of alcohol is a risk factor for a range of NCDs, including liver disease, cancer, 
and CVD. Assessment of the prevalence of excessive consumption is hard in most countries, owing to 
difficulties in obtaining reliable responses in surveys, and the potential impact of illicit consumption. Sri 
Lanka is no different given a significant level of illicit alcohol production and consumption. Nevertheless, 
the mean per capita consumption of alcohol (non-illicit) is considered a reasonable proxy indicator for 
drinking levels in a population.  
WHO statistics show that average alcohol consumption in Sri Lanka is far lower than in most countries 
(excluding countries with predominantly Muslim populations). Annual per capita consumption of alcohol 
among adults aged 15 years or older was estimated to be 0.28 liters in 2003, compared with an average of 
4.0 liters in lower-middle-income countries, and 9.07 liters in high-income countries (WHO, 2008b).  
The situation in Sri Lanka is characterized by a high prevalence of abstinence from alcohol, and very low 
rates of consumption in women (WHO, 2004b). According to WHO the rate of abstainers during the last 
year (prior to the study) in Sri Lanka was 67.6 percent (total), 41.4 percent (males), and 92.9 percent 
(females). WHO also found that the rate of last-year heavy and hazardous drinking (defined as average 
daily consumption of 40 g or more of alcohol for men and 20 g or more of alcohol for women) among 
drinkers was 15.6 percent for men and zero for women (WHO, 2004b). 
Given that alcohol consumption is largely confined to men—as with smoking—the main problem in Sri 
Lanka is that excessive alcohol consumption and heavy drinking are concentrated in a small proportion of 
the male population, and these people tend to be poorer and less educated. National consumption patterns 
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show that 3.4 percent of monthly household expenditures are for alcohol and tobacco, but this pattern 
varies considerably with urban, rural, and tea estate population expenditures at 2.1 percent, 3.6 percent, 
and 13.4 percent, respectively (Household Income and Expenditure Survey 2006-7). Thus, there appears 
to be a significant concentration of both heavy alcohol and tobacco use intake in the tea estate population. 
Indeed, alcoholism is a significant social problem there.  
Socioeconomic and Geographic Differentials in NCD Burden and 
Risk Factors 
Dimensions of Inequality 
Inequalities in health needs and health outcomes are important issues for public health policy 
internationally, but especially in Sri Lanka where the concern for equity has been a major motivating 
factor in guiding policies. NCDs might give rise to significant inequalities in the incidence of illness and 
in obtaining treatment for NCDs, and to inequities caused by the costs of illness. The key dimensions of 
potential inequalities relate to income and socioeconomic status, and to where people live (urban or rural).  
In developed countries, NCDs disproportionately affect the poor. Disadvantages in access to health care, 
increased incidence of disease and risk factors associated with employment and living conditions, and 
poor health behaviors result in the poor generally suffering a higher NCD burden than the rich.  
The situation in developing countries is much less understood, but the limited available evidence suggests 
that the relationship with income is reversed, with the rich suffering more from NCDs than the poor 
(WHO, 2002). In South Asia this is particularly the case for IHD and diabetes in India, for which many 
studies exist. However, in the case of Maldives, recent research indicates that the socioeconomic gradient 
for several NCDs is shifting from one where NCDs are more prevalent in richer and better educated 
persons to one where they will be concentrated in poorer and less educated persons (Anuranga et al., 
2009).  
Poor social policies and programs, inequitable economic arrangements, and bad politics all bring in their 
train an unequal distribution of health-damaging experiences. This section now examines the relationship 
between socioeconomic status (SES) and overall and NCD-related mortality, then presents some evidence 
on inequalities for morbidity and risk factors for NCDs. It rounds off the chapter by looking at the 
relationship between NCDs and social determinants, especially poverty.  
SES and Overall Mortality 
In order to examine NCD mortality across SES levels, all registered deaths during 1999–2003 
(n = 553,192) were pooled and the deceased residence mapped from Registrar General Department 
Districts to the corresponding Divisional Secretariat Divisions (DSDs). The DSDs were then mapped to 
household amenities and other characteristics identified in the 2001 Census and assigned a tentative 
wealth status (see Appendix 3). 
 
Figure 2.14 shows the geographic variations in SES and in standardized mortality rates for all causes by 
DSDs for the period 1999–2003. Statistics for DSDs in the east and north are not reported, owing to 
conflict and the unavailability of Census 2001 population data for these areas. Figure 2.15 shows the 
relationship between all-cause mortality and SES quintiles.  
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Figure 2.14 SES and mortality rates for both sexes combined by DSDs, Sri Lanka, 1999–2003 
Ranking by SES deciles using asset indexes 
 
Standardized mortality rates (all causes) 
 
Source: Institute for Health Policy 2010. 
 
All-cause mortality in Sri Lanka tends to be highest in richer areas. This is consistent with the pattern in 
Sri Lanka since the 1960s, when mortality rates in rural areas were first noted to be below those in richer 
areas. However, increased mortality rates are seen in the north–central and eastern areas, which border the 
former conflict areas.  
An examination of all-cause mortality rates in relation to SES (Figure 2.15) suggests a possible slight 
increase for both sexes with increasing socioeconomic position. An increase in mortality with SES is seen 
across all major disease groups, including infectious diseases, maternal, neonatal, and child health 
conditions, injuries, and NCDs. 
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Figure 2.15 All-cause mortality by SES quintiles, Sri Lanka, 1999–2003  
 
Source: Institute for Health Policy 2010.  
 
This finding of higher or equal mortality rates in richer areas, although unusual along an international 
perspective, is not new. It is consistent with the demographic records in Sri Lanka, where official life-
table estimates have consistently reported the highest life expectancies and lowest overall mortality rates 
in some of the poorest and most rural districts of the country since at least the 1970s; mortality rates in 
rural areas have long been lower than in urban areas (Meegama, 1986).  
SES and Mortality for NCDs 
Figure 2.16 shows mortality by SES quintiles for hypertension, IHD, diabetes, and cancer. Without 
exception, within the poorer quintiles a significant absolute mortality burden from NCDs is present, 
although it not always greater than among richer quintiles. Relative comparisons across all the quintiles to 
detect gradients are not conclusive in most cases. Mortality from hypertension may tend to increase at 
lower quintiles. By contrast, mortality from IHD, diabetes, and cancer may tend to increase with SES. 
Asthma mortality has the most striking gradient, with a much higher burden among the poor.  
However, these mortality findings across SES quintiles, when morbidity is also considered, must be 
interpreted cautiously. A mismatch between underlying morbidity and observed mortality would be 
consistent with a scenario where the prevalence of a condition increases with SES, but where better 
access to diagnosis and treatment among higher SES quintiles might group results in a lower net 
mortality. Consistent with this possible scenario is that of World Bank (2008), which found that it was 
much more likely that the poor perceived their health to be poor than the rich, while at the same time, 
among the rich, self-reported chronic diseases were more common than among the poor (see Appendix 4).  
A context for each condition-SES profile in Figure 2.16 is now discussed.  
Hypertension 
In developed countries socioeconomic gradients for hypertension-related mortality tend to be weak or 
negative (higher among the poor). Lower levels of psychosocial stress in higher-income groups might 
(Percentile) 
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explain the pattern of hypertension mortality, and this would be consistent with findings from other 
countries (Pickering, 1999; Steptoe and Willemsen, 2004).  
IHD and Diabetes 
The suggested positive gradients (greater burden among richer populations) for IHD and diabetes are 
opposite to those reported from developed countries, where gradients are either generally negative (IHD), 
or absent or negative (diabetes) (Chaturvedi, 2004). The reasons for this different pattern in Sri Lanka 
may be higher levels and/or longer duration of risk factor exposure in higher-income groups. In addition, 
Sri Lanka is, perhaps, evolving from the patterns seen in developing countries to those in developing 
countries.  
Cancer (malignant neoplasms) 
The SES gradient in cancer mortality may be positive (higher among the rich), but less so than for IHD 
and diabetes. Interpreting cancer trends is problematic since there are many different types of cancer, each 
of which may have different risk factors ranging from behaviors (such as tobacco use) to exposure to 
environmental toxins and risk factors. In addition, cancer outcomes (such as mortality) can vary by access 
to early screening and treatment, which can also be SES related.  
Asthma 
Asthma mortality is highest among the lower SES quintiles and then decreases significantly in the top two 
quintiles (Figure 2.17). Given the high rates of asthma mortality in Sri Lanka and the known sensitivity of 
asthma mortality to treatment, this condition provides a clear case of where access to and use of effective 
treatment can play a significant role in determining mortality among the various SES quintiles. The higher 
levels of mortality in the lower quintiles may reflect worse access to care, while those in the richest 
quintiles are able to access care and prevent mortality. This possibility is confirmed by the geographic 
pattern of asthma mortality rates, which are highest in the tea estate areas of the central hill country and 
Eastern province (Figure 2.18). These high rates may, in part, be due to poor access to treatment. 
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Figure 2.16 Mortality from hypertension, IHD, diabetes, and cancer by SES quintiles, Sri Lanka, 1999–2003 
Hypertension 
 
IHD 
 
Diabetes 
 
Malignant neoplasms  
 
 
Source: Data provided from analysis by Chamara et al., November 2009, Institute for Health Policy. Mortality data for Sri Lanka from Institute for Health Policy Registrar General 
Analysis Project. Analysis by Institute for Health Policy Equitap Mortality Differentials Project. 
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Figure 2.17 Asthma mortality for all ages by SES quintiles, Sri Lanka, 1999–2003 
 
 
 
 
Source of data: As Figure 2.16. 
Figure 2.18 Asthma mortality for all ages by DSDs, Sri Lanka, 1999–2003 
 
Source: Institute for Health Policy 2010.  
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(Deaths per 100,000) 
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Evidence for Morbidity and Risk Factor Inequalities 
The SLDCS collected data on NCD risk factors and prevalence of diabetes and heart disease from a 
nationally representative sample of 5,000 adults (Katulanda et al., 2008). Although the survey did not 
collect detailed and reliable data on the SES or income of its respondents, for this current analysis, an 
index to proxy for respondents‘ SES was developed.13  
The prevalence of morbidity (hypertension and diabetes) and CVD risk factors (smoking, obesity, low 
physical activity, and unfavorable lipid profiles) by SES deciles is shown in Figure 2.19. Diabetes, 
obesity, lipid profiles, and low physical activity all tend to increase among those at higher SES levels, 
whereas hypertension and smoking do not reveal a clear trend. However, the concentration indexes are 
positive and statistically significant for all these conditions with p values ≤ 0.001 (except for a high total 
cholesterol:HDL ratio, p ≤ 0.038) suggesting that these risk factors are higher in the rich. By contrast, 
smoking decreases with income, although the concentration index is not statistically significant 
(p ≤ 0.23).  
Another study on smoking in urban and rural areas (Colombo and Polonnaruwa district, respectively) 
found similar smoking rates (29.9 percent and 24.4 percent, p=0.52) (De Silva et al., 2009). However, 
significantly higher smoking rates were found among the poorest quintile (44.8 percent urban, 25.7 
percent rural) than the richest (21.6 percent urban, 12.8 percent rural).  
Figure 2.19 Distribution of morbidity and CVD risk factors by SES quintile, 2005 
 
Source: Computations by Institute for Health Policy based on data from Katulanda et al. (2008). 
Note: Statistics are national estimates for both sexes combined. 
 
The total cholesterol:HDL-C and other dyslipidemia ratios in Sri Lanka are worse among the rich, in 
contrast to the lack of a consistent pattern in developed countries (Riddell and North, 2003). The high 
burdens of obesity, hypertension, and diabetes among the rich are comparable to those generally reported 
in developing countries, but are the opposite to those seen in developed countries (WHO, 2002; Riddell 
and North, 2003).  
                                                     
 
13  Detailed descriptions of the methodology used in this parallel study will be reported in a forthcoming publication by the 
Institute for Health Policy and University of Colombo.  
(Percentile) 
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These results suggest that the patterns of inequalities in cardiovascular risk factors in Sri Lanka fall 
between those in developing and developed countries. Sri Lanka is, perhaps, transitioning between the 
two patterns. This would be consistent with the patterns observed in Maldives, where higher living 
standards and the level of modernization probably place it further ahead in the transition than Sri Lanka 
(Box 2.1).  
 
Box 2.1 Maldives: SES, morbidity, and risk factors 
A recent analysis by Anuranga et al. (2009) in Maldives indicates that the profiles for obesity, 
hypertension, and diabetes are either mixed or run counter to those in Sri Lanka. In Maldives, the gradient 
for diabetes in both sexes and for obesity in males was negative with increasing SES, although neither 
statistically significant, while the gradient for hypertension was flat.  
By contrast, the gradient for physical inactivity was increasing with rising SES, which is similar to that in 
Sri Lanka. However, this gradient was due to a strong relationship with education, and income was not a 
significant explanatory factor.  
A similar analysis of the correlates of some of these risk factors in Sri Lanka is warranted, and is currently 
being undertaken by a joint team from the Institute for Health Policy and researchers from the University 
of Colombo.  
 
Social Determinants and NCDs  
Dramatic differences in health are closely linked with the degree of social disadvantage found within 
countries (CSDH, 2008; WHO/SEARO, 2008). These inequities arise because of the circumstances in 
which people grow, live, work, and age, and the systems put in place to deal with health and illness. The 
conditions in which people live and die are, in turn, shaped by political, social, and economic forces. In 
addition, the relationship between NCDs and poverty is bidirectional via social determinant forces (Figure 
2.20).  
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Figure 2.20. Social determinants, NCDs, and their relationship to poverty  
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Authors. 
 
In developed countries the poor and disadvantaged experience a larger NCD burden than the rich. Sri 
Lanka does not show this pattern, although that may be changing. As seen, this report finds mortality for 
some conditions clearly higher for the poor, as is the case with asthma. However, most of the burden and 
risk factors are currently similar among the rich and the poor. But even if the burden is similar, there is an 
inequitable situation if the poor have more difficulty in accessing comprehensive care and are less able to 
adopt healthy lifestyles due to their social and financial position.  
Addressing social determinants requires not only health policies that are sensitive to the situation but also 
attention across many other sectors. Education and social protection are the key human development areas 
alongside health. Most of the items in the development agenda—economic opportunities; the distribution 
of power, money, and resources; and living conditions—influence social determinants.  
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Chapter 3: Health Sector Organization, Capacity, and 
Response to NCDs 
Key Messages 
 Health services are organized with a decentralized system. The central MOH manages 
tertiary curative services, drug procurement, training of health staff, and oversight of the 
health sector, in addition to performing stewardship functions. Provincial MOHs manage 
preventive and lower-level curative services.
14
  
 The central MOH is responsible for NCD prevention and control, which is led by three 
key central directorates with many other directorates playing supporting roles. 
 Curative care is delivered through an extensive system of clinics and hospitals at primary, 
secondary, and tertiary levels.  
 The preventive health system is managed by the public sector and services are provided 
through Medical Officer of Health areas covering the entire country. 
 Over the last three decades public sector health workforce numbers have risen in almost 
all categories. About half now work in the central MOH and half in the provincial system. 
Eighty-nine percent work in curative care and 11 percent in preventive care.  
 Inequitable distribution of staff across provinces is compounded by lack of a solid human 
resource development plan and postings driven by current demand.  
 Essential clinical investigation equipment and medical equipment necessary for diagnosis 
and management of NCDs is frequently unavailable at primary and secondary care levels.  
 Low availability and use of essential drugs for treatment of NCDs has been a long-
standing problem; recent data confirm this is still the case.  
 Health information systems do not collect key inpatient data (there are no demographic 
indicators) or outpatient data (there are no demographic or morbidity indicators), which 
severely limits their usefulness. NCD surveillance is still at a very early stage.  
 The pattern of health service delivery, low availability of drugs, and no formal referral 
system encourages outpatient care for NCDs to be delivered in higher-level facilities. In 
addition, after-hours outpatients are often admitted as inpatients. 
 Promising NCD pilots for prevention and control should create an evidence base to 
develop appropriate policies.  
                                                     
 
14 The terms ―preventive‖ and ―curative‖ services warrant some explanation. Public health theory describes three levels of 
prevention: primary (specific prevention, such as immunization, micronutrient supplementation, statins to prevent heart 
attacks, and health promotion such as good hygiene, healthy diet, smoking cessation); secondary (early detection of disease 
and treatment); and tertiary prevention (disability limitation and rehabilitation). Thus, ―curative‖ services are actually part of 
secondary prevention, making the distinction between ―preventive‖ and ―curative‖ services conceptually untenable. However, 
these terms are in common parlance, having specific meanings in the Sri Lankan context, and are therefore used repeatedly in 
this report. While not wishing to lose the very helpful concept of the three levels of prevention, for the purposes of this report, 
we would like to define ―preventive services‖ as primary prevention efforts and ―curative services‖ as secondary and tertiary 
prevention (while acknowledging that rehabilitation services are often beyond the curative system).  
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Health Sector Organization and Capacity 
Central Level 
At the central (national) level, health services function under the central MOH (see Appendix 5). The 
Secretary, MOH is the chief executive and chief accounting officer of the ministry and is responsible for 
the implementation of the government‘s national health policy. The Minister of Health Care and Nutrition 
is the representative of the Cabinet of Ministers within the ministry, and is accountable to the Cabinet for 
all matters related to the health of Sri Lankans.  
A National Health Policy statement adopted by the Cabinet in 1996 emphasized the goal of increasing life 
expectancy by reducing preventable deaths due to both infectious and noncommunicable diseases and to 
improve the quality of life by reducing preventable diseases, health problems, and disability. The National 
Health Policy identified areas needing attention, including nutritional health, oral health, mental health, 
accidents, coronary heart diseases, hypertension, diabetes, cerebrovascular disease, renal disease, 
substance abuse, and malignancies.  
The MOH, through the Director-General of Health Services, supports implementation of the National 
Health Policy by provincial councils (Appendix 5) and provides technical guidance to them on all matters 
related to health service delivery in the country, including preventive, curative, and rehabilitative services. 
However, there is blurring of responsibilities between the central MOH and the Department of Health 
Services. MOH is involved in running day-to-day programs and projects that may impact aspects of 
policy development.  
The MOH deals with all recruitment, appointments, and transfers related to medical officers for both 
central and provincial levels. Furthermore, all teaching hospitals and specialized hospitals are managed by 
the MOH and are under the Deputy Director-General, Medical Services. In addition, some provincially 
managed hospitals, over time, have been transferred to the MOH. Currently the MOH manages 50 
institutions including all teaching hospitals. Most provinces have a centrally managed hospital.  
The National Institute of Health Sciences and 14 nurse training schools, under the MOH, conduct training 
of auxiliary medical care personnel such as nurses, medical laboratory technicians, public health 
inspectors, and public health midwives, even though the legal framework for Sri Lanka‘s devolution has 
such training addressed by the provinces (see Appendix 6). Some other activities, too, have not been fully 
decentralized and continue to be managed centrally, including blood transfusion services (a network of 
more than 64 blood banks) and all drug procurement.  
Provincial MOH and Local Governments 
Provincial MOHs are responsible for the health services within a province. The Provincial Director of 
Health Services assists the Provincial Minister in all activities pertaining to the health sector within the 
province, the Deputy Provincial Director of Health Services (DPDHS) within the respective districts of 
the province, and the Divisional Director of Health Services (DDHS) within the respective divisions in 
each of the districts.  
Structure Specific to NCDs  
The central MOH organizational structure in relation to NCDs is shown in Figure 3.1. The responsibility 
for NCD management has evolved over the years. Directorates for NCDs, Mental Health, and Cancer 
Control work within the MOH and are responsible for major NCDs-specific activities. (In addition to 
these directorates, others are also important but their roles have not been finalized yet.)  
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Figure 3.1 Central MOH organizational structure in relation to NCDs 
 
Source: MOH.  
YEDD = Youth, Elderly, Displaced and Disabled. 
 
NCD Directorate 
The NCD Directorate was created in the late 1990s with few support staff. The staffing structure was 
revised in 2009 and two consultant community physicians and four medical officers were added. The 
objective of the directorate is to plan and coordinate the national NCD response for prevention and 
management of NCDs. It is tasked with CVD, endocrine (diabetes), respiratory (asthma/chronic 
respiratory) diseases, acute unintentional injuries, and renal system–related chronic diseases.  
The directorate recently prepared, and the Cabinet approved, The National Policy and Strategic 
Framework for Prevention and Control of Chronic Noncommunicable Diseases, 2010. In addition, the 
Cabinet had decided that the MOH should formulate an action plan in association with other relevant 
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institutions to achieve the objectives of the policy (Box 3.1). The action plan is currently under 
development.  
 
Box 3.1 Objectives of The National Policy and Strategic Framework for Prevention and Control of 
Chronic Noncommunicable Diseases, 2010 
 Support prevention of chronic NCDs by strengthening policy, regulatory, and service delivery 
measures for reducing the level of risk factors of NCDs in the population 
 Implement a cost-effective NCD screening program at the community level with special emphasis on 
cardiovascular diseases 
 Facilitate provision of optimal NCD care by strengthening the health system to provide integrated and 
appropriate curative, preventive, rehabilitative, and palliative services at each service level 
 Empower the community for promotion of healthy lifestyles for NCD prevention and control 
 Enhance human resource development to facilitate NCD prevention and care 
 Strengthen the national health information system, including disease and risk factor surveillance 
 Promote research and utilization of research findings for prevention and control of NCDs 
 Ensure sustainable financing mechanisms that support cost-effective health interventions in both 
preventive and curative sectors 
 Raise priority for and integrate prevention and control of NCDs in policies across all government 
ministries and private sector organizations. 
 
The directorate is also preparing and has nearly finalized a national policy and strategic plans for injury 
prevention and management, which will soon be up for Cabinet approval. This effort was coordinated 
with the Trauma Secretariat, the National Centre for Medical Toxicology, and the various agencies 
involved in road safety, both within and outside the health sector.  
At the provincial level, positions for district medical officers for NCDs have been created in 25 districts. 
They report to the Regional Director, Health Services, and the Provincial Director, Health Services, and 
receive technical guidance and stewardship from the central NCD Directorate. Their main functions are to 
liaise with other stakeholder departments for prevention of NCDs (education, sports, youth, media, etc.) 
as well as to train primary health care staff in NCD prevention. They also collect, analyze, and 
disseminate information on NCDs and monitor NCD-related activities in the province. They are expected 
to organize screening programs and review NCD activities periodically. In addition, they coordinate 
injury prevention activities, promote school programs, and monitor implementation of the Tobacco and 
Alcohol Act in the provinces. The central technical guidance and stewardship provided to the district 
medical officers for NCDs have mostly been ad hoc, though since 2009 this support has become more 
systematic.  
Mental Health Directorate 
This directorate was established in early 2000. Its objective is to plan and coordinate the national mental 
health response to prevent and manage the mental health–related conditions in the country.  
The directorate has a Director and support staff. Implementation of activities are facilitated by 47 Medical 
Officers (Mental Health) and Medical Officers (Psychiatry) who are posted mostly within secondary-level 
hospitals that do not have staff clinical psychiatrists. They support the clinical psychiatrist (if present), 
provide clinical psychiatry services in institutions without a specialist psychiatrist, provide outpatient care 
services for mental health within hospitals, and coordinate community activities with the MOH offices.  
Cancer Control Directorate 
This, the first NCD-related directorate, was established in 1980 as the National Cancer Control Program. 
It currently functions with a staff of more than 15 that includes a Director, Deputy Director, consultant 
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community physicians, a data expert, medical officers, and other support staff. Its objectives are to control 
or eliminate risk factors of preventable cancers through public awareness and thereby to reduce the 
incidence of cancers and its morbidity and mortality.  
Directors of Teaching Hospitals and Other Specialized Hospitals 
All hospitals managed under the MOH have a direct budget line for operations and provide services based 
on the demand and available human resources. As the specialist medical officers complete their training 
programs, there is a tendency for them to be posted to locations with inadequate facilities and equipment 
for fully practicing their specialty. (Existing specialists may also need their facilities and equipment to be 
upgraded for the same reason.) Examples include advanced radiology, cardiac surgery, eye surgery, 
pediatric surgery, oncology surgery, neurosurgery, and rehabilitation services.  
If NCD clinics (such as hypertension or diabetes clinics) are loaded beyond capacity, the practice has 
been that additional general and specialized clinics are introduced or additional staff are added to the 
existing clinics, both leading to ―immediate need‖ personnel requests, with only minimal planning or 
strategic policy directives from the MOH (see Human Resources for Health, below).  
Director Tertiary Care 
The Director Tertiary Care provides support to all tertiary care hospitals. The unit facilitates 
communication and coordination among hospital directors.  
Bureaus and Units Supporting NCD Prevention and Control 
Health Education Bureau 
The Health Education Bureau in the MOH is responsible for health promotion and building capacity 
among personnel engaged in health development for both government and nongovernment sectors. This is 
achieved through the mobilization of resources of the health and health-related sectors and the 
community. Health promotion and community mobilization is the responsibility of the primary health 
care teams at the peripheral level. Volunteer health workers use holistic approaches and carry out 
activities at the grassroots level. The MOH NCD Directorate uses Health Education Bureau resources and 
services for incorporating NCD efforts into programs.  
Family Health Bureau (Directorate for MCH) 
This unit has been in existence since 1968 and it leads maternal and child health services. The Bureau 
introduced Well Women Clinics that provide NCD screening services for women over 35 years old (see 
Health Sector Responses to NCDs, below).  
Epidemiology Unit 
In place for more than four decades, it leads (besides infectious disease surveillance) the immunization 
program for vaccine-preventable diseases, the Acute Respiratory Disease Control Programme, and the 
Diarrhoea Prevention and Control Programme. Relevant data are sent to the Medical Statistics Unit for 
publication in the Annual Health Bulletin of the MOH. This unit has the capacity to introduce NCD 
surveillance programs countrywide.  
Medical Statistics Unit  
The unit has staff (statisticians and others) dedicated to collecting and analyzing medical statistics from 
the Census and Statistics Department. The unit trains data collection officers at each hospital. Current 
efforts are focused on improving data collection formats. Data are received from all hospitals with 
inpatient facilities through the Indoor Morbidity and Mortality data returns and other relevant documents. 
The unit provides morbidity and mortality information based on the International Classification of 
Diseases, 10th Revision (ICD-10). This ICD-10 expertise has the potential to be used for coding relevant 
NCD data.  
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The Medical Statistics Unit produces the Annual Health Bulletin, and MOH directorates provide 
summary write-ups to the unit on each of their programs.  
Health Information Unit 
The unit coordinates human resource and hospital data. It is also responsible for providing relevant data 
for planning, monitoring, and evaluation of the health sector. This unit currently provides technical 
support for the development of a national NCD surveillance system.  
Director Youth, Elderly, Disabled and Displaced 
This directorate attends to the needs of these special groups of persons in the community. In addition, the 
unit coordinates the functioning of day care services for the elderly at each of the MOH levels. Specific 
NCD prevention programs are held at some centers for the elderly.  
Medical Supplies Division 
This is the sole agency that coordinates the total drug and consumables budget for the public health 
sector. The unit purchases required items with the support of the State Pharmaceuticals Corporation 
where required, based on requests from provinces and all major hospitals.  
Laboratory Services 
The Deputy Director-General, Laboratory Services coordinates the laboratory support required for 
different levels of care for the country. But hospitals tend to make decisions for different laboratory 
services based on demand, availability of human resources, and experience. Many NCDs require 
laboratory services for diagnosis and clinical management.  
Biomedical Engineering Services Directorate  
This directorate provides technical guidance (including details of specifications when required) and 
coordinates the procedure for purchase of all biomedical equipment funded for all health institutions 
managed under the MOH. It also provides technical guidance to provinces and supports the province-
based biomedical units as required.  
Primary Health Care Directorate 
This directorate works closely with other units already providing support to primary care services. 
However, an NCD-related role has not yet been identified for this unit.  
Health Services Units  
Public Sector 
Sri Lanka has a well distributed network of hospitals and preventive health offices. The majority of the 
population has reasonable access to either a private or government health care facility. On average, Sri 
Lankans are within 1.4 kilometers of a basic health clinic and 4.8 kilometers from a free, government-
sponsored allopathic health care facility (Annual Health Bulletin 2003). 
Curative Health Services 
A total of 1,084 public hospitals and outpatient facilities (646 hospitals with inpatient facilities and 438 
central dispensaries which provide only outpatient facilities) were functioning as of December 2008 
(Annual Health Statistics 2008 from the Medical Statistics Unit). The government has three levels of 
curative care institutions depending on the size and the facilities offered by the institution—primary, 
secondary, and tertiary (Table 3.1).  
Primary care institutions include central dispensaries, maternity homes, rural hospitals, peripheral units, 
and district hospitals—now collectively called divisional hospitals. All these institutions offer 
nonspecialist inpatient and outpatient care, except central dispensaries (outpatient only). Secondary care 
institutions include base, general, and provincial hospitals, now also called district general and base 
hospitals A and B. These hospitals, in addition to providing outpatient care, provide specialist care 
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through general surgical and medical units, at least one obstetric or gynecology unit, and a pediatric unit. 
In addition, some of these hospitals have specialist units. Tertiary care institutions, essentially the 
teaching hospitals, have all the facilities and units that secondary care institutions have but they also have 
various other ultra specialist units, such as neurology and cardiology.  
 Table 3.1 Basic statistics and information about all public sector hospitals (curative) in Sri Lanka, 
2007 and 2008  
Type of care Hospital name/ category Total number 
of hospitals, 
2008 
Range in total 
number of 
beds per unit, 
2007 
Total 
beds, 
2007 
Facilities provided
a
 
Tertiary care  Teaching hospitals 17  
(in 8 districts) 
257–3,264 18,451 
(27%) 
Specialist and 
subspecialist care 
through inpatient, clinic 
care and outpatient care
b
 
Secondary 
care 
Provincial hospitals, 
district general hospitals, 
general hospitals, base 
hospitals, and other 
specialized hospitals
c
 
122  
(in 25 districts)
d
 
13–1,328 24,923 
(36%) 
Specialist inpatient, 
clinic care and outpatient 
care
b
  
Primary care 
(inpatient and 
outpatient)  
Divisional hospitals, 
district hospitals, rural 
hospitals,
e
 and peripheral 
units and tea estate 
hospitals 
507 (in all 26 
districts) 
1–484 25,320 
(37%) 
Inpatient and outpatient 
care
b
 (managed only by 
medical officers; 
specialist medical 
officers not available) 
Primary care 
(outpatient 
only) 
Central dispensaries 438 (in all 26 
districts) 
0 0 General outpatient care
 b
 
(managed only by 
medical officers or 
assistant medical 
officers; specialist 
medical officers not 
available) 
Total All facilities 1,084 
(countrywide) 
0–3,264 68,694 
(100%) 
 
Source: Computed by World Bank from Annual Health Bulletin provisional data for 2008 and data from Annual Health Statistics 
2007. 
a. Outpatient and inpatient care are provided to any patient at any of the levels of care without a referral. Only clinic-based care 
patients need to be referred from an outpatient medical officer or directly from the relevant specialist medical officer when 
working in the private sector.  
b. All outpatient services are provided only from 8.00 am to 12 noon and 2.00 pm to 4.00 pm; all other patient visits are admitted. 
c. Includes mental, chest, leprosy, police, prison, fever, cancer, dental, and rehabilitation hospitals 
d. Except Mullativu district, other specialist hospitals are in seven districts that also have other secondary care hospitals. 
e. Includes tea estate hospitals. 
 
Preventive Health Services 
The core of the preventive health system is managed by the public sector and services are provided 
through 297 divisional health units known as Medical Officer of Health areas covering the entire country 
(Annual Health Bulletin, provisional data for 2008). A few of these units are municipal council–managed 
and the others are managed by provincial health authorities. A Medical Officer of Health unit provides 
comprehensive preventive health care for a population of 80,000–100,000. The unit is staffed by a team 
of multidisciplinary health workers. A medical officer of health functions as unit manager and the team 
includes public health nursing sisters, supervising public health midwives, supervising public health 
inspectors, public health inspectors, and public health midwives.  
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Preventive services include comprehensive antenatal, postnatal, and family planning care, including house 
visits; nutrition services for mothers and children including nutrition supplementation and growth 
monitoring of children below five years; immunization services for vaccine-preventable diseases in 
children; Well Women Clinic services; environmental and occupational health services including 
inspection of food stores for hygiene, factories for safety, and school for environmental cleanliness and 
screening of children in school years 1, 4, and 7; field activities for rabies, dengue, malaria, filaria, and 
tuberculosis control; and preventive dental health services for antenatal mothers and school children 
below 12 years.  
Private Sector 
The private health sector has seen growth in the last two decades and currently provides outpatient and 
inpatient curative care to people demanding such services in urban and semiurban areas. Outpatient care 
is provided through private clinics and private hospitals. Of private sector inpatient beds, about 50 percent 
are in Colombo and the remainder are in a few districts (Kandy, Galle, Kurunegala, and Anuradhapura) in 
small hospitals (20–30 beds each). The total number of private sector beds was estimated at 8,850 in 2008 
(Central Bank Annual Report 2008). In addition, specialized private health services provide laboratory 
tests, nursing, and other services.  
The government has encouraged private medical practice since 1977, largely by permitting government 
medical officers, who provide care in the public system, to provide private medical services outside their 
official duty hours. The majority of the private sector medical staff also work in the public sector as 
medical specialists and general medical practitioners.  
Human Resources for Health  
Over the last three decades public sector health workforce numbers have risen in almost all categories and 
a recent shortage of nurses has been resolved (Table 3.2). The public sector staff headcount is 95,805 with 
approximately half the employees (46,492) working for the MOH and the other half (48,839) posted to 
provincial health units. 
Table 3.2 Trends in key health personnel in the health sector  
Year Medical officers
a
 Nurses Public health midwives 
 Number Rate
b
 Number Rate
b
 Number Rate
b
 
1982 2,035 13.4 6,931 45.6 2,296 15.1 
1992 3,345 19.2 11,214 64.4 4,108 23.6 
2002 9,290 48.9 16,517 86.9 4,819 25.4 
2007 11,023 55.1 31,466 157.3 6,167 30.8 
Source: Annual Health Bulletin 2008. 
a. Covers all medical officers in curative, administrative, and preventive services, including specialists and interns. 
b. Per 100,000 population. 
 
The central administrative level has 15 Deputy Directors-General and 67 Directors leading different 
aspects of health services, including administrative and supportive functions. The provincial 
administrative level under the Provincial Director of Health Services has (depending on the number of 
districts) between two and four district-level Regional Directors. The majority of other staff are hospital– 
and preventive sector–based service providers (Annual Health Bulletin 2008). Most staff work in the 
curative sector (89 percent) while 11 percent work in the preventive sector (Table 3.3). 
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Table 3.3 Government health sector staffing categories by service provision, 2008  
Staffing category and sector Number % 
General administrative (senior and deputy) 117 0.1 
Preventive  10,422 10.9 
Medical officers 865 0.9 
Nurses 290 0.3 
Technicians (includes dental and entomological assistants) 472 0.5 
Public health inspectors (includes environment, sanitation and food hygiene 
related inspectors) 
1,766 1.8 
Public health midwives 6,384 6.7 
Other field officers 645 0.7 
Curative  85,266 89.0 
Medical officers (includes specialists, general medical officers, dentists and 
interns, postgraduate Institute of Medicine, Registered Medical Officers) 
12,549 13.1 
Nurses (includes supervising nurses, matrons, and pupil nurses) 31,176 32.5 
Statistics officers 701 0.7 
Support technical staff (includes specialized technicians, hospital midwives, 
dispensers, and microscopists) 
6,973 7.3 
Support nontechnical staff (attendants, laborers, etc.) 33,867 35.3 
Total 95,805 100 
Source: Computed by World Bank based on data from Annual Health Bulletin 2008. 
 
Within the health sector, human resource distribution historically has been based on demand. When a 
hospital is upgraded to a higher level, the infrastructure as well as the diagnostic and treatment capability 
are improved. This is followed by more human resource allocation to meet the resulting demand. A well-
developed human resource development plan linked to curative and preventive sector development is not, 
though, in place.  
Unplanned expansion of human resource posting has led to maldistribution of staff in several categories 
(Table 3.4; see bold). While these data cannot define the optimal ratio of staff to population or staff to 
hospital beds, they can identify variation and potentially inequitable distributions. The Northern Province 
has the worst profile with especially low ratios for medical specialists, medical officers, nurses, medical 
officers of health, and public health midwives. Other provinces also have some inequitable distributions. 
Medical specialists and dentist ratios both have substantial variation throughout. Nurse ratios are low in 
Eastern and North Central provinces, the statistics officers, essential for data reporting, have a low ratio in 
Western Province. In terms of prevention, Central, Northern, and Northwestern provinces have low ratios 
for medical officers of health while Central and Western provinces have low public health inspector 
ratios.  
Chapter 3: Health Sector Organization, Capacity, and Response to NCDs 
41 
 
Table 3.4 Availability of different categories of human resources in the government sector by 
province, Sri Lanka, 2007 
Description Western  Central  Southern  Northern  Eastern  North 
Western 
North 
Central 
Uva Sabarag
amuwa 
Total 
Population (000) 5,707 2,599 2,417 1,159 1,493 2,276 1,196 1,275 1,888 20,100 
No. of hospital beds 
Beds per 1,000 pop 
20,977 
3.7 
10,150 
3.9 
7,224 
3.0 
4,249 
3.7 
5,098 
3.4 
6,303 
2.8 
4,489 
3.8 
4,766 
3.7 
5,438 
2.9 
68,694 
3.4 
Medical specialists 
No.  336 126 104 18 55 78 44 49 42 852 
Per 100,000 pop  5.9 4.8 4.3 1.6 3.7 3.4 3.7 3.8 2.2 4.3 
Per 1,000 beds 16.0 12.4 14.4 4.2 10.8 12.4 9.8 10.3 7.7 12.4 
Medical officers (all hospital-based categories) 
No.  4,004 1,569 1,124 392 609 960 392 597 781 10,428 
Per 100,000 pop  70.2 60.4 46.5 33.8 40.8 42.2 32.8 46.8 41.4 52.1 
Per 1,000 beds 190.0 154.6 155.6 92.3 119.5 152.3 87.3 125.3 143.6 151.8 
Dental officers (all hospital-based categories) 
No.  687 167 75 33 54 88 42 53 70 1269 
Per 100,000 pop 12.0 6.4 3.1 2.8 3.6 3.9 3.5 4.2 3.7 6.3 
Nurses 
No.  11,433 4,256 3,603 751 1,689 4,004 1,353 1,804 2,283 31,176 
Per 1,000 beds 545.0 419.3 498.8 176.7 331.3 635.3 301.4 378.5 419.8 453.8 
Statistics-related officers 
No.  132 141 86 57 55 100 17 52 61 701 
Per 1,000 beds 6.3 13.9 11.9 13.4 10.8 15.9 3.8 10.9 11.2 10.2 
Support staff—Technical categories (technical officers) 
No.  2,167 733 895 364 568 748 361 447 690 6973 
Per 1,000 beds 103.3 72.2 123.9 85.7 111.4 118.7 80.4 93.8 126.9 101.5 
Nontechnical support staff (laborers and attendants, etc.) 
No.  8,790 5,207 3,356 2,770 2,823 3,818 1,939 2,185 2,970 33,867 
Per 1,000 beds 419.0 513.0 464.6 651.9 553.7 605.7 431.9 458.5 547.8 493.0 
Medical officers of health  
No.  221 79 79 14 47 65 41 50 72 668 
Per 100,000 pop 3.9 3.0 3.3 1.2 3.1 2.9 3.4 3.9 3.8 3.3 
Public health inspectors 
No.  379 169 244 126 206 153 136 110 243 1,766 
Per 100,000 pop 6.6 6.5 10.1 10.9 13.8 6.7 11.4 8.6 12.9 8.8 
Public health midwives  
No.  1284 932 879 242 747 654 426 462 758 6,384 
Per 100,000 pop 22.5 35.9 36.4 20.9 50.0 28.7 35.6 36.2 40.1 31.9 
Source: Computed by World Bank based on data from Annual Health Bulletin 2008. 
 
Many of these staff have key roles for both preventive and curative services delivery. As the NCD burden 
increases, these inequities will have an impact on the public sector response.  
Finally, at present, there are no formal in-service training programs for NCDs for any level of staff, 
though ad hoc programs have been carried out during the last five years at provincial and district levels. 
Clinical guidelines for some selected NCDs are available (see Health Sector Responses to NCDs, below). 
Recently, the public health inspector curriculum has been revised to include a module on NCDs.  
Availability of Investigation and Medical Equipment  
The availability of essential clinical investigation equipment and medical equipment necessary for 
diagnosis and management of patients among the nearly 950 provincial managed facilities is a critical 
issue to providing quality care. Unfortunately, no database with hospital information is available. 
However, the Director of Policy Analysis and Development in the MOH conducted a special survey in 
2008 on the availability of these facilities in selected secondary- and primary-level hospitals (Table 3.5). 
It found that, even in secondary hospitals, basic laboratory testing and medical equipment was often 
unavailable, and the situation was worse in primary hospitals.  
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Table 3.5 Availability of basic facilities from a sample of hospitals, Sri Lanka, 2008 
Medical equipment or basic laboratory 
test description 
Secondary-level 
hospitals 
Primary-level 
hospitals 
Primary-level 
outpatients only 
No of hospitals sampled / Total hospitals 
in 2008 (%) 
18/122 (15%) 74/507 (15%) 23/438 (5%) 
Availability of (%):    
Blood pressure apparatus (1 per 
medical officer) 
39 51 91 
Oxygen cylinder 67 42 9 
Nebulizer 72 54 61 
Suction apparatus 50 41 22 
Emergency tray 72 60 35 
Electrocardiogram 50 41 4 
Test for urine sugar 33 45 26 
Source: Computed by World Bank based on 2008 survey data from the Director of Policy Analysis and Development.  
Note: Data not available for tertiary-level hospitals.  
 
Drug Availability for NCDs  
The Medical Supplies Division procures all required drugs for centrally and provincially managed 
hospitals. Drugs from the national essential drugs list are purchased and the MOH then determines the 
types of drug that can be dispensed at different levels of care. In addition, each hospital has an allocation 
that is made available to the head of the hospital for emergency purchase of other additional drugs and 
consumables for seriously ill patients and poor patients.  
Substantial underprovision of the essential medicines required for routine management of chronic NCDs 
is a prevalent feature of Sri Lanka‘s public sector. Both international clinical guidelines (WHO and global 
best practice guidelines for developing countries) and Sri Lanka national clinical guidelines recommend 
the use of relatively cheap, essential medicines in primary care for secondary prevention
15
 and treatment 
of complications of the major chronic NCDs (IHD, diabetes, and asthma). There is an overall limited 
supply of these medicines at all levels, with a real lack of supply at the primary care level.  
A WHO study assessed the availability of 32 essential medicines for chronic diseases in Sri Lanka and 
five other low- and middle-income countries (Mendis et al., 2007). In Sri Lanka the median proportion of 
the 32 essential medicines available in public facilities was 28 percent (range: 8–75 percent) compared to 
79 percent (range: 2–96 percent) in private facilities. The study also examined affordability of various 
treatment regiments. For patients with established coronary heart disease, the standard medicine treatment 
regimen
16
 for one month would cost 1.5 day‘s wages, for hypertension (monotherapy), 0.01 day‘s wages, 
for diabetes, 6.1 days‘ wages, and for asthma, 2.3 days‘ wages.  
In an earlier WHO study, Mendis et al. (2005) assessed the extent to which registered IHD patients 
treated at health facilities received adequate prevention in 10 developing countries, including Sri Lanka. 
The study looked at diagnosed IHD patients registered in a secondary-level institution. They found that 
patients in most developing countries were inadequately treated, but surprisingly, that levels of treatment 
were lowest in Sri Lanka. For example, only 8.7 percent of IHD patients in Sri Lanka received beta-
blockers, compared with 34–72 percent in the other countries. Similar disparities were reported for the 
use of aspirin, angiotensin converting enzyme (ACE) inhibitors, and statins. Despite Sri Lanka‘s vaunted 
                                                     
 
15  Secondary prevention is the early detection and management of disease. Primary prevention includes specific prevention (for 
example, immunization) and health promotion (for example, good hygiene, healthy diet, smoking cessation). Tertiary 
prevention is disability limitation and rehabilitation. 
16  Aspirin, statin, beta-blocker, and ACE inhibitor, all at the lowest generic price. 
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good access to health services, IHD patients received worse treatment than in many developing countries, 
including those with weaker health systems.  
While the 2005 WHO study focused on secondary health care facilities in Sri Lanka, the lack of 
medicines is even greater at primary care level. Figures 3.2 and 3.3 show the availability of selected NCD 
medicines in MOH health facilities in three districts surveyed in an Institute for Health Policy/MOH 
Public Facility Survey in 2005. Availability is defined here as the supply to a facility during a 12-month 
period of any quantities of the relevant medicines. This is a rather generous definition of availability, 
since a facility that receives insufficient stocks of a medicine is still defined as having availability.  
Figure 3.2 presents the availability of the four medicines identified by WHO as essential treatment for 
patients diagnosed with IHD: aspirin, beta-blockers, ACE inhibitors or calcium-channel blockers, and 
statins. Most of these medicines were unavailable at the lowest health facilities, regarded as the entry 
point for primary care. At preventive care–oriented Medical Officer of Health units, only 8 percent of 
facilities were provided with aspirin, and none was provided with stocks of the other three medicines. 
Central dispensaries to rural hospitals fared a little better, but even at their level, no facilities were 
provided with statins, and less than half received stocks of calcium-channel blockers, such as verapamil, 
while supplies of beta-blockers were not universal. Only peripheral units and above had supplies of all 
three medicines, excepting statins, which were not made available to any facilities surveyed in the three 
districts.  
Figure 3.2 Any availability during year of essential medicines for IHD at different facility levels, Sri 
Lanka, 2005 
 
Source: Institute for Health Policy/Ministry of Health Public Facility Survey 2005.  
Note: Estimates are for the districts of Colombo, Badulla, and Matale.  
MOOH = Medical officer of health unit; RH = rural hospital; CDMH = central dispensary maternal home; CD = central 
dispensary; PU = peripheral unit; DGH = district general hospital; Base = base hospital. 
 
Figure 3.3 illustrates the availability of other medicines for asthma, diabetes, and heart disease. Again 
only peripheral units and above were assured of supplies of medicines for asthma (salbutamol) and 
diabetes (tolbutamide and metformin), while other essential medicines such as spironolactone and 
streptokinase (essential treatment for acute myocardial infarction) were only available in limited supplies 
in base hospitals and above.  
Medicine 
name 
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Figure 3.3 Any availability during year of essential medicines for asthma, diabetes, and heart 
disease at different facility levels, Sri Lanka, 2005 
 
Source: Institute for Health Policy/ Ministry of Health Public Facility Survey 2005. 
Note: Estimates are for the districts of Colombo, Badulla, and Matale.  
MOOH = Medical officer of health unit; RH = rural hospital; CDMH = central dispensary maternal home; CD = central 
dispensary; PU = peripheral unit; DGH = district general hospital; Base = base hospital. 
 
 
A review of 2009 data of drug availability at various levels found little change from the earlier studies 
(see Appendix 7). Most NCD drugs are available only at secondary- and tertiary-level hospitals. As 
health-seeking behavior is known to be based on drug availability, the current institutional arrangements 
tend to encourage patients to seek care at higher facilities, bypassing the lower ones. Based on current 
policy, even drugs required for first-line management of asthma, CVD, hypertension, and diabetes, as 
well as a few other basic drugs required for the management of these conditions, are not currently in the 
essential drugs list for primary care facilities.  
Health Information Systems and Surveillance 
Surveillance of NCD risk factors, mortality and morbidity trends, as well as health services utilization 
patterns, all provide important input for the strategic planning of a response to the current and likely 
future NCD burden. Several health information systems are operating in the public sector and collecting 
information routinely. In addition, special studies and surveys provide critical inputs.  
Health Information Systems 
The Medical Statistics Unit and many other directorates in the MOH collect, collate, and analyze data for 
management purposes and publications (for example, the Epidemiology Bulletin, and Family Health 
Bureau publications). They also provide summary data for the Annual Health Bulletin on curative and 
preventive health sector data. A separate, well-established paper-based system for transmission of health 
information is also in place for preventive health services managed by the Epidemiology Unit and the 
Family Health Bureau.  
Curative sector data are collated by the Medical Statistics Unit for the various returns on quarterly indoor 
morbidity and mortality; notification of infectious diseases and EPI; quarterly outdoor and clinic data; 
monthly maternity; annual bed strength and staff; maternal and child health; family planning; and others.  
Medicine 
name 
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These inpatient and outpatient data have major limitations. Hospital inpatient data are collected in 
aggregate form, without patient-level demographic information. Outpatient data include only aggregate 
numbers without demographic information, reason for visit, or diagnosis information. Thus detailed or 
cross-tabulation analyses are not possible.  
NCD Risk Factor and Morbidity Surveys 
Efforts have been made in the past to conduct subnational NCD risk factor surveys to supplement NCD 
data gaps. The NCD Unit at the MOH led risk factor surveys using the WHO STEPS methodology in 
2002 and 2006. The STEPS survey in 2006 covered five (of the 26) districts, and assessed the basic risk 
factors responsible for major NCDs but did not conduct biological assessments (see Appendix 8). 
Although the survey was completed and preliminary results have been made available, the report has not 
yet been finalized.  
Several small-scale surveys by individual researchers and by medical faculties have been conducted over 
the last decades and many are cited in this report (see for example Chapters 2 and 4). In addition, the first 
comprehensive national study on diabetes and pre-diabetes in Sri Lanka, the SLDCS (Katulanda et al., 
2008), measured chronic disease morbidity and risk factors for all age groups 18 years and above.  
The Ragama Risk Factor Survey, led by the University of Kelaniya in collaboration with the International 
Medical Center of Japan, has established a longitudinal cohort to study the prevalence of metabolic 
disorders, establish diagnostic criteria for metabolic syndrome, and determine risks factors for NCDs 
among Sri Lankans. In 2008, a baseline survey was conducted and a follow-up survey is being carried 
out. 
Cancer Registry 
The National Cancer Control Program started a cancer registry in 1985. The data are institution based and 
collected and reported periodically. A population-based cancer registry is yet not in place.  
Mortality Data 
Mortality data are recorded by the Registrar General‘s Department using data from death certificate 
records from all provinces in the country. This department uses ICD-10. Even though death certification 
coverage is more than 90 percent, the quality of the data on reported cause of death was low up to 2006, 
although since 2004, efforts have been taken to improve the quality those data by changing reporting 
structures and formats. Another issue is timeliness, since the latest available mortality statistics, including 
data on cause of death, are for 2005. 
Private Sector Data 
The private sector does not have an established system of collecting or sending health sector data to the 
public sector except for the notification of infectious diseases and for special studies done by researchers. 
Furthermore, little is known of the quality of the private sector‘s data systems.  
Health Sector Responses to NCDs 
Public Curative Services 
The current public system approach to health service delivery does not specifically target NCDs, aside 
from some NCD-specific initiatives and individual institutions. A new chronic NCD case is typically 
diagnosed at one of two locations: outpatient short-term care within the outpatient department or in the 
hospital when they are admitted as an inpatient. For newly diagnosed cases, no systematic procedures are 
in place in most institutions to ensure that standard diagnostic and treatment procedures are followed, 
leaving diagnosis and treatment dependent on the clinical awareness and training of physicians involved.  
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The current practice is that once diagnosed (for example, in the outpatient department short-term clinic), 
patients are referred to a specialist clinic for continuing care and management. In many secondary- and 
tertiary-level institutions these patients are permanently registered in specialist clinics, where they can 
continue to obtain care on a regular basis (at, for example, monthly clinics). At these clinics, patients may 
be given regular appointments for routine follow-up and management, as well as supplies of drugs and 
regular testing and monitoring of blood pressure, blood sugar, lipids, etc. When laboratory tests or drugs 
are unavailable in the facility, patients are requested to buy these services from the private sector at their 
own cost. This specialist-led treatment model, where patients are managed in specialist clinics, is 
currently the predominant approach for managing NCDs in the public sector. Complications and 
advanced-stage conditions related to NCDs are also handled in this way, or by admission to public 
hospitals.  
Patients are aware of the system‘s limitations, especially the lack of capacity at lower-level facilities, and 
so most patients who have been diagnosed show a strong preference to continue obtaining care from 
specialist clinics. This leads to systematic bypassing of the primary-level institutions for NCD care. 
Patients in rural areas often travel long distances and spend considerable time accessing specialist clinics. 
Spending significant amounts of money to obtain necessary drugs and tests for NCD care is frequently 
reported as the leading complaint and cause of dissatisfaction among public sector patients (for example, 
JICA Study Team, 2003). Persons seeking care after standard clinic hours are often admitted to hospital 
when the illness might not warrant it.  
Well Women Clinic 
The Well Women Clinic program, which started in 1996, aims to improve women‘s health through 
providing screening services for hypertension, diabetes, and breast and cervical cancer to women over 35 
years. It also provides referrals and follow-up as needed. Clinic participants receive general physical 
examinations; blood pressure measurements; urine screening for glucose; breast examination and 
instruction on breast self-examination; pelvic examination with screening for infections and cervical 
cancer; health education on menopause, STD/AIDS, and nutrition; and family planning needs.  
To maintain uniformity in implementation of the program and to ensure standards of care, clinics are 
provided with guidelines. Even though this program has been in existence for more than a decade and 
provides services through over 600 functioning clinics in most Medical Officer of Health areas 
(Table 3.6), the coverage of the target population is limited. In addition, Pap smear results often take time 
to come through, and low community awareness of the clinics is problematic.  
Table 3.6 Well Women Clinic Experience  
Activity 2007 
Total number of Well Women Clinics  611 
Total number of Pap smears examined 83,480 
Total number of abnormal smears detected 173 
Diabetes mellitus cases detected 2,338 
Hypertension cases detected 5,425 
Breast abnormalities detected 1,830 
Source: Report on Family Health. 2007. Family Health Bureau. 
 
Public Sector Referral System 
There is currently no formal referral system in the public or private health sector in Sri Lanka. Patients 
seek care in the medical institution of their choice. This is a result of the political system, in response to 
public pressure prioritizing equity in access over other technocratic and quality concerns. This policy 
implicitly recognizes that restrictions in access would result in different rights of access to higher-level 
care, which is more accessible to better-off Sri Lankans (Rannan-Eliya and de Mel, 1997). This 
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prioritization is similar to what has happened in Japan (Campbell and Ikegami, 1998), and, as in Japan, is 
a key reason for the good equity performance of the system. 
With growing patient expectations, awareness, and demand for specialist physician care, patients are 
increasingly seeking care from higher-level facilities, a trend that is most easily seen in the case of 
childbirth where 88 percent of deliveries take place in secondary and tertiary hospitals (Annual Health 
Bulletin 2008). In response, the public sector has incrementally expanded higher-level facilities over time 
and upgraded facilities to provide better services. 
Private Sector NCD Care Services 
NCD patients obtaining care in the private sector need to directly pay for the cost of consultations, 
laboratory tests, and all drugs. Since NCDs are typically excluded from coverage as preexisting 
conditions, private health insurance generally does not pay for NCD care (JICA Study Team, 2003). 
Nevertheless, use of private outpatient care is common by both high- and middle-income Sri Lankans, as 
outpatient consultation is affordable for many (see Chapter 4). 
To the extent that NCD patients can identify a private doctor whom they can see on a routine basis, access 
to continuity of care is feasible. This is most likely in the case of the minority of private sector physicians, 
who are full-time private family or general practitioners, or who are government specialists with 
established private sector practices. However, such practitioners are really only found in urban areas.  
There is limited evidence on the quality of care provided for private sector patients, but past studies 
indicate that the quality of treatment for common NCDs given by private general practitioners may be 
high. For example, analysis of data from the Sri Lanka Private Clinic Survey 2000 (Rannan-Eliya et al., 
2003), indicates that the pattern and appropriateness of drugs prescribed, the type and number of 
interventions, and the overall level of referrals for patients with asthma and hypertension seen by private 
general practitioners in Sri Lanka are comparable with the patterns reported for Australian primary care 
physicians. Such levels of quality are almost certainly related to the high levels of formal training in 
family practice of these private general practitioners, and to the high degree of professionalism that most 
gained during their training in the public sector. However, these levels may not be representative of the 
care received by most private sector patients, since these general practitioners see fewer than 15 percent 
of all private patients. Junior government doctors working in their off-duty hours, with no formal training 
in family medicine, see most private patients.  
Recent years have seen a significant increase in supply of high-technology NCD treatments by private 
hospitals. These range from coronary artery bypass grafts and angioplasty procedures for heart disease to 
specialized radiotherapy services. For some services such as coronary angioplasty, private sector 
provision may now be greater than the public sector‘s. However, as such treatments are effectively 
restricted to the richest Sri Lankans, they have no material impact on the country‘s overall NCD burden. 
NCD Activities 
Tobacco Control and National Authority on Tobacco and Alcohol 
In 2005, Sri Lanka was the first Asian country to adopt and ratify the Framework Convention on Tobacco 
Control. In collaboration with the WHO and Bloomberg Global Tobacco Initiative, the focus of efforts in 
Sri Lanka have been to protect young people. A ban on smoking in public places was passed by 
Parliament in 2006 with strong penalties for violators. Since the passage of the National Authority on 
Tobacco and Alcohol Bill (2007), tobacco control policies that have been developed include tax increases 
on cigarettes and tobacco products; restrictions on sales to youth; and restrictions on public and mass 
media advertising. Local control efforts include creation of district tobacco control cells with a lead role 
for them in implementing the provisions aimed at reducing tobacco use. (The smoking prevalence in Sri 
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Lanka cited in this report was measured before these initiatives were in place. Any impact from them 
would result in additional gains in tobacco use reductions.)  
Clinical Guidelines for Care of Selected NCDs  
The hospital efficiency and quality improvement component of the Sri Lanka Health Sector Development 
Project (a World Bank–financed project in 2005–2010) developed 93 clinical guidelines for care of 
selected conditions identified by teams of specialists from eight medical colleges (covering internal 
medicine, surgery, radiology, microbiology, gynecology and obstetrics, pediatrics, and anesthetics). Ten 
guidelines were for NCDs and related conditions including hypertension, diabetes, CVD, asthma, stroke, 
epilepsy, antithrombotic therapy, unstable angina, and non-ST elevated myocardial infarction. The 
guidelines consider local capacity and provide guidance at three levels: basic but mandatory components; 
desirable components where capacity is available; and optional components when capacity becomes 
available in the future. They were distributed to all specialist units in base hospitals, district general 
hospitals, provincial hospitals, and teaching hospitals. They were also distributed to primary-level care 
hospitals in Uva and Southern provinces.  
These clinical guidelines should prove to be a major asset, although barriers to their uptake include lack 
of a systematic plan to ensure continuous training of all frontline clinical staff in the protocols/guidelines 
and follow-up training of new staff, and monitoring of the implementation after training; distribution on 
CD-ROM when many institutions lack computer facilities (and only few paper-based guidelines are 
available); and failure to embed the initiative in an overall national process to continuously review and 
update the guidelines.
17
 (This outcome might be fairly typical of some projects where no long-term 
impact is realized, highlighting the need to evaluate and adjust pilots and programs.)  
Pilots for NCD Care 
Three important pilot schemes are ongoing and should provide data and an evidence base for developing 
interventions for prevention and treatment. In addition, they should provide better understanding of the 
additional burden that newly diagnosed cases will add to the public health care system during screening 
and early detection efforts. These pilots are now outlined.  
Population Screening for Selected NCDs  
The introduction of population screening for NCDs for men and women over 35 years was planned by the 
Regional Director, Health Services team and initiated in the Ratnapura district under funds available 
through the World Bank–financed Health Sector Development Project in 2005. Clinics were held in 
remote parts of each Medical Officer of Health area within the district. The team consisted of the Medical 
Officer of Health, relevant public health inspectors and public health midwives, and a pharmacist from a 
divisional hospital that was equipped with primary care drugs and basic medical and laboratory 
equipment for blood pressure assessments.  
In 2008, the NCD screening clinics were expanded to include asthma and selected cancers. Over the first 
three years of this activity, the number of clinics held and the numbers screened increased substantially. 
In years two and three the yield of new cases among those screened was approximately 3–4 percent 
(Table 3.7). This approach provided screening services to only a small fraction of the targeted population. 
The population that is reached with this effort may be quite small, even in the best of circumstances.  
However, gaps in follow-up care and overall low coverage led to the program‘s suspension in 2009. 
Current plans are to restart the program in July 2010 with outreach clinics in the rural areas in order to 
facilitate primary care units to screen patients over 40 years of age during clinic encounters, and to 
develop health card and referral forms. In addition, it is planned to provide screening services at 
                                                     
 
17  Countries such as the United Kingdom and the United States, which follow this type of approach, have update reviews 
embedded in the process. 
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workplaces. Guidelines are being prepared for the screening frequency and management of diagnosed 
patients.  
Table 3.7 Details of screening clinics held for selected NCDs, Ratnapura district, 2005–2008  
Description  2005 2006 2007 2008 
Number of outreach clinics held for screening at all 
Medical Officer of Health areas of district  
75 99 128 — 
Total number of persons screened for diabetes, 
hypertension, asthma, IHD, cancer, and other 
conditions 
3,023 12,598 15,314 — 
Total number of new cases detected for 
hypertension (HT), diabetes (DM), and IHD 
543 (18.0%)  
HT 404  
DM 84  
IHD 55 
547 (4.3%) 
HT 406 
DM 83 
IHD 58 
512 (3.3%) 
HT 377 
DM 94 
IHD 41 
614 
HT 373 
DM 177 
IHD 64 
Source: Regional Director, Health Services, Ratnapura district, 2010. 
— = data not available. 
 
Package of Essential NCD Interventions  
The Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in 
Low Resource Settings pilot (Mendis et al., 2009), supported by WHO, was recently started. The package 
includes six core activities as well as plans to introduce comprehensive NCD care within the primary care 
settings. The core activities are: assessing human resource availability; providing NCD care knowledge 
updates for staff; assessing availability of essential equipment needs for NCD care (including blood 
glucometers, peak flow meters, electrocardiograms, and nebulizers); making necessary changes to the 
essential drugs list to include first line for NCDs; developing and applying 10-year CVD risk charts to 
clinic populations; and developing and introducing protocols for follow-up care and management of 
NCDs. All preliminary assessments under each of these six core activities have been concluded and 
implementation is planned for late 2010 in Badulla district in three selected divisional secretariat areas. 
Three other such areas from the same district will be used for comparison.  
Health Promotion and Preventive Measures of Chronic NCDs 
The five-year Project on Health Promotion and Preventive Measures of Chronic NCDs, supported by the 
Japan International Cooperation Agency (JICA), began in 2008. Its purpose is to develop effective and 
efficient implementation strategies for controlling chronic NCDs. The project plans four major outputs: 
prevalence estimates of NCDs and risk factors; intervention strategies formulated using surveillance data; 
development of an implementation structure and mechanisms to implement strategies to control chronic 
NCDs in the target areas; and development of an outline for scaling up and generalizing relevant 
operations at the national level. 
In Kurunegala district the project is piloted in two Medical Officer of Health areas, and in Polonnaruwa 
district it is piloted in one such area. People aged 40 to 75 years without a past history of NCD (total 
target population 64,201 persons from the three areas) are provided with health guidance support, a health 
checkup, and a risk analysis. Patients are allocated into one of three risk groups based on blood pressure, 
BMI, and smoking status. Health promotion for low-risk people is provided in two settings—village and 
workplace. For those with newly diagnosed NCDs or already diagnosed, referrals are made to primary 
care centers or higher-level facilities as appropriate.  
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Chapter 4: Patterns and Trends in Utilization of Curative 
Care for NCDs 
Key Messages 
 The public sector provides nearly all the preventive care, not quite half the outpatient care, 
and most of the inpatient care.  
 Annual inpatient utilization rates in Sri Lanka are similar to those in OECD countries. 
 Bed-occupancy rates are 83 percent in tertiary, 56 percent in secondary, and 47 percent in 
primary facilities. This distribution points to inefficiencies in the system and places 
unnecessary strain on tertiary-level facilities. 
 Two-thirds of clinic-based services (mainly for chronic NCDs) are provided through 
secondary- and tertiary-level facilities. 
 Across household income quintiles, overall utilization of outpatient and inpatient services 
is similar, although richer quintiles use more private outpatient services, and the richest 
quintile uses more private inpatient services.  
 In 2008 in terms of inpatient morbidity, NCDs (excluding injuries) accounted for 
23.7 percent of hospital stays and injuries for 18.2 percent, while infectious diseases 
accounted for 26.3 percent, maternal and child health conditions for 11.5 percent, and 
others for 20.3 percent.  
General Patterns of Utilization of Curative Care Services 
Health services are provided by private and public sectors for allopathic and Ayurvedic (indigenous 
medicine) treatment. Over 25 years to 2003/04 the public system was the source of treatment by sick 
persons 45–50 percent of the time, mainly in the form of allopathic care (Table 4.1). The private sector‘s 
allopathic proportion grew while private Ayurvedic care declined, yet the total from the private sector 
(both types) remained constant at 45–50 percent.  
Table 4.1 Sources of treatment used by sick persons, Sri Lanka (%) 
Source of treatment 1978/79 1981/82 1986/87 1996/97 2003/04 
Public allopathic  42.6 45.6 44.1 50.7 45.2 
Private allopathic  34.3 34.2 37.2 38.1 46.7 
Public Ayurvedic 1.9 2.2 1.9 2.0 1.2 
Private Ayurvedic  16.1 12.1 12.9 7.6 5.2 
Others 5.1 6.0 3.8 1.7 1.7 
Total (%) 100 100 100 100 100  
Source: Computed by Institute for Health Policy from reports and data of Central Bank Consumer Finance Surveys. 
Note: The percentages are for those who reported falling ill during a 14-day reference period and used any source of treatment, 
including both inpatient and outpatient treatment. Private allopathic sources include pharmacies.  
 
In terms of the type of care, the public sector provides nearly all the preventive care, not quite half the 
outpatient care, and most of the inpatient care. The private sector provides the rest (Table 4.2). 
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Table 4.2. Health service provided by different sectors, Sri Lanka (%) 
Type of care Private providers Public providers 
(government) 
Preventive  Minimal Nearly 100 
Curative—Outpatient 50–60 50–40 
Curative—Inpatient 10–15 90–85 
Sources: Annual Health Bulletin 2003 and Central Bank Annual Report 2008. 
 
Levels of Curative Care Utilization 
Sri Lanka‘s extensive health care system facilitates a high level of utilization. Inpatient utilization rates 
are in the middle or at the higher end of the OECD range, while outpatient rates are at the lower end 
(Table 4.3).  
Table 4.3 Annual rates of medical care utilization, Sri Lanka and OECD countries 
Indicator Sri Lanka (2006) OECD range 
Outpatient visits per capita 4–5 3–14 
Inpatient admissions per 100 capita 22–24 6–28 
Acute care bed-days per 100 capita 90–100 40–180 
Bed-occupancy rate (%) 74 65–91 
Source: Institute for Health Policy estimates based on its own data, MOH data, and OECD Health Data 2008. 
 
The main explanation for this variation comes from the high pressure under which the public sector has to 
operate (Hsiao and Associates, 2001). While empirical evidence is lacking, given the current organization 
of the service delivery system in the community, this pattern may reflect the fact that patients go to 
hospital outpatient departments to consult, even for most minor illnesses, and if diagnosis is uncertain (for 
example, due to lack of diagnostic tests), conservative treatment would be to admit patients to hospital.  
Utilization by Type of Institution 
The curative care institutions of the central and provincial MOHs account for almost all public sector 
curative care provision, with only a very limited volume of other services provided by a few dispensaries 
run by municipal councils, and two small hospitals for the army and police.  
Secondary and tertiary hospitals provide care for about two-thirds of inpatient admissions and have 
relatively higher bed-occupancy rates than primary care hospitals (Table 4.4). Two-thirds of the long-term 
clinic visits, which would include NCD patient visits, are also made at secondary and tertiary care 
facilities. Primary care hospitals and clinics manage the majority of outpatient visits (short-term patients 
with three-day treatment).  
These patterns reflect the general trend of at least the past half-century for public sector patients to 
increasingly use higher-level facilities. The health system‘s organization and treatment patterns have also 
resulted in the majority of chronic NCD primary care being provided at higher-level public hospitals in 
long-term clinics rather that at short-term, lower-level, public outpatient facilities.  
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Table 4.4 Distribution of public sector institutions and patient utilization by level of facilities 
Hospital level Number of 
hospitals 
Beds (%) Bed-
occupancy 
rate (%) 
Inpatient 
admissions 
(%) 
Clinic visits 
(%) 
Outpatient 
visits (%) 
Tertiary care 17 27 82.6  25.6 31.7 12.3 
Secondary care 122 36 56.3 43.1 34.3 24.8 
Primary care  507 37 47.2 31.3 28.0 48.5 
Primary care 
(outpatient only) 
438 0 0 0 6.0 14.4 
Total 1,084 100 49.8 100 100 100 
Source: Computed by World Bank based on Annual Health Statistics 2008 provisional data and 2007 data from the Medical 
Statistics Unit.  
Note: Total beds = 68,694; total inpatient admissions = 4,897,815; total clinic visits = 17,609,370; total outpatient visits = 
45,381,715.  
 
Utilization by Income Level 
The overall volume of curative services utilization is essentially equal across income levels (Figure 4.1). 
If the need for medical care were greater among the poor, the use of care would not be equitable, but as 
seen in Chapter 2, unlike other countries the evidence on this is mixed in Sri Lanka, with infant and child 
mortality higher among the poor, but overall mortality rates possibly higher among the better-off.  
Figure 4.1 Share of health care utilization of outpatient and inpatient services in public and private 
sectors, by quintile of household SES, Sri Lanka, 2004 (%) 
Outpatient services  
 
Inpatient services  
 
 
Source: Institute for Health Policy estimates from Central Bank of Sri Lanka (2005). 
 
Still, patterns of use of public and private services differ, with public services used more by the poor and 
private services used more by the rich. Outpatient care has a pronounced poor–rich gradient (the rich use 
more private services). However, inpatient care finds a more complex pattern. In the lower quintiles 
public inpatient services are the dominant source. In the fourth quintile, private use equals public and then 
in the richest quintile, private is the dominant source. This pattern of use of public and private services by 
income level is also found in Malaysia, Hong Kong (China), and some Pacific islands.  
% 
% 
Percentile Percentile 
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Patterns of Curative Care Services by Patients with NCDs 
Contribution of NCDs to Curative Care Use  
Systematic data on the use of curative care services by patients with NCDs are limited to public services 
and inpatients (outpatient data are not routinely classified) and these statistics are aggregated as they are 
nationally compiled, which does not allow for cross-tabulations. However, provisional data for inpatient 
morbidity for 2008 can lend some broad insight.
18
 In 2008 injuries accounted for 18.2 percent of inpatient 
stays while the remaining NCDs (excluding injuries) accounted for 23.7 percent. Infectious diseases 
accounted for 26.3 percent, maternal child health for 11.5 percent, and other causes for 20.3 percent.  
Further analysis of inpatient services was made by the Public Hospital Inpatient Discharge Survey 
(PHIDS) (Perera et al., 2009). It collected 10,000 patient discharges from government hospitals in 2005 
and is the only nationally representative database of patient-level records available for analysis of 
inpatient discharges by type of disease.  
According to PHIDS data, one-third of all hospital admissions in the public sector were due to the major 
NCDs. Their importance at each level is shown in Table 4.5. Injuries account for a little less than half of 
all NCD admissions at all levels of the system, although have a bigger share of admissions at primary and 
secondary institutions than tertiary ones. Of the rest, asthma was the leading cause of admission at all 
levels, but it was much more important at the primary level (7.7 percent) than in higher-level institutions 
(2–3 percent). The next major cause of NCD admissions was CVD. Cancers account for almost no 
admissions at primary and secondary level, but their share increased at higher levels.  
Table 4.5 Share of patient discharges accounted by selected NCD and other conditions at different 
levels of health care institutions, Sri Lanka, 2005 (%) 
Primary diagnosis   Tertiary   Secondary   Primary   
All 
levels 
Asthma   1.8     3.0     7.7     4.2  
Other chronic respiratory disease   2.1    3.2    5.8    3.7  
Diabetes mellitus   1.1    1.4    1.2    1.2  
IHD   1.8    2.4    1.8    2.0  
Hypertension   0.9    1.5    3.5    1.9  
Other CVD   2.2    2.2    1.4    2.0  
Cancers   6.5    0.5    0.2    2.3  
Other NCDs   3.3    1.6    1.5    2.1  
Injuries   11.1    18.5    19.7    16.6  
Maternal/neonatal/congenital/nutritional   13.4    16.3    7.8    12.6  
Infectious and parasitic disease   6.7    8.3    16.6    10.5  
Others    49.2     41.1     32.8     40.9  
Total  100.0  100.0  100.0  100.0 
Source: Institute for Health Policy estimates based on data from Perera et al. (2009). 
Note: NCD causes ranked in order of decreasing size. For this analysis other diseases not included in NCD category include 
peptic ulcer disease/gastritis, other diseases of the digestive system, urolithiasis, disorders of the female genital system, other 
genitourinary diseases, skin diseases, and all ill-defined conditions. 
 
Table 4.6 provides additional information on the inpatient demand from NCDs. It classifies the overall 
composition of inpatient discharges, bed-days, and costs in the public sector in 2005. Injuries account for 
the largest share of overall patient discharges and for hospital costs. However, the average length of stay 
(ALOS) for injuries is relatively short, indicating that most such admissions are probably for minor 
injuries. Furthermore, a community-based injury incidence survey indicated that even though the injury 
                                                     
 
18  Provisional data provided by MOH Medical Statistics Unit for indoor morbidity in 2008.  
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burden was very high (24.6 per 100 population), only 25 percent of those injured required inpatient care 
(Navaratne et al., 2009). Although some NCDs, such as cancer, account for only a moderate proportion of 
actual discharges, they account for a greater proportion of bed-days and overall inpatient costs. Cancer, 
diabetes, and CVD in particular tend to be more costly than the average admission. In general, the more 
expensive NCD diseases are more likely to be handled in higher-level hospitals. 
Table 4.6 Patient discharges, bed-days, and inpatient costs by major categories in the public sector, 
Sri Lanka, 2005  
Cause 
Discharges 
(%) 
ALOS 
(days) 
Bed-days 
(%) 
Costs (%) 
Injuries 16.6 3.4 13.4 14.7 
Malignant neoplasms 2.3 10.8 5.8 7.2 
CVD 4.0 4.4 4.1 5.8 
Chronic respiratory diseases 7.9 4.0 7.4 5.2 
Diabetes mellitus 1.2 6.3 1.8 1.5 
Hypertension 1.9 3.8 1.8 1.0 
Other NCDs 2.1 10.4 5.3 3.7 
Infectious and parasitic diseases 10.5 3.6 8.9 7.4 
Maternal, neonatal, congenital, and nutritional 13.0 5.2 15.8 17.7 
Other 40.5 3.7 35.7 35.8 
Sources: Institute for Health Policy estimates from data collected in PHIDS 2005; cost estimates from Institute for Health Policy 
Sri Lanka Disease-specific Accounts Project in 2005.  
International Comparison of NCD Inpatient Demand 
The rates of hospital admission for selected major NCDs are compared to those for OECD countries in 
Table 4.7. As the table shows, overall rates of inpatient demand for many NCDs, with the exception of 
myocardial infarction which is lower, are already comparable to the average in OECD economies, despite 
Sri Lanka‘s relatively younger population.  
The most notable difference in the table between Sri Lanka and OECD countries is that Sri Lanka‘s 
admission rates for asthma are nearly 10 times as high as the OECD average, and three times as high as 
the highest rate reported by any OECD country. Asthma is inherently a treatable, though not curable, 
disease through appropriate medical care, so hospitalization for asthma is essentially a consequence of 
insufficient medical treatment in the community or may reflect provider behavior and reluctance to treat it 
in the outpatient department. For this reason, asthma admission rates are used in many OECD countries as 
a health system quality indicator. For example, asthma admission rates are a High Level Performance 
Indicator in the U.K. National Health Service, and both pediatric and adult admission rates are part of the 
U.S. National Healthcare Quality Report (OECD, 2007). This exceptionally high rate of admission for 
asthma may suggest deficiencies in care.  
Table 4.7 Rates of admission for selected NCDs (discharges per 100,000 population), Sri Lanka and 
OECD countries, 2005 
Cause of admission Sri Lanka OECD mean OECD range 
Acute myocardial infarction 70 183 15–390 
Diabetes mellitus 177 197 66–498 
Schizophrenia 87 93 4–370 
Asthma 893 97 27–301 
Bronchitis/COPD 138 200 20–414 
Cataracts 196 208 2–902 
Source: Sri Lanka estimates are Institute for Health Policy computations based on data from Perera et al. (2009), and are for the 
public sector only. OECD estimates are from OECD Health Data 2008. 
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Future trends in Health Care Utilization  
Projecting Future Inpatient Demand  
Building on a model originally conceived with funding from the U.S. National Institute on Aging, 
Rannan-Eliya (2008) developed projections of future health care costs in Sri Lanka. This study found that 
population aging would be only one of many factors to influence growth in future health care costs. It 
concluded that changes in health care seeking behavior, in public sector productivity, and in private sector 
price inflation would be equally important determinants, and that sustained productivity growth and 
continued public sector dominance of health financing would be able to minimize the impact of aging on 
health care costs. These projections, however, did not explore further the trends in demand for curative 
care, or look in detail at trends in specific diseases.  
It is not possible to meaningfully project future trends in utilization of NCDs in Sri Lanka at the current 
time, as there is a lack of data on past trends in prevalence and only minimal data on the relationships 
between risk factors and disease prevalence in most cases. Another approach might be to use population 
projections for Sri Lanka (De Silva, 2007) and the rate of admissions for each disease category, and then 
project forward, taking account of the projected changes in the age and sex structure of the population. 
This allows assessment of how future population aging might affect the pattern of inpatient care use, both 
for NCDs and other diseases. However, this modeling assumes that age–sex specific rates of inpatient 
admission for each disease category will not change. In reality, this is unlikely to be the case. Hence, any 
modeling of future trends needs to be interpreted with great caution and many caveats.  
Utilization of Pharmaceuticals for NCDs 
Use of NCD Medicines in International Comparison 
Overall rates of use of NCD medicines in Sri Lanka are at the lower end of the range among developed 
countries with comparable standardized mortality rates for chronic NCDs. Figure 4.2 contrasts levels of 
use of antibacterial drugs and selected NCD drugs in Sri Lanka, measured in terms of defined daily doses 
per 1,000 capita a year (WHO Collaborating Centre for Drug Statistics Methodology, 2008) with the 
range seen in OECD countries. The figure presents the rates of use in the lowest, median, and highest 
OECD countries.  
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Figure 4.2 Consumption of selected NCD medicines in defined daily dose units, Sri Lanka, 2008 and 
OECD countries, 2006 
Antibacterials 
 
Beta-blockers 
 
Antidiabetics 
 
Drugs for obstructive airways disease/asthma 
 
Source: OECD countries for 2006 from OECD Health Data 2008, and Sri Lanka for 2008 computed from data provided by MOH and 
IMS-Health (Sri Lanka). 
 
The data show that while the rates of use of medicines for infectious disease in Sri Lanka are near the 
median range of OECD countries, the rates of use of NCD medicines in Sri Lanka are all below the 
lowest OECD countries in the case of many NCD medicines, such as beta-blockers for IHD or drugs for 
asthma. Rates of use in Sri Lanka may be considered more optimal if overall rates of use in OECD 
countries are too high. However, analyses of the prescribing of these medicines in OECD countries 
generally find that almost all these NCD medicines are underprescribed and underconsumed in relation to 
clinical guidelines (Dickson and Jacobzone, 2003; Stolk et al., 2006), indicating that the gap with actual 
need is even greater in Sri Lanka than these data suggest. 
Of course, it could be argued that the side-by-side comparisons made in Figure 4.2 may be misleading, 
since the aggregate NCD burden in Sri Lanka will be lower given its younger population, despite having 
comparable standardized mortality rates. To address this, Figure 4.3 extends the comparison by charting 
the levels of use of these medicines against the crude death rates for relevant diseases, which are a 
measure of the total burden of disease. In OECD economies, the figure shows a clear linear relationship 
between the underlying disease burden and the use of relevant medicines. However, in all the cases, 
consumption of relevant medicines in Sri Lanka is less than the expected level, with the differences least 
for antibacterial drugs and beta-blockers, and most for asthma. This result implies not only that overall 
medicine utilization is less in Sri Lanka, but also that the disparity is most substantial for asthma. 
However, the disparity for beta-blockers would be consistent with research in OECD countries that has 
found that cross-country variations were least for the cheapest and oldest heart disease medicines, such as 
beta-blockers (Dickson and Jacobzone, 2003). 
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Figure 4.3 Consumption levels of medicines and mortality rates for relevant NCDs, Sri Lanka and 
selected OECD countries 
Antibacterials and infectious disease 
 
Beta blockers and CVD 
 
Antidiabetics and diabetes 
 
Drugs for obstructive airways disease and asthma 
 
Source: For medicine consumption as in Figure 4.2; crude death rates for OECD countries for 2003 from WHO Mortality Database, 
and Sri Lanka from Registrar General data (2005). 
 
One explanation for the low overall levels of use of NCD medicines in Sri Lanka is the low volumes of 
essential NCD medicines available in the public sector (as seen in Chapter 3). Other explanations include 
provider practice patterns and low patient compliance with treatment. In OECD economies the bulk of 
NCD medicines are purchased through public financing, and considerable evidence exists to indicate that 
if not for this public financing, overall levels of use of NCD medicines in OECD economies would be 
substantially less (Dickson and Jacobzone, 2003). In the next chapter, we examine in detail the current 
pattern of NCD drug purchasing in Sri Lanka.  
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Chapter 5: Financing of Health Services for NCDs 
Key Messages 
 Total health expenditures in Sri Lanka increased from 3.5 percent of GDP in 1995 to 4.0 
percent in 2008, of which the share of public spending declined from 47 percent to 43 
percent. These overall expenditures are lower than in countries with comparable 
demographic indicators. 
 The expenditures for treatment of cancers and acute heart attacks in 2005 were 
predominantly publicly financed while those for diabetes, asthma, and heart disease were 
predominantly privately financed. Private expenditures were mainly out of pocket.  
 From two-fifths to nearly all expenditures on NCD medicines are from private sources 
(mostly out of pocket). For CVD, diabetes, and asthma about half the out-of-pocket 
expenditures are for outpatient care and drugs.  
 The need for frequent clinic visits created repeated costs. Patients from rural, low-income 
areas with diabetes are often unable to go to a clinic, contributing to a deterioration in 
their condition.  
 The private sector handles approximately three-fifths of the market requirements for drugs 
while the government handles the balance, implying high risk of inequity. 
 Because public sector unit prices for key NCD drugs are a small fraction of private sector 
prices, it may be financially feasible with public funds to increase drug supply to 80 
percent of the median utilization rate in OECD countries.  
Overview 
Total health expenditures climbed from 3.5 percent of GDP in 1995 to 4.0 percent in 2008, while the 
proportion of public spending declined from 47 percent to 43 percent of this total. This level of spending, 
overall, is lower than in other countries with comparable demographic indicators (Table 1.1and 1.2). 
Health financing in Sri Lanka is from two main sources: general taxation and out-of-pocket household 
spending. Supplementary private insurance, whether provided by employers or self-purchased, covers 
only a small fraction of individuals in higher-income groups; moreover, as the available benefits are 
usually inadequate for treatment of serious or chronic illnesses, these conditions are predominantly treated 
by the public sector. Most public funds come from taxes on goods, services, and incomes. Neither the 
central nor provincial MOHs have succeeded in revenue-generating schemes within the health system. 
The general public is sensitive to equity issues and carries the persuasion that basic government medical 
services should be free to all.  
Most inpatient care and almost all preventive care is funded by the government, while most private 
expenditures are for outpatient services and purchase of medicines from pharmacies and clinical 
investigation tests from private laboratories. Catastrophic illnesses are mostly covered by public funds 
that provide hospital, outpatient, and public health care, to the extent feasible.  
The MOH receives grants and loans from external development partners for NCDs including the World 
Bank, WHO, and JICA. These external resources accounted for less than 5 percent of total health 
expenditures during the last decade.  
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Financing of NCD Expenditures 
Figure 5.1 illustrates the relative contributions of public and private financing to spending on several 
major NCDs. Owing to the current organization of the health system, much care for NCDs is delivered in 
the private sector. In the private sector, patients pay for almost all their treatment costs. In the public 
sector, patients making clinic visits do not pay fees, although they must frequently pay for the costs to the 
private sector for prescribed medicines and laboratory tests. However, for emergency inpatient care of 
NCDs and for some illnesses such as cancer, most patients have to rely on the public sector. Treatment of 
cancer and acute myocardial infarction is predominantly publicly financed, while expenditures on chronic 
NCDs, such as diabetes, asthma, and other types of IHD, are predominantly privately financed.  
Figure 5.1 Expenditures on major NCDs, by public and private sources (%), Sri Lanka, 2005 
 
Source: Computed from estimates of the Institute for Health Policy Sri Lanka Disease-specific Accounts Project in 2005. 
 
Figure 5.2 shows how spending on selected NCDs is distributed by type of services and goods. For those 
NCDs where private financing is predominant (diabetes, CVD, and asthma), a large proportion of 
spending is for medicines and for ambulatory care services because patients must largely finance these 
costs themselves. These findings point to public sector underfinancing of medicines in ambulatory care 
for NCDs. (As this is an important —though not the only—issue, the next section examines it in greater 
detail.) 
These findings have been confirmed through in-depth interviews and focus group discussions conducted 
in four Sri Lankan districts investigating the care-seeking behaviors of persons with diabetes from 
households at different income levels (Perera et al., 2007). In addition, these visits to clinics with the 
capacity for diagnosis and management of diabetes, are often far their communities. This implies that 
clinic visits also incurred losses in income from missed work. The need for frequent visits also creates 
repeated costs. Many patients, especially those from low-income, rural households, may not be able to 
maintain their management regimen, and their condition deteriorated. These findings suggest that existing 
facilities that are closer should have diagnostic and management capacity and that financal support for the 
poor is required to prevent their foregoing preventive and curative care.  
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Figure 5.2 Expenditure on major NCDs, by major spending areas (%), Sri Lanka, 2005 
Financing of Medicines 
Overview  
The pharmaceutical sector is heavily dependent on imports with only 14 percent of needs met by local 
manufacturers. Almost all imports by the private sector are channeled to retail pharmacies, private 
hospitals, and physicians (general practitioners) through wholesale distributors. MOH hospitals also 
purchase urgently required drugs from private sector importers. All drugs necessary for treatment of NCD 
patients are  imported.  
The State Pharmaceutical Corporation purchases drugs both for the private and public sector through a 
tender procedure. The private sector also imports directly from the manufacturers under individual import 
licenses issued by the Import Control Department. The private sector imports drugs under brand names, 
while the government, as far as possible, restricts imports to generic names. The share of the government 
health budget spent on medicines and supplies for outpatient and hospital use is about 18.7 percent 
(2006). The total pharmaceutical market for outpatient medicines is currently estimated to be nearly 
SLR16 billion, which accounts for per capita consumption of medicines of roughly SLR800 a year. 
In the public sector, all drugs issued to both inpatients and outpatients are free of charge. However, health 
care facilities routinely ask patients to purchase their own medicines and supplies from private suppliers 
when these are not in stock. Although in the private sector there is no price control, all importers adhere 
to a formula agreed with the government in pricing drugs to the consumer.  
Patients‘ actual needs for NCD drugs and available public financial resources to purchase them have to be 
considered in light of three important points. The first is that the Sri Lankan public sector operates a 
highly cost-efficient procurement mechanism for medicines, making extensive use of global tendering 
and generic and bulk purchasing. Consequently, the average price paid by the public sector for most 
medicines is substantially lower than in other countries, and the volume of medicines purchased with the 
government budget is greater than it would otherwise be. Second, there is an implicit recognition that the 
public sector cannot afford to stock all medicines needed all the time, and an official policy of 
transparency requires institutions to inform public sector patients when medicines are unavailable, so that 
they know when they need to purchase them themselves.  
 
Source: Computed from estimates of the Institute for Health Policy Sri Lanka Disease-specific Accounts Project in 2005. 
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The third point is the prioritization by the MOH of what medicines it buys with its budget. In recent years, 
the budgetary allocation has provided for three-quarters of the stocks of medicines requested by 
government medical institutions.
19
 The initial requests for medicine supply are generated each year by 
institutions, and then collated and transmitted upward to formulate an overall estimate of national needs. 
The Medical Supplies Division then decides what medicines to purchase, taking into account the actual 
budget allocations. This rationing process involves internal deliberation, where vital medicines are the 
highest priority, followed by essential medicines. The lowest priority is for non essential drugs.  In 
practice, purchases of medicines for treatment of acute and life-threatening illnesses are prioritized, while 
purchases of medicines for chronic NCDs tend to be given lower priority. This favors medicines for 
conditions such as injuries and acute NCD events, including acute myocardial infarction, but results in 
underpurchasing of medicines for long-term treatment of NCDs. In recent years, there has been an 
increasing demand from institutions for NCD drugs, particularly for heart disease, but this has only been 
partly reflected in increased purchases. 
Financing Medicines for NCDs 
Appropriate use of drugs for diseases such as asthma, IHD, and diabetes can substantially cut mortality 
rates, and reduce levels of disability and illness. Sri Lanka has reduced its overall mortality rates to levels 
close to those in developed economies, but has done less well in reducing mortality rates from NCDs that 
are amenable to treatment. A major concern of any NCD policy in Sri Lanka must therefore be to ensure 
that the population has access to and makes use of adequate quantities of cost-effective NCD medicines.  
Figure 5.3 presents a profile of the pattern of financing and supply of selected NCD medicines in Sri 
Lanka in 2008. This is based on analysis of the purchases of the Medical Supplies Division (responsible 
for more than 95 percent of all public sector purchases), and of data provided by IMS-Health (Sri Lanka) 
on the volume and cost at wholesale price of medicines supplied through pharmacies, which account for 
85 percent of total private sector distribution. The volumes of medicines distributed in public and private 
sectors are compared after converting all quantities into defined daily dose units, as defined by WHO 
(WHO Collaborating Centre for Drug Statistics Methodology, 2008). To provide a comparison with non-
NCD medicines, statistics for antibacterial drugs are provided.  
                                                     
 
19  Institute for Health Policy personal communication from Director, Medical Supplies, MOH, November 2009. 
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Figure 5.3 Analysis of financing and supply of NCD medicines by public and private sectors and 
funding gap, Sri Lanka 2008 
Share of expenditures on selected medicines by 
source (%) 
 
 
Share of volumes of selected medicines 
financed by source (%) 
 
 
Ratio of public to private sector unit wholesale 
prices for selected medicines (%) 
 
Cost to increase MOH supply to 80% of OECD 
median level (SLR million) 
 
 
Source: Sri Lanka for 2008 from MOH and IMS-Health (Sri Lanka), and OECD countries for 2006 from OECD Health Data 2008. 
 
For most medicine classes, public sector expenditures are only a small fraction of those in the private 
sector (top-left panel). For beta-blockers, calcium channel blockers, and antidiabetic agents, for example, 
private spending is more than four times public spending. However, in terms of volume of supply (top-
right panel), the public sector accounts for half, or more, of actual consumption, with the exception of 
statins. Extensive use of bulk purchasing and competitive tendering ensures that MOH purchases most 
medicines at less than half the price paid by the private sector. 
The bottom-left panel of Figure 5.3 shows the ratio of public to private prices for selected medicines. For 
most NCD classes, the public sector purchases at prices ranging from half to one tenth of wholesale prices 
in the private sector. Its ability to purchase at far lower prices than the private sector means that for many 
NCD medicines, if the public sector was to expand its purchasing, it could reach OECD levels of supply 
while still spending less than current combined public and private spending. OECD levels can be 
considered a reasonable indication of what is appropriate for Sri Lanka, given comparable levels of 
NCDs.  
(%) 
(Rs, million) 
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The bottom-right panel of Figure 5.3 illustrates this point. It shows the additional cost to the government 
of increasing public provision of NCD medicines to raise the overall volume of public sector supply to 
80 percent of the median level in OECD economies. This assumes that the public sector can purchase the 
additional medicines at the same average price as current stocks, which is a reasonable assumption given 
that increased MOH purchasing can only enhance its ability to negotiate prices. The increases implied are 
either significantly less than or comparable to current private expenditures for most medicine classes: 
SLR86 million versus SLR113 million for beta-blockers; SLR91 million versus SLR79 million for 
diuretics; SLR173 million versus SLR619 million for antidiabetics; and SLR83 million versus SLR514 
million for drugs to treat obstructive airways disease and asthma. The only drug class for which the 
increased public cost would be substantially greater than current private spending would be statins, where 
the SLR2 billion increase required is four times current private spending.  
These calculations imply that to raise supply levels of these essential NCD medicines, excluding statins—
namely, antidiabetics, antihypertensives, beta-blockers, calcium channel blockers, diuretics and drugs for 
obstructive airways disease and asthma—to OECD levels would come to less than SLR700 million, or 
US$7 million a year. In 2008, this would have represented less than 1 percent of total public sector health 
expenditures of more than SLR72 billion.
20
 However, procurement costs of medicines are only part of the 
costs. Overheads (storage and management) and transportation costs, which can all be substantial, also 
need to be considered.  
Such a move assumes that public financing is needed to raise overall consumption levels of these 
medicines to more desirable levels with better supplies in public facilities and/or expanding the sale of 
these medicines at low prices through government owned or subsidized pharmacies. However, this is a 
logical inference given the experience of OECD countries. There, the evidence shows that the levels of 
public financing or reimbursement by public insurance schemes have major impacts on the overall level 
of use of essential heart disease drugs (Dickson and Jacobzone, 2003).  
 
                                                     
 
20  To put this into perspective, the cost compares well with other important public expenditure priorities in 2008, such as the 
average cost of building 2 kilometers of the Southern Express Highway, which was SLR1,200 million. 
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Chapter 6: Prevention and Control Strategies from 
Developed Countries and their Potential Impact in 
Sri Lanka 
Key Messages 
 Most NCDs can be controlled, but not cured, and require lifelong treatment.  
 About half the decline in cardiovascular mortality in developed countries from the 1950s 
to the 1970s was attributed to changes in population-level cardiovascular risk factors (such 
as lower tobacco use) and half to treatment of chronic NCDs and their complications (with 
most of the treatment effect due to drug use). 
 Developed countries provide an evidence base for CVD reduction at both the population 
level by reducing tobacco use and improving diet (salt, trans fats, and saturated fats) and 
at primary care level by treatment of conditions with drugs (for example, hypertension and 
cholesterol).  
 NCDs have emerged as a major health issue in developing countries. The focus was and 
remains on prevention strategies involving predominantly health promotion and primary 
prevention through population-level risk factor reduction. But the revolution in low-cost 
medical therapies for NCDs, in particular for CVD, suggests that developing countries 
should now consider both sets of strategies. 
 Simulations of policy option scenarios for CVD in Sri Lanka indicate that population-
based risk factor reduction and clinic-based interventions (with drugs), using a total 
cardiovascular risk approach with treatment thresholds based on CVD risk, can 
substantially reduce mortality.  
 High-income countries have developed several service delivery models for NCDs that 
focus on efficiently providing primary care. The structures and costs of the different 
models are very country specific and depend on existing health system structure, 
incentives, and traditions. Still, common lessons have emerged.  
 Selected middle-income countries in the region have service delivery models that include 
well-developed primary health care components.  
Developed-country Experiences  
Population aging and the increased prevalence of NCDs present new challenges. Two features are at the 
heart of this issue. First, most NCDs are the result of accumulated exposure to risk factors over a lifetime, 
and modern medical knowledge can only control them, not cure them. The second is that increased 
incidence of chronic NCDs with age means that the numbers and proportion of the population living with 
these conditions will increase. Consequently, in contrast to many infectious diseases, a very large 
proportion of the population may eventually be living with chronic NCDs at any given time.  
As noted in Chapter 1, developed countries during the second half of the 20th century saw a major decline 
in CVD mortality. Several analyses of these developed-country trends have found that about half the 
reduction can be attributed to population-level changes in cardiovascular risk factors, such as from lower 
tobacco use and more favorable dietary intake and physical activity, and about half to treatment of 
chronic NCDs and their complications (Moïse, 2003; Cutler et al., 2005; Ford et al., 2007). This decline 
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in cardiovascular mortality is especially important because CVD accounts for the largest share and more 
than half of overall NCD mortality, and an even greater share of the observed reductions in NCD 
mortality. It may also explain more than half of all the declines in older adult disability ratios that have 
occurred in these same countries (World Bank, 2008).  
In past decades as NCDs have emerged as a leading health issue in developing countries, the focus has 
been on prevention strategies involving predominantly health promotion and primary prevention through 
population-level risk factor reduction. This is still the case. However, the revolution in low-cost medical 
therapies for NCDs, in particular for CVD, in the past three decades suggests that developing countries 
should now consider both sets of strategies. This, in fact, is the strong recommendation of WHO (2008b), 
based on global evidence and multiple expert reviews.  
CVD, Diabetes, Asthma, and Common Cancers 
As said, this report focuses most of its attention on CVD, diabetes, and asthma, and to a lesser extent 
cancer, and their risk factors, because the burden from them is large and the evidence base to reduce their 
impact tends to be stronger than for other NCDs.  
CVD  
There are four major types of intervention available to prevent and reduce CVD morbidity and mortality: 
smoking cessation; other preventive health and health promotion activities; treatment-based secondary 
prevention; and hospital treatment of advanced disease, including surgical interventions. (Appendix 9 
details several interventions and their cost effectiveness—which for most of them is highly favorable.)  
Of these four interventions, smoking cessation is the single most effective intervention, and success in 
reducing smoking has been the most important reason for the decline in CVD in developed countries. 
Tobacco control strategies include taxation, which is highly effective in reducing consumption, in 
conjunction with advertising bans, health information, warning labels, smoking restrictions, and control 
of smuggling. Through the use of tobacco taxation and other restrictions on the sale, advertising, and 
consumption of tobacco, Sri Lanka has already made solid gains compared with other countries in the 
region.  
Other preventive health and health promotion activities include salt-intake reduction efforts. These use 
public awareness campaigns in conjunction with legislation to reduce the salt content of manufactured 
foods. Trans fat and saturated fat intake-reduction efforts use similar methods, and aim to eliminate trans 
fats, lower saturated fats, and increase unsaturated (that is, healthier) fats in manufactured foods. Low- 
and middle-income countries have had some success in improving dietary oil consumption. In Mauritius, 
an NCD prevention program that started in 1987 promoted health lifestyles. In addition, between 1987 
and 1992, the government changed the composition of the universally used cooking oil from 75–100 
percent palm oil, which is high in saturated fat, to 100 percent soya bean oil, which is high in unsaturated 
fats (Uusitalo et al., 1996). A population-based follow-up survey in 1992 found cholesterol concentrations 
dropped significantly in both men and women (0.79 mmol and 0.82 mmol, respectively), and that dietary 
changes accounted for most the impact.  
Another important example in this vein, but this time concerning consumption of dietary oils, can be 
taken from Poland (Zatonski and Willett, 2005). In 1960 mortality from circulatory disease was high, and 
IHD roughly doubled through 1991. Since 1991, however, the fall in IHD was larger than that observed in 
any other country during peace time. During the rapid devolution of the Soviet Union in the late 1980s the 
change in fat consumption was large due to the move to a market economy. A dramatic shift occurred, 
from animal sources that were previously subsidized and high in saturated fats to vegetable fats with more 
unsaturated fats. The roles of several changes during this period, including availability of foods and 
alcohol, smoking prevalence, socioeconomic indicators, and access to medical care, were carefully 
examined. Of these, the more healthy dietary fats and greater fresh fruit intake were the most likely 
candidates to account for these positive changes.  
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Introducing food policy to change from harmful to healthier fats can be challenging. A recent study 
investigated the barriers and opportunities for trans-fat policy development in low- and middle-income 
countries (Perez-Ferrer et al., 2010). It showed that more trans fat policies have been implemented in 
developed countries. Voluntary reductions by the food industry, following labeling and/or consumer 
lobbying, has been tried by several developing countries with varying degrees of success, leading to 
major differences in formulation among developing countries. Developed countries have moved to 
mandatory approaches. Common factors for successful trans fat reduction include increased consumer 
and political awareness of the harmful health effects of trans fats and advocacy by consumer 
organizations.  
For clinical-based treatment of CVD, several classes of medicines are now recommended as standard for 
patients or those at high risk of developing the disease. Such an essential package includes aspirin, beta-
blockers, other antihypertensives (such as ACE inhibitors or calcium channel blockers), and statins for 
reducing LDL-cholesterol. These are part of the Package of Essential NCD (PEN) primary care 
interventions for CVD (noted in Chapter 3). 
Hospital treatment of advanced disease, including surgical interventions, tends to be expensive and less 
accessible for most people, limiting their population impact. In addition, their cost-effectiveness can be 
very unfavorable.  
Diabetes 
A much increased understanding of prevention and control strategies for diabetes has been gained over 
the last few decades. Exercise and diet interventions, similar to those important for reducing CVD, can 
prevent or delay development of diabetes in high-risk groups (Narayan et al., 2006). Also, basic primary 
care interventions with continuity of care can prevent or delay the onset of complications. Finally, 
because diabetes also increases the risk for CVD, aggressive CVD risk-factor reduction (such as tobacco 
and hypertension control) is recommended.
Asthma 
Substantial improvements in asthma treatment have resulted in declining mortality and ill health in the 
past two decades in developed countries. The reductions in asthma mortality have occurred despite an 
increasing prevalence of the disease in many of these countries. So effective has ambulatory treatment 
been in preventing the severe complications of asthma that hospital admissions and mortality from asthma 
are now regarded in OECD countries as indicators of failure in the health care system (OECD, 2007). 
Asthma now accounts for only a small share of overall mortality in these countries, and for a much larger 
share of averted mortality.  
Common Cancers 
Common cancers in men (oral and lung) can be prevented with tobacco control, while those among 
women (breast and cervical) can be detected early through primary care–based screening and then treated 
(Brown et al., 2006).  
Impact of Health Promotion and Drugs on CVD 
The potential benefits of expanding interventions for CVD can be explored by simulating policy scenarios 
and comparing their impact. Focusing on CVD is strategic for two reasons. First, as already noted, CVD 
accounts for a significant share of the recent reductions in NCD mortality in developed countries, which 
Sri Lanka has not yet matched. Second, the evidence base for treatment of CVD is the most developed of 
all the chronic NCDs, and uniquely allows for quantitative exploration of the impact of expanding 
treatment.  
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Taking advantage of globally available knowledge bases, the approach of Manuel et al. (2006) was used 
with data from the SLDCS (Katulanda et al., 2008) to simulate the impact of different lifestyle and drug 
interventions on CVD outcomes.  
The SLDCS collected information on diabetes and CVD risk factors, including laboratory measurements 
of blood lipids and fasting glucose, electrocardiogram heart examination, and information on the drugs 
that respondents were taking for diabetes and heart disease (Katulanda et al., 2008). These data can help 
predict future CVD risk and mortality in the surveyed individuals using the Framingham cardiovascular 
risk prediction equation (Anderson et al., 1991). 
This equation, which predicts future risk of coronary heart disease (CHD) morbidity and mortality, 
including stroke and stroke death, was applied to the adult Sri Lankan population (18–74 years). For this 
analysis, the focus was on CHD death. The future risk of CHD death at 10 years for each SLDCS 
respondent, under different intervention scenarios, was then simulated. In doing this, the assumption was 
that the whole population was screened according to the New Zealand CVD prevention guidelines (New 
Zealand Guidelines Group, 2003), which are comparable to the national guidelines used in most OECD 
countries. The intervention scenarios considered were: 
 Baseline scenario (counterfactual)—no intervention was made, but individuals continue 
to take any drugs they are currently taking. 
 Population health strategy to reduce cholesterol by 2 percent—lowering total cholesterol 
uniformly in the population by 2 percent, which is the mean reduction in cholesterol 
observed over 10 years in WHO‘s 21-country MONICA study21 (Kuulasmaa et al., 2000; 
Tunstall-Pedoe et al., 2000). 
 Population health strategy to reduce cholesterol by 9 percent—lowering total cholesterol 
uniformly in the population by 9 percent, which is the mean reduction in cholesterol 
observed in the top decile of country performances over 10 years in the 21-country 
MONICA study. 
 Single risk factor strategy—screening the whole population, and treating everyone with 
total cholesterol concentration >8 mmol/l with a standard dose of statins.  
 Treatment of high individual risks with an antihypertensive—screening the whole 
population, and treating everyone with a high risk (>15 percent at 10 years) of CVD, or 
anyone with blood pressure more than 170/100 mm Hg. 
 Treatment of high individual risks with a statin—screening the whole population, and 
treating everyone with a high risk (>15 percent at 10 years) of CVD, or anyone with total 
cholesterol >8 mmol/l. 
 Treatment of high individual risks with two drugs—screening the whole population, and 
treating everyone with a high risk (>15 percent at 10 years) of CVD with a combination of 
one antihypertensive and one statin.  
The impact of aspirin was not explicitly simulated, since the estimates of its impact on coronary heart 
disease death are not so clear, although it does have other CVD benefits.  
In the baseline scenario, out of the 13.3 million Sri Lankans aged 18–74 years in 2005, an estimated 
164,000 CHD deaths would occur after 10 years. In all the treatment scenarios, the model predicts a 
reduced number of deaths at 10 years. This is summarized in Figure 6.1. It shows that the 2 percent 
population cholesterol reduction strategy and the single risk factor treatment strategy will save the least 
numbers of lives—avoiding fewer than 6,000 deaths over 10 years. Treatment with one or two medicines 
saves substantially far more lives, ranging from 16,000 deaths avoided with the use of one 
                                                     
 
21  A study that has tracked population changes in cardiovascular risks and outcomes in a large number of mostly developed 
countries over several decades. 
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antihypertensive, to 38,000 lives with the use of both an antihypertensive and one statin. A population 
strategy that achieves a 9 percent reduction in population cholesterol would do almost as well as the use 
of just one statin, but this level of cholesterol reduction would be far better than what most countries 
achieved in the MONICA study.  
Figure 6.1 Deaths avoided at 10 years under different intervention strategies for CHD, Sri Lankans 
18–74 years 
Source: Institute for Health Policy computations using the Framingham cardiovascular risk prediction equation and data from 
Katulanda et al. (2008). 
 
A reduction of 38,000 deaths (23 percent) over 10 years in CHD mortality with the use of just two drugs 
is substantial, and in combination with other measures is of the order of magnitude necessary to reduce 
Sri Lankan CHD mortality rates to the levels seen in OECD economies. These simulations indicate that 
increasing treatment of NCDs would allow Sri Lanka to close the gap with developed countries in adult 
mortality rates.  
Expanding access to primary care–based treatments and implementing some population-level 
interventions would have a major impact on CVD in Sri Lanka, and should be a necessary component of 
any overall NCD strategy, supplementing other preventive health measures. Furthermore, the population-
level strategy that has had the most impact in developed countries is reduction in smoking, which was not 
included in this simulation. Thus, in conjunction with gains in population-level risk factor reduction from 
lowering tobacco use and improvements in diet with salt reduction and lower trans fats and saturated fats, 
these gains might be larger. 
The SLDCS also allows us to look at the distributional impact of the different strategies.  
Figure 6.2 shows the number of avoided deaths by SES quintile in three strategies. These results indicate 
that primary care–based strategies using drugs will benefit the poorest quintile more than a population-
based strategy that achieves a uniform 9 percent reduction in cholesterol. This comparison almost 
certainly understates the pro-poor advantage of treatment measures, since any population strategy will 
rely substantially on behavior change through health education, and global experience indicates that such 
measures will change behavior in the richest and most educated households the most.  
Intervention strategy 
 
 Number of avoided deaths 
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Figure 6.2 Distribution of avoided deaths at 10 years by SES quintile under different intervention 
strategies for CHD, Sri Lankans 18–74 years 
 
       Percentile 
Source: Institute for Health Policy computations using the Framingham cardiovascular risk prediction equation and data from 
Katulanda et al. (2008). 
 
So, how much would it cost to expand access to essential medicines for treatment of CVD and thereby 
save a substantial numbers of lives? It is not feasible to estimate the cost of the delivery system, since 
almost certainly the current system may be evolving (see next section). However, the cost of the 
additional medicines can be estimated. In all the treatment strategies modeled above, the share of the adult 
population that would need to be prescribed new medicines ranges from 9 percent to 11 percent, or about 
1.3 million people.  
In 2008, the price of purchasing a single standard dose of an antihypertensive ranged from SLR0.18 to 
SLR1.1, depending on the medicine class, and the price of one dose of a statin was just SLR1.02. At these 
costs, it would cost just SLR1.5 a day to purchase one antihypertensive and one statin for each individual 
who needed them. This would come to less than SLR700 million a year (less than 2 percent of 
government health expenditures). These cost estimates indicate that the cost of purchasing these drugs 
will not be the principal barrier to expanding access. In practice, however, the costs are likely to be lower, 
since it is unrealistic to expect that, even with the best primary care system, all those who need drugs will 
be identified and treated. 
Service Delivery Models for Primary Care in High- and Middle-
income Countries 
High-income Countries 
Most health systems, including Sri Lanka‘s, are developed to treat and manage acute illnesses with 
definite end-points, and so are organized around an episodic, acute-care model. This approach is not 
suitable for managing the problems of chronic NCD patients, who require prolonged and coordinated 
management by health care professionals who have ready access not only to essential medicines, but also 
to appropriate screening and monitoring equipment, in addition to possessing counseling skills.  
As a consequence of this service delivery model, health systems in developed countries have responded to 
the emergence of NCDs by evolving new organizational arrangements. In so doing, most of these 
(%) 
 70 
 
countries have benefited from being able to build on an organized system of primary care where treatment 
is led by primary-care physicians, who are expected to provide care on a routine and sustained basis to 
patients within the community. Even with this, most developed countries have still had to develop new 
models of care to cope with the challenges of managing chronic NCD patients.  
There is, in short, no universal model that countries are using to manage chronic NCDs. Rather, each 
country‘s model reflects the characteristics of its health system, in terms of governance mechanisms and 
the relationships between, and responsibilities of, different stakeholders in the regulation, funding, and 
delivery of health care. Nevertheless, recent reviews have identified some common patterns in the 
approaches adopted by developed countries for managing chronic NCDs (Nolte et al., 2009; Nolte and 
McKee, 2008), and these have important lessons for Sri Lanka. Some of these lessons are now 
summarized.  
The most coordinated response has been in developed countries where multi-professional teams of 
physicians, nurses, and other health professionals were already responsible for delivering primary care, 
including most routine curative care, and where patients are registered with a specific primary care 
facility. In these countries, health care personnel at the primary level play the dominant role in managing 
NCDs and other chronic diseases. However, in all these cases, health care provision at the primary care 
level is closely coordinated and integrated with the delivery of hospital and secondary care services.  
These countries have witnessed a progressively larger role for nurses in managing many chronic diseases, 
commonly taking the form of nurse-led clinics, discharge planning, and/or case management. This has 
been the case in Sweden (where such clinics are extensive) and the United Kingdom (less so), and more 
recently, the Netherlands. In Sweden nurse-led clinics are now common at primary health care centers 
and in hospital polyclinics. They manage diabetes and hypertension, with some also managing 
allergy/asthma/COPD, psychiatric disorders, and heart failure.  
Given differences in professional roles within Europe, it is evident that caution is required in applying this 
model elsewhere (even in Europe). In England, while nursing staff make an increasing contribution, 
general practitioners have been entrusted with the lead role, but working with larger primary care teams 
employing both nurses and other health care professionals. Through the use of a national performance 
framework, which pays general practitioners according to quality of care and health outcomes, primary 
care physicians are being incentivized to expand and improve the quality of care provided to NCD 
patients. However, the feasibility of such incentivization depends on the high degree of computerization 
in primary care in the United Kingdom, and on a tradition of independent but highly administered general 
practitioners who are financed from public funds.  
In other developed countries, such as Canada, France, and Germany, there is usually more of a history of 
separation between primary care and hospital sectors, and patients have often had free choice of both 
family practitioners and clinic-based specialists. Physicians are more likely to work as individual 
practitioners, and national responses have focused on introducing structured disease-management 
programs to improve the care given for selected diseases. In these three countries, there has been more 
concern about the lack of coordination and continuity of care, both in the outpatient and inpatient settings. 
Governments have often attempted to address this issue by encouraging or developing coordination 
mechanisms between providers, including provider networks, but many of these initiatives have been 
criticized for lacking an integrative vision. In all these countries, the tradition of primary care delivered by 
solo doctors, often with limited support staff, has made more difficult the development and 
implementation of new roles and competencies.  
Another common finding in developed countries is that payment systems often hinder the delegation of 
tasks from doctors to other health professionals. A lack of appropriate incentives has also been identified 
as creating barriers to greater involvement by general practitioners in integrated approaches to care in 
Denmark and the Netherlands. In France, the payment of providers on a fee-for-service basis does not 
encourage improved coordination between physicians and nurses.  
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As Busse and Mays (2008) note, those health systems with a tradition of patient choice of any provider, 
and little or no enrollment with particular providers paying for services episodically using fee-for-service 
payments as the predominant method of reimbursement, seem to face the greatest challenges in adapting 
their payment arrangements to provide effective chronic care. Such systems tend to discourage continuity 
of care or a population perspective. In contrast, systems with strong primary health care are more likely to 
give greater attention to the management of people with chronic conditions and to obtain better results.  
Singapore, a high-income country in the region, provides useful lessons (Cheah, 2001). Chronic diseases 
present challenges that include readmissions for exacerbations of disease on long-term complications, the 
need for long-term follow-up and medications, and the importance of multidisciplinary clinical 
management. Lack of coordination among providers can lead, among other issues, to duplicated 
laboratory and radiological investigations, sporadic, unplanned patient education, and inconsistent care 
plans.  
The Ministry of Health in Singapore has adopted a multipronged disease-management approach that 
includes a framework with the following main aims: identifying the chronic disease and defining the 
target population for a disease-management program; organizing a multidisciplinary team; defining the 
core components, treatment protocols, and evaluation methods; and measuring outcomes and aims toward 
continuous quality improvement. (Unfortunately, little information on the impact of this approach is yet 
available.)  
Middle-income Countries 
Much less is known about the performance of middle-income countries‘ models of care delivery. Both 
Thailand and Malaysia have service delivery models that include well-developed primary health care 
components, which in the past have, similar to Sri Lanka‘s, been the cornerstone for achieving infectious 
disease and maternal and child health successes.  
In Thailand, chronic diseases are a growing and major health problem (Pagaiya and Noree, 2008). Heart 
disease hospitalization increased from 56.5 per 100,000 in 1985 to 691 per 100,000 in 2003. Similar 
trends are found for cancer and diabetes. The country‘s efforts to tackle chronic diseases led to a three-
tiered system with subdistrict health centers, district hospitals, and general/regional hospitals. The rural 
health system comprises district hospitals and subdistrict health centers that serve the majority of the 
population. Subdistrict health centers are staffed by nurses and primary care workers. District hospitals 
serve as the essential link between the health centers and the upper-tier facilities by an effective referral 
system. Nurse and village health volunteer competency is a high priority and in 2007 nationwide 
retraining emphasized prevention, control, and screening for hypertension, cancer, and diabetes. The 
impact of these efforts has yet to be evaluated.  
One key component of the Thai system has been the universal insurance coverage scheme introduced in 
2001 to increase coverage and quality of care (Gottret et al., 2008). The main goals of the scheme were to 
increase accessibility, restructure financing, and improve quality of care. Other schemes have evolved and 
include the Civil Service Benefit Scheme for civil servants and dependents funded by tax revenue and fee 
for service; the Social Security Scheme, which is funded by employers, employees, and government; the 
Universal Coverage Scheme (the ―30 Baht Scheme‖), which covers preventive and curative care for 75 
percent of the population and is financed exclusively by tax revenues; and a very small private health 
insurance scheme, which covers less than 2 percent of the population.  
In Malaysia, policies and a focus on maternal and child health have resulted in commendable 
achievements of the key health indicators (maternal and infant mortality) and increase in life 
expectancy—similar to Sri Lanka‘s achievements (Table 1.2, above). Primary health care has been the 
thrust of health services since the Seventh Malaysia Plan in 1996 (Merican and Rohaizat, 2002). It is 
provided by both the public and private sectors, although the public sector is the larger source, accounting 
for 58.4 percent of total health expenditures in 2006. In the public sector, services are heavily subsidized 
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at minimal or no cost to patients and delivered by a team of doctors, paramedics, nurses, and support staff. 
In the private sector, clinics are run by solo providers or small groups and payment is mostly out of 
pocket. The data suggest that most people with chronic diseases receive their care from public facilities 
rather than private, although the data used to make this conclusion may not be fully representative of 
private clinics (Ramli et al., 2008). Systematic data from both public and private sectors are unavailable 
to examine morbidity patterns, resource utilization, and practice patterns.  
In recent years, the Malaysian Ministry of Health has introduced policy changes pertaining to chronic 
disease management in primary care. However, the current primary care systems remains oriented toward 
acute, episodic care and maternal and child health. Several primary care–based studies find that a 
substantial proportion of the patients have not received effective therapy and that optimal disease control 
has not been achieved. For example, a national study on hypertension found that only 35 percent of 
patients were aware of their status; and of the 32 percent who were taking medicines, only 27 percent 
were under control (Rampal et al., 2008). Diabetes care is also a challenge. In an earlier study of the 
private primary care system, only 12 percent were receiving routine monitoring and more than 80 percent 
were not under good control (Mafauzy, 2005).  
Several barriers have emerged, including a shortage of human resources, specifically family medicine 
specialists; lack of coordination between public and private sectors, leading to duplication of services and 
inefficiencies; absence of a developed information system (although an electronic clinical information 
system is being piloted); and chronic shortages of medicines.  
Another source to which low- and middle-income countries can turn is WHO‘s Innovative Care for 
Chronic Disease Framework, designed in particular to be relevant to low- and middle-income countries 
(WHO, 2006). It organizes the evaluation along macro (policy and financing), meso (health care 
organization and community), and micro (patient and family) levels of the health care system. This 
framework is centered on a triad of partnerships between the patient, health care team, and community. 
This triad is placed in the background of organized and well-equipped health care teams and a positive 
policy environment. The model is comprehensive and seeks to provide high-quality care as well as 
continuity, while involving patients, health care teams, and communities, as well as policy makers. The 
guiding principles of the framework are evidence-base decision making, population focus, prevention 
focus, quality focus, integration, flexibility, and adaptability.  
Implications for Sri Lanka 
High-income countries have some understanding of each model‘s impact, but middle-income countries 
less so. Still, the Sri Lankan care delivery system has many common characteristics with those in middle-
income countries. While the context and population are different, these examples reveal the elements for 
policy makers and others to consider when retooling the delivery system and present lessons on how these 
models can perform. 
Among other things, the care model for Sri Lanka will need to be sensitive to the state‘s financing limits 
and patients‘ out-of-pocket expenses, particularly since patients already pay a lot for CVD, diabetes, and 
asthma care, especially—in relative terms—the poor. Thus financing should be considered carefully 
alongside the adoption of a new model, a subject to which we now turn. 
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Chapter 7: Policy Options and Actions  
Key Messages 
 The NCD burden will increase the need for long-term care among the elderly and affect 
labor-force participation among older working-age adults. Both these effects will have a 
significant impact, the former through higher costs of health care and the latter through 
productivity losses.  
 Government expenditures on health—as a share in total health financing and as a share of 
total government expenditures—are less than expected for the country‘s level of national 
income.  
 Policy options for health financing include mobilizing greater resources for NCD 
prevention and control (from both public and private sources), establishing mechanisms 
for higher contributions from richer population groups, increasing efficiencies in the 
public sector, reducing costs in the private sector, and raising public financing of NCD 
drugs targeted to poorer segments of the population.  
 Piloting social health insurance to cover catastrophic expenditures needs serious 
consideration. 
 A strategic approach for tackling NCDs is to focus on selected diseases such as CVD, 
diabetes, asthma, and cancer, in view of their disease burden and availability of cost-
effective interventions to address them that also include population-wide strategies to 
lower risk factors.  
 An intensified national NCD control program with sufficient resources and authority to 
make it effective—working through existing systems and structures rather than being 
established as a vertical program—is an option for developing, organizing, and 
implementing national prevention and control policy.  
 The current health services organization has separate preventive and curative care 
mechanisms (each with their own staff and facilities) and needs to align them in order to 
provide the spectrum of services required to mount an appropriate response to NCDs.  
 Better efficiencies may be gained from increasing use of lower-level public facilities for 
NCD care and from refining after-hour hospital admission policies that encourage 
overutilization of inpatient services.  
 More decentralization of health services may result in better coordination of care among 
different facility levels and allow the central MOH to focus on policy, governance, and 
regulation.  
 Well-trained and competent health personnel will be needed, in adequate numbers and 
appropriate categories, and who are capable of treating, counseling, screening, and other 
preventive services with regard to NCDs.  
 A national NCD surveillance system is required for strategic planning and for assessing 
progress with prevention and control efforts. It should cover behavioral risk factors, as 
well as NCD morbidity, mortality, health services utilization and quality of care, and 
special registries (among others, for cancer and injuries).  
 Private sector health service delivery remains poorly understood and its outputs mostly 
uncharacterized, yet its contribution to provision of health care makes a strong argument 
for a more proactive policy of public–private engagement.  
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Future Implications of NCDs in Sri Lanka 
Sri Lanka is facing an increasing burden from NCDs with high levels of morbidity and mortality relative 
to other low-income countries. This report has found that the current population-based prevention efforts 
in tobacco and other risk factor reduction could be bolstered, that the health system‘s capacity to provide 
integrated care for NCDs is limited, and that substantial underuse of medicines against NCDs is adversely 
impacting program effectiveness.  
This growing NCD burden has broad negative implications for Sri Lanka‘s health and social systems, and 
for its economy. With population aging, the impacts of this burden will tend to get worse, placing 
increasing pressures on the country‘s health system, including the government‘s health budget. 
Furthermore, households are already bearing a sizable burden, with even public sector patients frequently 
having to purchase drugs and laboratory tests from the private sector. Such out-of-pocket expenditures 
threaten the poverty reduction achievements of the past, through their potentially impoverishing effect.  
Looking beyond the health care system, this future burden may substantially increase the need for long-
term care among the most elderly Sri Lankans. Recent medical research suggests that CVD may be an 
important cause of physical frailty in the elderly (Newman et al., 2006), and that future demand for long-
term care will be closely linked to the numbers of the physically dependent elderly. As governments in 
developed countries have found in the past decade, once the need for such care becomes substantial, it 
may not be possible to depend solely on households and the private sector to finance it. In the long run, 
the costs of providing long-term care could end up with the public sector, and these costs will be 
substantial, being of the order of 2 percent or more of GDP (Huber et al., 2009). Such an increased cost 
on the public exchequer is even more likely in the Sri Lankan context, where there is a strong tradition of 
the state bearing social costs. 
A growing NCD burden will also have broader economic costs through its impact on the labor force and 
productivity. Apart from the mortality caused by NCDs, the disability and consequent loss of productive 
workdays would be significant, especially given the chronic nature of these diseases. Moreover in Sri 
Lanka, chronic illness has been reported as the leading cause for older working-age adults to retire from 
work (World Bank, 2008).  
The financing of retirement incomes is undoubtedly an important long-term macroeconomic challenge in 
view of the rapidly aging population. As developed countries have come to accept in the past few years, a 
key policy for managing this challenge will be to encourage people to work longer and retire later: 
developed nations are increasing retirement age to as high as 67 or 70 years. However in Sri Lanka, such 
a policy is unlikely to be feasible when so many workers in their 40s and 50s are either becoming 
chronically sick from NCDs or are dying prematurely.  
Ensuring that people live healthier lives and work longer will be central to managing the challenges of 
pensions and retirement income financing. Even in the absence of a policy to increase the retirement age 
(which is currently somewhat controversial in view of concerns about the potential for youth 
unemployment), the NCD burden in the aging population will add significantly to the costs to be borne by 
the productive population. 
Policy Options and Actions: Overview 
In this section, strategic options and actions are presented for consideration by the government of Sri 
Lanka to respond effectively to NCDs (and see Appendix 10). Some options are in the domain of policy, 
while others are programmatic and operational in nature. The actions are based on, and should be read 
together with, the evidence, findings, and analyses presented in earlier chapters. These options are 
primarily aimed at prevention and control of chronic NCDs with, as always in this report, a focus on 
CVD, diabetes, asthma/COPD, and, to a lesser extent, cancers.  
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To avoid the NCD program becoming a vertical ―single-purpose‖ intervention with its own structures, it 
is important that it be firmly embedded within the framework of the health system, using and building on 
existing structures. Therefore, some policy options and actions are broader in scope than others, and 
systemic in nature. Strengthening the health sector to address chronic NCDs may also have positive spin-
off effects that will improve the infrastructure and capacity for prevention and control of other conditions 
as well.  
Addressing NCDs warrants strong and concerted action on the part of nonhealth sectors as well. As most 
NCDs have important social determinants—causative or risk-enhancing factors—the solution often lies 
outside the health sector when it comes to prevention, especially in terms of broader population-level 
interventions. Trade policies, educational programs, legislative and regulatory measures, and 
environmental approaches are just some of the necessary actions. 
Financing 
Increasing Financial Resources for NCD Prevention and Control  
Some of the factors that will drive increased future health expenditures in general and NCD interventions 
in particular are:  
 The NCD burden in Sri Lanka, which is already at a level comparable to that of developed 
countries, is set to increase further as the demographic and epidemiologic transitions 
progress further.  
 Current system capacity needs significant strengthening to meet the growing NCD burden.  
 The population expects the government to ensure the provision of high-quality curative 
care services through the public sector delivery system, free at the point of delivery, and 
these expectations will only rise as Sri Lanka‘s economic status improves.  
 The cost of addressing the NCD challenges will be much higher than that of infectious 
diseases and maternal and child health issues.  
 For its level of income, health spending in Sri Lanka is still at the lower end of the 
international spectrum. Within this overall low spending, out-of-pocket expenditures, 
especially for drugs and laboratory investigations, constitute a relatively high proportion.  
 Government expenditures on health—as a share in total health financing and as a share of 
total government expenditures—are less than expected for the country‘s level of national 
income.  
Population-level risk factor reduction efforts will also increase resource needs. Such efforts will need to 
be financed from public funds as they deliver public goods and/or positive externalities. Equity 
arguments, efficiency concerns, and risk protection, as well as the strong social welfare culture in Sri 
Lanka, argue for increased public spending for coverage of curative services as well. The feasibility of 
sustainably increasing public spending on health care needs careful assessment of the medium- to long-
term strains on fiscal space. Such examinations should take into account that the e current low level of tax 
revenue, as a percentage of GDP, and recent developments that have resulted in relaxation of fiscal 
constraints, such as the end of the civil conflict.  
Evidence shows that the NCD burden is not exclusively among the richer population. Further, evidence 
from other countries indicates that over time the burden of NCDs will shift to the poor. If public funds are 
inadequate, government may need to consider policies to protect the poor segment of the populations.  
A major objective would be to develop mechanisms that reduce out-of-pocket expenses by the poor.  How 
this can be accomplished is a complex question; some new analysis on the benefits publicly financed and 
provided services will help develop a good evidence base for policy development. 
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At present in the Sri Lankan health sector, around 90–95 percent of inpatient care is financed and 
provided by the public sector, while about 50 percent of ambulatory care is financed and provided by the 
private sector. However, over 50 percent of the total health care spending is from private sources, largely 
from out-of-pocket spending (with a minimal presence of insurance mechanisms and some contribution 
from private employers). In other words, the half of total health spending that comes from the private 
sources covers about half the outpatient care and only 5–10 percent of the inpatient care.  
This variance between private and public expenditure and services use may be explained by two main 
factors. First, the unit cost
22
 of care in the private sector is higher than that in the public sector. Though 
intuitively expected, this is not a given. In some countries there is evidence to show that inefficiencies and 
system losses in the public sector can more than offset the profits made by the private sector, making 
private provision more cost-efficient even for publicly financed services. Evidence for Sri Lanka finds 
that public provision and financing has been highly effective at low costs, although efficiency gains may 
still be possible.
23
 Second, the overall volume of outpatient care is higher than that of inpatient care. In 
2008, there were 4.9 million episodes for inpatients while roughly 63 million episodes of illness were 
treated as outpatients or clinic patients (Table 4.4, above). With private inpatient care unaffordable to the 
majority of the population, there is a selective utilization pattern, that is, more inpatient care from public 
sources, but significant private sector market share for ambulatory care (and related drugs and 
investigations), with the exception of the wealthiest, who can afford to get their inpatient care, too, from 
private hospitals.  
It is important to recognize that resources have competing uses in general and specifically within the 
health system. NCD care has to compete with infectious diseases and emerging diseases. The fact is that 
infectious diseases have not been eradicated altogether and the government will continue to need 
significant resources for dealing with continuing, emerging, and reemerging diseases in this category. 
Rabies, dengue, leptospirosis, and influenza are just a few examples in Sri Lanka; additionally the threat 
of a future HIV epidemic cannot be ruled out. Even those diseases which are under control, such as 
malaria, will need resources for the maintenance of programs and interventions on a sustained basis. 
Maternal and child health services (which include a combination of infectious diseases and 
noncommunicable conditions) will need continued allocations. And beyond the selected set of NCDs 
considered by this report, significant resources will be needed to tackle other NCDs such as malnutrition, 
mental health, and injuries. Thus one needs to bear in mind the ―double burden‖ of noncommunicable and 
infectious diseases when considering future resource allocations. 
A financing policy option package for Sri Lanka should consider efforts to: mobilize greater resources for 
NCD control and prevention (from both public and private sources) which may require expanding public 
financing and/or exploring alternative sources; establish mechanisms for reducing out-of-pocket 
contributions from the poorer segments of the population; look for ways to increase efficiencies in the 
public sector,  for example, bulk purchase negotiations by the government on behalf of the population; 
and ensure that additional allocation for NCD does not come at the expense of action to control infectious 
diseases or to provide maternal and child health services. 
In summary, overall spending and public spending on health are relatively low in Sri Lanka. Public 
spending has not kept up with the needs and demands of the population, and out-of-pocket spending has 
been increasing as a share of total spending. NCDs will increase and accelerate the demands on the 
system, along with other factors that will push up future health care costs. The question to be asked at this 
time is: How will these needs be met? Raising tax revenues commensurate with the increasing demands 
                                                     
 
22  Unit cost of production is different from unit price (which is unit cost plus a margin). One usually refers to unit cost of 
production for the public sector (in the absence of any margin), but unit price for the private sector. Therefore any calculations 
that take the ratio of total spending to volume of output need to make note of such differences.  
23 Hsiao W, Li KT. A Preliminary assessment of Sir Lanka’s health sector and steps forward. Cambridge, Massachusetts, USA, 
2000.  
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might be the best way forward. However, in the context of consecutive years of budget deficits and a low 
revenue base, securing  sources of financing other than taxes, may need to be considered to cope with 
future increases in health care costs. 
Increasing Access to NCD Drugs, Especially for the Poor 
The evidence presented in Chapter 4 indicates underutilization of essential drugs for NCD management in 
Sri Lanka. Examples (due to lack of availability, and/or lower prescription patterns) include beta-
blockers, statins, ace inhibitors, and even aspirin. Such low availability has been found to be more acute 
at the primary care level than secondary and tertiary levels, at least partially contributing to the 
inappropriate use of higher-level facilities by patients who could have been managed at lower-level 
facilities. Chapter 4 also argued that to ensure adequate supply of essential NCD drugs, the most 
appropriate approach would be public sector procurement of these drugs, due to economies of scale.  
Increasing the drug supply through public financing and/or procurement is a cost effective option. Since 
even patients visiting public providers have to pay for drugs mainly because care facilities routinely ask 
patients to self-purchase medicines and supplies from private suppliers when these are not in stock, 
providing these drugs at public facilities would reduce overall expenditures on these drugs. It may be 
financially feasible in Sri Lanka to increase the level of drugs to 80 percent of the utilization rates in 
OECD countries through public financing for two reasons. First, public sector unit prices for obtaining 
key NCD drugs are often a small fraction—even one-fourth—of those purchased through private sources. 
Second, the overall cost of these drugs is a relatively small fraction of total public spending on health. The 
cost of obtaining essential NCD medicines, excluding statins, would have represented less than 1 percent 
of total public sector health expenditures in 2008.  
If the supply of drugs in the public sector remains inadequate, then the government many need to consider 
policies to protect poor segments of the population who may underutilize drugs because they cannot 
afford to pay for them out of pocket.  
Addressing Social Determinants 
The causal and risk-enhancing determinants of most NCDs include social factors. Educational status, 
income levels, gender constructs, peer pressures impinging on lifestyles (such as smoking, harmful 
alcohol use, unhealthy diet, and lack of exercise), occupational exposure to certain carcinogens, and 
environmental health are just some examples illustrating the importance of policies and actions in 
nonhealth sectors to any national efforts to prevent and control NCDs.  
Successful prevention of NCDs therefore calls for well-coordinated intersectoral action, but such actions 
need to be initiated and led by the MOH. Institutional mechanisms need to be created to involve various 
nonhealth ministries in a multidisciplinary effort to address NCDs in Sri Lanka. Examples of ministries 
that need to be part of any such mechanism are Education, Social Services, Agriculture, Environment, 
Labor, Commerce, Law & Justice, Urban Development, Home Affairs (Police) and, of course, Finance 
and Planning.  
The Education Ministry would have a valuable role in including important lifestyle-related education in 
the school and university curricula, so as to inculcate healthy behaviors from a young age. The 
Agriculture Ministry may well be helpful in developing and implementing appropriate policies for crop 
diversification and ensuring adequate supply of nutritious foods. The Ministry of Industry and Commerce, 
along with the Ministry of Law and Justice, will need to regulate the goods imported into the country, in 
terms of their health impact, as well as the advertisements targeted to NCD risk factors, such as smoking. 
The Environment Ministry would be critical in reducing the levels of particulate matter in the atmosphere 
that could be detrimental to health. The Ministry of Urban Development could help plan the cities in a 
manner that provides for many greener spaces. Together, these two ministries should develop and 
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implement policies for better urban air quality. The Ministry of Transportation could promote the use of 
public transportation by making it safer and more convenient, and the National Roads Authority could 
focus on road safety (to prevent injuries, which are acute NCDs). 
As NCDs increase with age, and have important long-term care implications beyond medical treatment, 
there is a critical role for the Ministry of Social Services in developing services for the elderly, with 
special attention to those with NCDs. Currently, this ministry has an Elders‘ Secretariat and is managing a 
small program to take care of the older individuals who may not have the family support to look after 
them; these ―elderly homes‖ need to be equipped with the necessary facilities to take care of those who 
are at a risk of or are suffering from NCDs. 
Policies targeting workplaces with a view to making them conducive to healthy lifestyles should be 
developed and implemented. For instance, firms and offices employing more than a certain number of 
workers might provide exercise facilities. Those workplaces which offer canteen facilities could pay 
attention to the nutritious value of the diet provided. Workplaces can offer regular NCD screening and 
awareness-raising information services. 
Finally, the MOH itself should design and implement effective communication campaigns aimed at 
changing population behaviors with respect to the major modifiable risk factors. 
Strategic Focus 
Prioritizing Focus on Specific NCDs  
The evidence presented in earlier chapters argues the need to focus on a selected set of NCDs. A special 
focus on these problems, keeping in mind the disease burden as well as available cost-effective 
interventions to address them, is a strategic approach for consideration. What is proposed is an intensified 
(or special) program on selected NCDs, while dealing with other unmet needs in the areas of malnutrition, 
mental health, and injuries.  
Such an intensified national NCD control program, rather than a broad-brush approach for all NCDs, 
would make sense, both from the point of view of effectiveness and affordability. Since certain risk 
factors are common to several NCDs, common risk-reduction strategies could help address multiple 
diseases. As the program matures, other NCDs could be added to its mandate. 
Addressing Undernutrition as well as Overnutrition 
While this report has emphasized the importance of dietary factors in reducing the risk of diabetes, 
hypertension, and CVD, its general focus has been on overnutrition and obesity, along with lack of 
exercise. However, recently, there has been a growing body of evidence that low birth weight and 
childhood undernutrition could increase the risk of NCDs at a later age (see Fetal and Childhood 
Undernutrition and Epigenetic Determinants in Chapter 2). Reducing childhood and maternal 
undernutrition is an unfinished agenda for Sri Lanka, in an otherwise impressive record of improvements 
in health status; therefore, appropriate policies and programs are urgently needed to achieve this goal. 
Community-based nutrition interventions are required, targeting the vulnerable population groups such as 
mothers and children in the tea estate sector and in certain rural districts. The targeting needs to be at the 
right age group of conception to 24 months, (generally described as the ―window of opportunity‖ for 
nutrition interventions), and adopt a lifecycle approach (that is, include adolescent girls and lactating 
women). Such interventions need to focus on household-level behaviors related to eating, feeding, and 
caring. 
At the other end of the spectrum, overweight and obesity are a growing public health problem, causing 
another sort of ―double burden‖. Both population-based and personal interventions aimed at improving 
dietary practices would be similar to those targeting other risky behaviors. 
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Organizational Structure 
Creating an Intensified National NCD Program 
There has been considerable debate about the central organizational arrangements for health in Sri Lanka. 
There is a director for NCD, but control of all the resources needed for NCD prevention or management is 
not vested in this position. Rather, the NCD Director has to work through other directors/departments (for 
example, Medical Services and Health Education Bureau) to make the NCD interventions effective and to 
ensure availability, quality, and access for NCD curative services. Similarly, to fulfill NCD information 
needs, the NCD Director relies on the Epidemiology Unit and the Management Information Systems 
Unit. Thus, the job is one of coordination rather than actual execution.  
So, as NCDs are a growing part of the disease burden and the future of public health in Sri Lanka will be 
dominated by NCD issues, a policy option would be to consider elevating the NCD function to the level 
of Deputy Director-General (DDG), under whose supervision all the relevant functions would be located 
(that is, prevention, curative services, health education, and others). This is understandably a sensitive 
subject and there are strong opinions on both sides of the argument. While a better coordinated and 
stronger response to NCDs offers benefits, arguments against creating a dedicated DDG for NCDs 
include the following:  
 The bulk of the caseload is already NCDs, such that much of the health system is caring 
for NCDs anyway. In that sense, the responsibility for NCD control and management is 
actually vested in the Director-General of Health Services, in reality, even higher than the 
proposed DDG level.  
 Service delivery at primary and secondary levels is decentralized to provinces and 
districts, and the function of MOH is one of coordination and stewardship in any case.  
 Functions of the Health Education Bureau and the Management Information Systems 
Unit, for example, need to remain as separate support functions and cannot be brought 
under a DDG for NCDs as they cater to infectious diseases as well.  
How to resolve? One option is to create an intensified national NCD control program with sufficient 
resources and authority to make it effective. This program should work through existing systems and 
structures, rather than being developed as a vertical program. 
The major activity of this program would be to assure engagement and ownership by all key stakeholders 
of the national policy and strategic plans for unintentional injuries and for chronic NCD prevention and 
management.
24
 The program would also be tasked with implementing this policy. In addition, it would 
build on tobacco efforts, as well as lead and coordinate population-based prevention efforts (including 
those focusing on salt and harmful fat consumption, injuries, and mental health).  
Strengthening and Reorganizing NCD Prevention and Curative Care Services 
The emergence of NCDs as a major health care problem may need fundamental reorientation in the way 
that primary care is delivered in Sri Lanka. Primary health care comprises public and private services. The 
former include preventive services managed by medical officers of health and their teams, and a separate 
stream of curative services. The latter include private physicians who work independently of the public 
sector on a fee-for-service basis.  
This organization of the health system is not well placed to deliver primary care for NCDs for the 
following reasons: preventive efforts such as individual counseling on diet, exercise, or smoking tends to 
be neglected by the purely curative-oriented providers, especially in the private sector; Medical Officer of 
Health unit activities on prevention are difficult to coordinate with the independent stream of curative 
                                                     
 
24  Currently being finalized; see Health Sector Organization and Capacity in Chapter 3. 
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services; and private practitioners, being outside the purview of the public system, do not report data on 
patients seen by them, and are extremely difficult to regulate on quality.  
Expansion and improvement of the curative services must be an integral component of a successful 
response to NCDs. Currently, with exception of the specialist clinics, the delivery system is not set up for 
providing organized, continuing care for NCD patients. Outpatient clinics have no system to ensure long-
term follow-up management of NCD patients.  
The curative care response to NCDs should prioritize the expansion of treatment with cheap and cost-
effective drug treatment of NCDs, in particular for CVD. However, drug availability needs to be closely 
linked with service delivery system. Even if all NCD medicines were made available, the current primary 
care system probably lacks the capacity to assess patients adequately with the routine follow-up tests, 
provide long-term follow-up with appropriate calibration of treatment schedules, and coordinate with 
treatment of other chronic conditions. The use of specialist clinics based in higher-level hospitals makes 
expansion unlikely to be feasible with a specialist-led care model, and will require expansion of the 
primary care system, with specialists shifting their role to providing backup for more difficult cases, as 
well as supporting initial assessment of new patients.  
A fundamental question about the health services organization is whether the separation of preventive and 
curative services (each with their own staff and facilities) is helpful in mounting an appropriate response 
to NCDs. The argument in favor of this separation is that it has served Sri Lanka very well thus far, with 
near 100 percent immunization coverage, high antenatal care services coverage, and other highly positive 
health indicators (Table 1.2, above). It is also feared that an integration of preventive and curative 
services could result in ―medicalization‖ and perhaps the dilution of the preventive sector. However, the 
Medical Officer of Health system is also led by medical doctors, and the concern of medicalization is 
perhaps overblown. Moreover, in the case of NCDs the distinction between preventive and curative 
services is less marked than, for instance, in the case of vaccine-preventable diseases.  
As explained in Chapter 3, primary and secondary prevention are represented by preventive and curative 
services, respectively. The current system places screening for NCDs under curative services (as 
investigative facilities are linked to curative facilities); but since periodic screening is to be done on 
―healthy‖ individuals it is difficult to attract them to the hospital, where only sick persons are supposed to 
go. Individual and family counseling on diet, exercise, or smoking is an important preventive step, which 
needs to be provided to already diagnosed patients, that is, linked to curative services. Similarly, the data 
for surveillance, which constitute an important piece of the prevention jigsaw, have to come from the 
curative sector. Much of the curative care can be provided in a community-based manner, for which the 
outreach network of the preventive sector is an asset.  
While full integration of preventive and curative services is probably unrealistic in the current context of 
the Sri Lankan health system, undoubtedly there is a need to find ways of strong collaboration and 
coordination between prevention-oriented MOH units and the curative sector. 
Policies therefore need to consider prevention in a comprehensive manner—not merely primary 
prevention, but secondary and tertiary prevention as well. Regardless of how secondary prevention is 
organized, there is a need for much greater emphasis on this service. Available evidence suggests that 
screening facilities are inadequate, especially at the primary care level. The key action in this regard 
would be to strengthen access to screening facilities. Location of improved screening facilities should 
follow the availability of diagnostic and treatment facilities, especially drugs that can keep risk factors 
like hypercholesterolemia and hypertension at bay (statins and antihypertensives). A key point is that 
screening will detect more cases and the system must have the capacity to effectively treat these new 
cases when added to the current case load.  
Finally, continued treatment of NCD patients—beyond the early stages—is also important, to prevent 
sequelae and disabilities (tertiary prevention). For example, persons with diabetes need to keep their 
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blood sugar under control to avoid delayed wound-healing. Although diet and exercise continue to be 
important in such patients, drugs become indispensable. And while tertiary prevention will fall 
legitimately under curative services, the continuum between primary, secondary, and tertiary prevention 
(one that essentially encompasses curative care within the concept of prevention) has to be maintained. If 
the above view of such a continuum is accepted, there will be broader policy implications for how to 
organize health services in Sri Lanka.  
Moving Services Closer to Clients, and Improving Efficiency 
The population‘s clear preference for higher-level health facilities—not only for NCDs—results in 
underutilization of more peripheral health care units, causing inefficiencies and placing unnecessary strain 
on tertiary-level facilities, in turn risking their quality of services. Bed-occupancy rates of tertiary, 
secondary, and primary facilities show this difference quite clearly (Table 4.4, above).  
Many of the patients treated at tertiary facilities could be managed at lower cost in a secondary or even 
primary facility. This would also be more convenient for the patients, if they see this benefit. The fact that 
they are willing to travel longer distances to tertiary facilities shows that the quality differential 
(perceived as well as real) is significant. Therefore, unless higher-quality care—perceived to be as good 
as what is offered in a tertiary hospital—is provided in secondary and primary facilities (and in the 
absence of an effective referral system or gate-keeping function of primary care providers), this trend 
cannot be reversed. Once the quality improvements are made, in terms of the availability of skills, 
equipment, and drugs, an education campaign needs to be launched to change care-seeking behaviors. 
Additionally, anecdotal observations indicate that many inpatients could have been managed as 
outpatients or clinic patients (long-term ambulatory care, with periodic clinic visits for checkups, 
investigations, and drugs); this clearly has cost implications and results in systemic inefficiency. It is 
explained as a cultural phenomenon, where the population sees a hospital as a place to recuperate from 
illness, and not merely to get medical treatment. But since, clearly, the choice of being admitted to the 
hospital is not the patient‘s, the doctors who make the decision on admission to the ward and how long 
they need to stay there also seem to have a tendency to overuse the inpatient option. One study in the 
National Hospital found that 25 percent of those admitted were discharged within 24 hours (Delpachithra 
and Jayasinghe, 2001).  
Added to this has been a policy that compels public sector hospitals to admit any patient who shows up 
after 4 pm (for overnight stay) regardless of the clinical need. This is being addressed by the introduction 
of emergency treatment units and preliminary care units, but these are not yet available in all facilities and 
the policy of compulsory admission for ―after-hours patients‖ is still widely prevalent.  
The issue of unnecessary admissions needs further careful analysis, to see whether the patients who are 
currently being admitted do need inpatient care from a medical standpoint, based on their diagnoses and 
severity of illness and on the type of treatment required. After such an analysis, a clear policy needs to be 
established on triaging outpatients before admission to the ward, a nationwide training program launched 
for doctors on appropriate practices with regard to inpatient admissions, and an education campaign 
initiated to effect appropriate attitudinal and behavioral changes among the population. 
Further Decentralizing and Devolving Health Service delivery 
Based on the 13th Amendment to the Constitution, Sri Lanka has already seen much decentralization of 
health services (Appendix 6). The central level is vested with stewardship functions, such as financing 
policy making, planning, coordination, monitoring and oversight, standard setting, guidelines 
development, and a few support functions such as human resources and pharmaceuticals. The provinces 
(and districts under them) are responsible for service delivery with the exception of tertiary (teaching) 
hospitals and a few selected secondary-level hospitals.  
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Though the current system functions relatively smoothly, there is general agreement that it does not have 
an effective referral system. Though such a lack has other dimensions than decentralization, a seamless 
referral system may be easier to achieve if all service delivery is decentralized, including tertiary 
hospitals. As medical education and its curricula are not under the MOH (it is under the Ministry of 
Higher Education), the logic of placing teaching hospitals under MOH is less clear. One argument in 
favor of central management of larger hospitals is that the provinces lack the resources for this function; 
in fact some of the hospitals decentralized to provincial control have been ―recentralized‖ for this reason. 
But if a hospital transfer happens along with corresponding resource transfers and a strong program of 
capacity building, there is no reason why the fully decentralized system cannot work effectively. 
Human Resources 
Human Resource Development for NCD Prevention and Control 
Putting more financial resources into NCD prevention and control is just the beginning. Unless spent 
efficiently and effectively on the right set of inputs, those additional finances will not yield the desired 
results. The first of those inputs would be well-trained and competent health personnel, in adequate 
numbers and appropriate categories. Such a workforce should be capable of treating NCDs with state-of-
the-art techniques and of providing counseling, screening, and other preventive services. Thus a human 
resource needs assessment of current and future NCD effort would provide much-needed guidance for 
developing an appropriate strategy.  
Medical, nursing, and other relevant curricula do currently include the various NCDs, but improvements 
could be made in terms of the latest knowledge and by emphasizing the commonalities of risk factors 
between several NCDs. Such a more integrated approach could result in preventive interventions that can 
deal with multiple conditions at the same time. In addition, the newly developed (2008) national clinical 
standards and guidelines
25
 include many NCDs but these are yet to be applied in practice. This invaluable 
asset needs to be institutionalized by integration into training curricula; in-service training for current 
staff; and periodic updating and review to assure that the latest information is incorporated.  
An aspect of NCD service provision that may need to be included explicitly in medical education and its 
curricula (and subsequent in-service training) is aligning the appropriate care level needed with patients 
and effective referral processes, so that care providers can make the right decisions on when and where to 
refer cases. Similarly, the proper triaging of patients before admission to the ward also warrants inclusion. 
Aside from greater emphasis on NCD management in the undergraduate medical, nursing, pharmacist, 
and other curricula, there is probably a case for increasing the training of specialists in relevant 
specialties, such as cardiology, endocrinology, and oncology.  
Information Systems and Surveillance 
Creating a National NCD Surveillance System 
A national NCD surveillance system is needed. The major elements to be incorporated include behavior 
risk factors; NCD morbidity; mortality; health services utilization and quality of care (public and private 
sectors); special registries (for example, cancer and injuries); and the economic burden. In addition, as 
prevention efforts using nonhealth sector policies are developed and implemented (for example, taxation 
of tobacco, and reductions in salt and harmful fats in manufactured foods) surveillance of key indicators 
outside the health sector will be needed (again, related to cigarette consumption and salt and fat content in 
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manufactured foods). The current National Policy and Strategic Framework for Prevention and Control 
of Chronic Non Communicable Diseases, 2009, covers some of these elements.  
Two WHO-developed STEPS behavior risk factor surveys have been conducted but currently no plans or 
resources are committed to build on these and expand them nationally. Options for the MOH that could be 
explored are to integrate elements of such a survey with other ongoing surveys at periodic intervals. 
Future surveys should also include the measurement of biological indicators, allowing clearer analyses of 
the links between risk factors and their impact on the human body. Policy based on such analyses should 
then be developed. 
NCD morbidity data from both inpatient and outpatient services are limited. For public inpatients at all 
levels, although the diagnosis is recorded, individual data with demographic information and other 
characteristics are not. For public outpatients, neither diagnosis nor individual demographic information is 
collected in the returns. In addition, no data collection for private sector health service delivery is 
routinely conducted. Efforts to capture population-based morbidity and trends, such as with the SLDCS 
and the Ragama Risk Factor Study on NCDs, are needed, both to assess the disease burden and to present 
simulations of policy options (as was done for this report).  
Mortality will continue to be an important element of surveillance and Sri Lanka has a comprehensive 
system in place, in contrast to many other developing countries. However, areas needing improvement 
include the accuracy of recording the cause of death; appropriate coding; and timeliness of data 
collection, collation, and analysis, and of report dissemination. Finally, as prevention efforts unfold, 
development of surveillance tools for outside the health sector should be tailored to track progress and 
evaluate impacts.  
Public–Private Partnerships 
Aligning Service Delivery  
Sri Lanka aspires to providing universal access to free health care through the public sector for the entire 
population. In reality, private financing is substantial and increasing. The market share of private 
providers in the Sri Lankan health sector is significant (about 50 percent of ambulatory care and 10 
percent of inpatient care), almost all of which is financed through out-of-pocket payments. Therefore, the 
private sector‘s contribution to both financing and provision of health care is significant. Moreover, given 
the rising cost of NCD care and the need for modern technology, there is an even stronger argument for a 
more proactive policy of public–private sector engagement to contain cost escalation. Alternatives to 
effectively mobilizing private financing should also be considered 
Private sector service delivery remains poorly understood and its outputs mostly uncharacterized. 
Therefore, the first step in building a platform for effective public–private partnerships is to carry out a 
private health sector assessment so that public policy makers can understand the configuration of the 
clinics, clientele, costs, and quality of services delivered by private providers. The aim of public–private 
partnerships would be to leverage the private sector toward public policy goals. Several key areas for 
public–private partnerships could be: development of risk-pooling mechanisms; information systems to 
track utilization patterns and to capture data about private sector patients; regulation and accreditation of 
private providers; adoption of national guidelines; coordination of care; and an effective referral system 
across the public and private sectors. 
Apart from a private health sector assessment, the government might consider piloting innovative 
initiatives to explore ways of partnering with the private sector, in a way that results in win-win solutions. 
For instance, the concept of corporate social responsibility could be promoted in terms of large companies 
giving back to the community through well-designed communication campaigns focusing on healthy 
lifestyles. Large firms that do not currently offer a good package of health benefits to their employees 
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may be persuaded to do so. This would be in their own interest, as a healthier workforce would be a more 
productive one. Expensive diagnostic equipment purchased by public sector hospitals could be permitted 
for use by private providers on a fee basis. Private practitioners could be allowed to use government 
hospitals for providing the services that are infeasible in their own clinic settings on a cost-recovery basis. 
Overall, a public–private partnership that benefits both the private and public sectors should ultimately be 
in the interest of addressing the NCD burden facing the population of Sri Lanka. 
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Appendixes 
Appendix 1: Technical Notes on Mortality Data in Sri Lanka 
Sri Lanka has had an effective death registration system for many decades. It counts almost all deaths, 
and systematically codes the cause of death. In addition, recent upgrading of the Registrar General 
Department‘s systems has led to the computerization of the annual mortality statistics, which makes it 
easier to undertake extensive analysis.  
Unfortunately, the Registrar General‘s data have not been systematically used in recent years to inform 
policy making. The major reasons are a substantial delay that has built up in the publication of the annual 
mortality returns, which were last published for 1997; and lack of access to more recent electronic data 
for domestic researchers. There are significant problems also with the quality of coding of the cause of 
death, particularly by non-medically qualified registrars, which leads to a significant fraction (at least 20 
percent) of all deaths being coded incorrectly to invalid or indeterminate causes.  
To overcome these limitations, the Institute for Health Policy obtained access to the raw electronic data of 
the Registrar General‘s Department to examine all deaths registered in 1990–2003. These data were 
processed to resolve the problem of invalid causes of death, by reassigning such deaths in a prorated 
manner to all other causes of death, except injuries. This was done after completing an analysis of the 
variations in invalid coding over time and by area. This approach does not fully address the problem of 
deficiencies in the quality of coding of cause of death, but to the extent that these problems cause errors in 
multiple directions, they will cancel out to some extent.  
This database was then combined with the 2001 census estimates of the age structure of the population to 
estimate standardized mortality rates for 1999–2003. Such rates were not computed for earlier years, as 
reliable data on the age structure are not available. For comparisons with other countries, the WHO 
Mortality Database was used, as were data from Maldives (Anuranga et al., 2009). 
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Appendix 2: NCD Mortality Rates and International Comparisons  
Sweden is the country in the Organisation for Economic Co-operation and Development (OECD) with the 
lowest overall mortality rates (UN ESCAP, 1976). Using Sweden as the base case and the vertical axis in 
each graph is the mortality rate in each country as a percentage of that in Sweden. The Russian Federation 
is included in the comparison, as it is the country best known for an excessive burden of NCD mortality 
(Suhrcke et al., 2007).  
The first point to note (Figure A2.1) is that overall mortality rates in Sri Lanka are modestly higher than 
in developed countries, and that the ratios of mortality from all diseases to those in Sweden are 100–
200 percent higher. This reflects the reality that Sri Lankan‘s mortality patterns are almost comparable to 
those in developed nations. However, when overall mortality rates are examined by sex (Figure A2.2), it 
is evident that the higher mortality rates in Sri Lanka compared to developed countries are largely in men, 
with female mortality rates being comparable to or even lower at some ages than in some OECD nations, 
including the United States.  
Looking more closely, cardiovascular mortality rates in Sri Lanka at all ages (Figure A2.1, top-right 
panel) are almost double those in developed countries. The burden of cardiovascular mortality in Sri 
Lanka is certainly not as high as that in the Russian Federation, where mortality rates are almost 10 times 
as high as in Sweden, but they are 200–300 percent of those in Sweden. This demonstrates that 
cardiovascular disease is the major driver of the higher overall rates of NCD and all-cause mortality in Sri 
Lanka. 
Relative diabetes mortality rates in Sri Lanka are comparatively high and increase with age, but are not as 
systematically higher as in the case of cardiovascular disease, with diabetes mortality rates being similar 
or less than those in some OECD countries, such as the United States and the Republic of Korea. 
Interestingly, diabetes is one NCD where the Russian Federation does not have such high relative rates. 
Mortality rates from injuries in Sri Lanka are also double those in Sweden, but again within the range of 
some OECD nations. 
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Figure A2.1 Age-specific mortality rates as a percentage of those of Sweden, Sri Lanka, and other selected economies (circa 2001) 
 
Source: Institute for Health Policy 2010. 
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Figure A2.2 Age-specific mortality for all causes as a percentage of those in Sweden, Sri Lanka, and other selected economies (circa 2001),  
Females 
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Source: Institute for Health Policy 2010. 
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Appendix 3: Using Mortality to Assess Differentials in NCD 
Burdens by Socioeconomic Status 
Almost no systematic population surveys collect information on disease prevalence in relation to 
socioeconomic status (SES) in Sri Lanka. The single exception is the Demographic and Health Survey 
(DHS), which contains data mostly for child and maternal health indicators. The 1993 and 2003 DHSs 
found generally pro-rich gradients in most indicators, except for family planning uptake (Rannan-Eliya 
and Somanathan, 2006; Saleem-Ismail et al., 2007; Rannan-Eliya and Sikurajapathy, 2008). However, the 
DHSs do not cover adult mortality or NCDs. To then examine this point, other data sources and methods 
are required. The following sections present a profile of inequalities in the NCD burden along income and 
geographic dimensions, exploiting primarily mortality data. 
Sri Lanka‘s mortality registration system achieves almost universal coverage, but the death registration 
system does not record information on the SES of the deceased, so it is not possible to directly infer SES 
inequalities in mortality from these data. To overcome this limitation, this study uses variations in 
mortality by small areas as a proxy for variations in mortality by SES. This method, which is adapted 
from that used in Australia (Moon and Waters, 2006), exploits the fact that death certificates in Sri Lanka 
record both the place of death as well as the place of usual residence of the deceased, and that this 
information is available in the national mortality database at the level of the Registrar General‘s Divisions 
(RGDs). This is the first time this method has been used in Sri Lanka, since the data on usual place of 
residence have until now not been publicly available.  
All registered deaths (numbering 553,192) during 1999–2003 were pooled in an analysis carried out by 
the Institute for Health Policy (IHP, 2010), and the place of death mapped from RGDs to the 
corresponding Divisional Secretariat Divisions (DSDs). The Registrar General‘s data actually code the 
place of usual residence at a lower level than RGDs, but these data are unreliable, so were not used. 
The cause of these deaths was coded using the International Classification of Diseases, 10th edition (ICD-
10), and this information plus data from the Population Census 2001 on the age–sex composition of the 
populations resident in each DSD in 2001 were used to estimate the age–sex standardized mortality rates 
for major disease categories for each DSD. In doing this, deaths that were coded with an invalid cause of 
death were redistributed on a pro-rata basis across the valid causes of death in their respective DSD and 
age and sex category. Such deaths account for 26 percent of all registered deaths. To relate mortality to 
SES, an index of average SES level was generated for each DSD applying principal component analysis 
to rank them using Census 2001 data on the DSD-level averages for household amenities and other 
characteristics. The DSDs were then grouped into quintiles of equal population.  
This index of relative DSD SES levels is preliminary, as the use of area averages is associated with some 
biases, which can only be overcome by use of individual household level data. Follow-up analysis is 
being undertaken to address this issue, by exploiting a 5 percent sample of the 2001 population census. 
For this report, we report the preliminary results of this analysis, which have been mapped to show the 
geographic variation in mortality rates, in a similar manner to analyses in the United States (Pickle et al., 
1996), European Union (Eurostat, 2009), and the United Kingdom (Gregory, 2009).
26
  
 
                                                     
 
26  An Assessment of the Burden, Issues and Policy Options in Curative Care Services Delivery and Non-communicable Diseases 
in Sri Lanka; Final Report, March 28, 2010. Ravi P. Rannan-Eliya, Chamara Anuranga, Lara Brearley, Ruwanthi 
Elwalagedara, APTL Abeykoon, Ahalya Balasundaram, and Shanti Dalpatadu. Institute for Health Policy, Colombo, Sri 
Lanka, http://www.ihp.lk. 
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Appendix 4: Poor Health and Chronic Disease in the Older Adult 
Population 
The Sri Lanka Aging Survey, carried out in 2006, collected information on self-reported health status and 
self-reporting of chronic disease in the older adult population (World Bank, 2008). Since most chronic 
disease is likely to be NCDs, this information provides another perspective on the relative burdens from 
NCDs. The levels of self-reported illness by socioeconomic quintiles are shown in Table A4.1. 
Table A4.1 Distribution of health status by socioeconomic quintiles, 2006 
 
The concentration index for age–sex standardized self-assessed poor health is -0.10, which indicates 
prevalence of the perception of having poor health is higher in poorer quintiles, but chronic disease was 
associated with a positive concentration index indicating greater prevalence in higher quintiles. These 
results are consistent with the findings reported on the patterns in mortality by socioeconomic status in 
Chapter 2. 
 
 Expenditure Quintile  
Age–sex 
standardized 
indicators 
1 2 3 4 5 Concentration index 
ADL index 0.8386 0.8369 0.8315 0.8357 0.8483 0.0018 
Poor health 0.3904 0.3307 0.3275 0.2846 0.2160 -0.1012 
Chronic disease 0.6157 0.6242 0.6078 0.7205 0.6972 0.0326 
Acute disease 0.4850 0.4924 0.5009 0.4554 0.4346 -0.0235 
Source: World Bank 2008. 
ADL = activities of daily living. 
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Appendix 5: The Organization Structure of the MOH and 
Provincial MOH  
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Appendix 6: Administrative Decentralization in Health 
The first allopathic hospitals were military and specialized hospitals established by foreign rulers initially 
in the 1600s. In 1801 the first Civil Medical Department (CMD) was created for control of small pox. By 
the Health Services Act of 1952 on ―Reorganization of the Health Department‖ a Director of Health 
Services (DHS) and three Deputy Directors of Health Services, to be in charge of medical services, public 
health services and laboratory services, were appointed. The public health services were further 
strengthened by the creation of the specialized campaigns for the control of infectious diseases, and 
services. The DHS was assisted in the periphery by 15 Superintendents of Health Services, who were in 
charge of 15 health regions.  
In 1982 the Director of Health Services became the Director-General of Health Services, and the Deputy 
Directors of Health Services as Deputy Directors-General of Health Services. The Superintendents of 
Health Services were redesignated as Regional Directors of Health Services and were in charge of 
districts. Their numbers were increased to 25. Within each district under the Regional Director of Health 
Services, health services were delivered by medical officers of health who were in charge of delivery of 
health in the designated health areas in each district.  
In 1987 with the devolution of administrative powers to the provinces, provincial ministries of health 
were created. In each provincial council, under each of the Provincial Health Secretaries in each of the 
Provincial Health Ministries, the Provincial Director of Health Services post was created and the total 
responsibility for delivery of health care to the respective province was vested in that post. The earlier 
designation of Regional Directors of Health Services was replaced with Deputy Provincial Directors of 
Health Services (DPDHS) and they were now responsible for the delivery of health services to the 
respective district in each of the provinces directly under the Provincial Director of Health Services.  
In 1992 decentralization was further extended and each of the Medical Officer of Health areas delivering 
mainly preventive health care were designated as Divisional Directors of Health Services (DDHS) and 
were directly under the respective DPDHS in each of the districts in the respective province.  
In addition to the Provincial Health Ministry through its administrative structure of Provincial Director of 
Health Services, DPDHS and DDHS /Medical Officer of Health unit manages the curative and preventive 
health delivery system, the local government system, and also delivers important aspects of health 
delivery related to sanitation, water supply and solid waste issues. The municipalities/urban 
councils/pradeshiya sabha are responsible for managing these aspects of health care in their respective 
areas in each of the provincial councils.  
Following the establishment of provincial councils in 1987, the institutions involved in delivering public 
health in Sri Lanka encompassed several tiers of government. Table A6.1 describes the roles and 
responsibilities of each of those tiers. 
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Table A6.1 Responsibilities in Public Health in Sri Lanka Vested by Decentralization in 1987 
Institution  Responsibility 
Central  
Ministry of Health  
Responsible for subjects and functions relating to health specified in list II (reserved list) 
and those specifically excluded from list 1 (Provincial Council list) and inferred to come 
within the scope of list II and some of the functions specified in Section 9 Health in list III 
(concurrent list) of the ninth schedule to the constitution formulated under article 154A of 
the 13th Amendment. 
 
Central Government List II—Reserved List  
 National policy on all subjects and functions 
 Teaching hospitals and hospitals established for specified purposes  
 Procurement of drugs 
(the last two of the above three categories implicitly fall under list II as these functions are 
specifically excluded from list 1) 
 
List III Concurrent List—Section 9 Health 
9.1 Schools for training of auxiliary medical personnel 
9.2 The supervision of private medical care, control of nursing homes and of diagnostic 
facilities within a province 
9.2 Population control and family planning 
9.3 Constitution of Provincial Medical Boards 
Provincial Councils Established under Article 154A promulgated by the 13th Amendment to the Constitution 
and administered by provisions in the Provincial Councils Act No.42 of 1987 and 
responsible for the subjects and functions relating to health specified in section 11 of list 1 
(Provincial Councils list) of the ninth schedule to the Constitution formulated under Article 
154A of the 13th Amendment. 
 
Provincial Councils (List I)—Section 11, Health 
11:1 The establishment and maintenance of public hospitals, rural hospitals, maternity 
homes, dispensaries (other than teaching hospitals, and hospitals established for special 
purposes) 
11:2 Public health services, health education, nutrition, family health, maternity and child 
care, food and food sanitation, environmental health 
11:3 Formulation and implementation of Health Development Plan and of the Annual 
Health Plan for the Province 
11:4 The provision of facilities for all institutions referred to in 1 above within the 
Province, excluding the procurement of drugs 
11:5 Awarding of scholarships for post graduate education within Sri Lanka to personnel 
attached to public health institutions  
Municipal Councils, 
Urban Councils, 
Pradeshiya Sabhas 
Municipal Councils established under the provisions in the Municipal Councils Ordinance 
Cap 576 of Volume XVIII (revised edition) of the Legislative Enactments and responsible 
for subjects and functions relating to health. 
 
Urban Councils established under the provisions in the Urban Councils Ordinance  
Cap 577 of Volume XVIII (revised edition) of the Legislative Enactments and responsible 
for subjects and functions relating to health. 
 
Pradeshiya Sabhas established under Act No.15 of 1987 and responsible for subjects and 
functions relating to health specified in Part IV—sections 78–128—Powers and Duties as to 
Public Health. 
 
Local authorities‘ powers and duties in public health cover drainages, latrines, conservancy 
and scavenging, unsanitary buildings, nuisances, public utility service, and water supply 
and markets. Ordinance relating to Markets and Sale of Articles also address issues of 
public health in an indirect manner. 
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Appendix 7: Drug Availability Across the Three Health Facility 
Levels for CVD, Diabetes, Asthma, and Cancer  
Table A7.1 Essential drugs available at public sector hospitals by category of hospital, Sri Lanka, 
2009 
Name of drug / group of drugs Primary 
level 
Secondary 
level 
Tertiary 
level 
CVD/HT-related drugs 
Digoxin + + + 
Isosorbide dinitrate, Glyceryl trinitrate + + + 
Diazepam + + + 
Thiazides + + + 
Propranalol + + + 
Aspirin + + + 
Frusemide, Spironolactone - + + 
Atropine - + + 
Methl Dopa, Nifedinie, Verapamil,  - + + 
Codeine Phosphate, Pethidine, Morphine - + + 
Amiodaraone, Procainamide Hydrochloride - - + 
Mexiletine - - + 
Atenolol, Carvedilol, Metoprolol, Bisaprolol - - + 
Hydralazine, Sodium Nitroprusside - - + 
Phenoxybenzamine Hydrochloride, Prazosin hydrochloride - - + 
Phentolamine mesylate - - + 
Captopril, Enalapril, Losartan Pottasium, Trimetaphan camsylate - - + 
Gemfibrozil, Atorvastatin - - + 
Amlodipine, Diltiazem - - + 
Dobutamine, Dopamine - - + 
Isoprenaline hydrochloride - - + 
Heparin, Warfarin, Enoxaparin and Protamine sulphate - - + 
Clopridogrel, Dypiridamole - - + 
Streptokinase  - - + 
DM-related drugs 
Glibenclamide, Tolbutamide + + + 
Insulin soluble—human and biphasic isophane insulin - + + 
Metformin - + + 
Asthma-related drugs 
Salbutamol + + + 
Theophylline + + + 
Adrenalin + + + 
Prednisolone + + + 
Aminophylline - + + 
Inhalers—Ipratropium bromide, Fluticasone propronate, salbutamol, 
Beclomethasone, salmeterol, Xinafoate 
- - + 
Ephidrine - - + 
Montelukast  - - + 
Volumetric spacer and baby mask - - + 
All cancer drugs - - + 
Source: Computed by World Bank from data provided by the Ministry of Health, Medical Supplies Division and 
Noncommunicable Diseases Unit, 2009.  
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Appendix 8: Results of the Behavior Risk Factor Surveillance Study 
conducted in Five Districts using the WHO STEPS Methodology 
Table A8.1 Prevalence of NCD risk factors, Sri Lanka STEPS survey 2007 
Risk factor  Both sexes Males Females 
Tobacco use     
Currently smoke tobacco daily (%) 11.5 22.8 0.3 
Smoke manufactured cigarettes (% of smokers) 85.8 85.7 94.4 
Mean number of cigarettes smoked a day (smokers) 9.2 9.1 13.7 
Alcohol consumption    
Current drinkers (drank alcohol in the past 30 days, %) 13.5 26 1.2 
Drank alcohol on 4 or more days in the last week (%) 16.7 17.4 1.5 
Fruit and vegetable consumption (in a typical week)    
Mean number of days fruit consumed 3.7 3.6 3.7 
Mean number of servings of fruits consumed a day 1.1 1.1 1.1 
Mean number of days vegetables consumed 6.7 6.6 6.7 
Mean number of servings of vegetables consumed a day 2.2 2.2 2.1 
Ate less than 5 of combined servings of fruit and vegetables/day 
(%) 82.4 81.4 83.3 
Physical activity    
Low levels of activity, defined as <600 MET-minutes/week (%) 25 17.9 31.9 
Physical measurements    
Percentage (%) who are obese (BMI ≥ 30 kg/m2) 4.8 3.6 5.9 
Source: NCD Unit, Ministry of Health. 
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Source: Laxminarayan, Chow and Shahid-Salles, 2006. 
ACE = angiotensin converting enzyme. 
Appendix 9: Population-based and Individual-based Interventions for NCDs 
Table A9.1 Selected population-based interventions 
 
Condition Intervention Intervention description Intervention 
setting 
Objective Target 
population 
Cost–effectiveness 
(US$/DALY) 
Coronary artery 
disease 
Legislation  Legislation replacing 2% of dietary trans fat from 
partial hydrogenation in manufactured foods with 
polyunsaturated fat, at a cost of US$ 0.50 per adult, 
and assuming a 7% reduction in coronary artery 
disease 
Policy level Instrument of 
policy 
Adults 48 
Coronary artery 
disease 
Legislation  Legislation replacing 2% of dietary trans fat from 
partial hydrogenation in manufactured foods with 
polyunsaturated fat, at a cost of US$ 6 per adult, and 
assuming a 7–40% reduction in coronary artery 
disease 
Policy level Instrument of 
policy 
Adults 838 
Diabetes, 
ischemic heart 
disease, and 
stroke 
Legislation  Legislated reduction in salt content of manufactured 
foods and an accompanying public education 
campaign 
Policy level Instrument of 
policy 
All ages 1,937 
Diabetes, 
ischemic heart 
disease, and 
stroke 
Media  Media campaign to reduce saturated fat content in 
manufactured foods and replace part of the saturated 
fat with polyunsaturated fat 
Policy level Instrument of 
policy 
All ages 2,617 
Tobacco 
addiction 
Taxation  A 33% price increase due to tobacco taxes to 
discourage tobacco use, prevent initiation (and 
subsequent addiction) among youths, increase the 
likelihood of cessation among current users, reduce 
relapse among former users and reduce consumption 
among continuing users 
Policy level Instrument of 
policy 
Adolescents 
and adults 
22 
Tobacco 
addiction 
Nonprice  Advertising bans on television, radio, and billboards; 
health information and advertising in the form of 
health warning labels on tobacco products; 
interventions to reduce tobacco supply, such as 
smuggling control; restrictions on smoking 
Policy level Instrument of 
policy 
Adolescents 
and adults 
353 
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Table A9.2 Selected individual-based interventions 
Condition Intervention Intervention description Intervention 
setting 
Objective Target 
population 
Cost-effectiveness 
(US$/DALY) 
Congestive 
heart failure 
ACE inhibitor and beta-
blocker, with diuretics 
Use of ACE inhibitor and an optional beta-blocker 
(metoprolol), incremental to diuretics 
District hospital Secondary 
prevention 
Adults 150 
Ischemic heart 
disease 
Aspirin, beta-blocker, and 
optional ACE inhibitor 
Aspirin plus beta-blocker (atenolol) with optional 
ACE inhibitor (enalapril), with or without hospital 
availability 
District or referral 
hospital 
Secondary 
prevention 
Adults 688 
Myocardial 
infarction 
Aspirin and beta-blocker Aspirin with or without beta-blocker (atenolol) District or referral 
hospital 
Acute 
management 
Adults 14 
Myocardial 
infarction 
Streptokinase, with aspirin 
and beta-blocker 
Incremental use of streptokinase, in addition to aspirin 
and beta-blocker (atenolol) 
District or referral 
hospital 
Acute 
management 
Adults 671 
Myocardial 
infarction 
Tissue plasminogen activator, 
with aspirin and beta-blocker 
Incremental use of tissue plasminogen activator in 
addition to aspirin and beta-blocker (atenolol) 
District hospital Acute 
management 
Adults 15,869 
Myocardial 
infarction and 
stroke 
Polypill Combination treatment with aspirin, beta-blocker, 
thiazide diuretic, ACE inhibitor and statin, based on 
10-year risk of cardiovascular disease 
District hospital Secondary 
prevention 
Adults 409 
Stroke 
(ischemic) 
Aspirin Aspirin dose within 48 hours of onset of acute stroke Clinic or district 
hospital 
Acute 
management 
Adults over 
15 
149 
Stroke 
(recurrent) 
Aspirin and dipyridamole Daily aspirin dose or combination of aspirin and 
extended release dipyridamole 
Clinic or district 
hospital 
Secondary 
prevention 
Adults over 
15 
81 
Stroke and 
ischemic and 
hypertensive 
heart disease 
Polypill by absolute risk 
approach 
Combination treatment with aspirin, beta-blocker, 
thiazide diuretic, ACE inhibitor, and statin based on 
10-year risk of cardiovascular disease 
District or referral 
hospital 
Primary 
prevention 
Adults 2,128 
Tobacco 
addiction 
Nicotine replacement therapy Smoking cessation treatments in the form of nicotine 
replacement therapy 
Clinic Primary 
prevention 
Adults 396 
Source: Laxminarayan, Chow and Shahid-Salles, 2006. 
ACE = angiotensin converting enzyme.
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Appendix 10: Policy Option and Actions 
Table A10.1 Policy Options and Actions for NCDs in Sri Lanka 
Policy Area Goal Options / Actions General Considerations 
Financing To mobilize adequate 
resources for prevention and 
treatment of current and 
future burden of NCDs, 
through 
 Resources for 
population-level 
initiatives  
 Resources for clinical 
service delivery 
 Resources for drugs 
 
 Consider risk-pooling 
options 
 Increase contributions 
from the richer 
quintiles 
 Improve efficiencies 
 Promote public–private 
partnerships 
 Make available public 
funds for public 
goods/positive externalities 
 Address impoverishing 
effects of out-of-pocket 
payments 
 Need to consider equity, 
pooling of private 
resources 
 Assure equity and potential 
for large impact in high 
risk populations (poor) 
 Ensure that additional 
resources are not at the 
expense of infectious 
diseases and MCH 
Social determinates To address causative and risk 
enhancing social factors for 
NCDs 
 Coordinate and 
facilitate intersectoral 
actions to lower social 
determinates working 
with Education, Social 
Services, Agriculture, 
Environment, Labor, 
Commerce, Law and 
Justice, Urban 
Development, Home 
Affairs, Finance, and 
Planning 
 Each ministry will have a 
niche where opportunities 
exist 
 Vulnerable populations 
including the poor, 
disabled, and the elderly 
need consideration 
 Efforts should align with 
and inclusive growth 
development agenda  
 
Focus on Specific NCDs To target initial efforts on 
high-burden NCDs with 
effective interventions 
 Establish an intensified 
national NCD program, 
focusing first on 
selected NCDs 
 Address undernutrtion 
and overnutrition as 
risk factors for NCDs 
 Build on current efforts 
and refining focus; expand 
later to other conditions 
 Reinforce efforts to 
address maternal and 
infant/child undernutrition 
services  
 Simultaneously need to 
balance undernutrition and 
overnutrition efforts 
Organizational Structure To ensure that structure is 
optimal for effective 
response to NCDs 
 Set up an intensified 
national NCD program 
with high enough 
authority, but not a 
vertical program 
 Integrate curative and 
preventive care—or at 
least find mechanisms 
for better coordination; 
prioritize 
comprehensive 
prevention—not just 
primary prevention 
 Bring better quality 
services closer to the 
 Facilitate coordination 
across several tasks and 
assure implementation 
 Secure greater use of 
specialist clinics, 
outpatient departments, 
and medical officers of 
health 
 Focus on major tasks for 
central and provincial roles  
 Assure effective 
implementation in clinics 
 Increase use of lower-level 
capacity more  
 Introduce better triaging 
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Policy Area Goal Options / Actions General Considerations 
clients 
 Push through with 
fuller decentralization 
and more effective 
referral system 
system for inpatient care 
 
Human Resources To assure adequate 
workforce with the 
experience and skill to tackle 
NCDs 
 Carry out a human 
resource needs 
assessment 
 Improve education 
curricula 
 Launch in-service 
training 
 Apply national clinical 
guidelines across the 
country 
 Address both workforce 
size and skill level 
 Institutionalize existing 
guidelines  
Information systems and 
surveillance 
To assure availability of 
critical information for 
planning, implementing, 
monitoring and evaluating  
Areas covered: 
 Behavioral risk factors 
 Inpatient and outpatient 
morbidity 
 Mortality 
 National Surveillance 
System 
 Build on past efforts and 
develop and national 
ongoing survey 
 Expand data to individual 
level morbidity and patient 
characteristics 
 Improve timeliness 
 Collate, analyze, and report 
national NCD profile 
Public–Private Partnerships To develop mechanisms to 
leverage the private sector to 
contribute to public health 
goals. 
Areas covered: 
 Risk pooling 
 Financing 
 Service delivery 
 Regulation, 
accreditation, and use 
of national guidelines 
 Morbidity information 
 Referral system  
 Review current and future 
role of private sector in 
delivery services 
 Look at private sector role 
in financing, especially for 
the richer 
 Assure quality of private 
sector care 
 Track total morbidity and 
substantial proportion uses 
private sector 
 Improve outcomes, patient 
satisfaction, and service 
delivery efficiency  
 Source: Authors. 
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